???global.info.a_carregar???
RUI MEDEIROS . (Medeiros R, http://orcid.org/0000-0003-3010-8373, https://www.authenticus.pt/R-000-FXC). Rui Medeiros(RM) ¿ RM received his PhD in 2002 from the Medical Faculty of University of Porto (Prostate Cancer) and in 2006 his Aggregation Professor Degree at the ICBAS-Biomedical School of University of Porto. RM leads the Molecular Oncology and Viral Pathology Group at the Research Center of IPO Porto (CI-IPOP), is member of the Board of LPCCNRNorte-Portuguese League Cancer Against Cancer (https://www.ligacontracancro.pt/), President of ECL- European Cancer Leagues (https://www.europeancancerleagues.org/) and Co-Chair of the Action Network of the European Cancer Organization. RM published 500 papers in international peer-review journals and is solicited as reviewer for several International Grants and Journals. RM research focus on the molecular mechanisms that may influence cancer behavior and the response to therapy. His pioneer work on Liquid Biopsy and Pharmacogenomics/ Precision Medicine on Prostate Cancer has led to the mind-breaking concepts for new important biomarkers and provided new knowledge for the development of Precision Medicine in Cancer. RM has led or integrate the team of several competitive national (FCT) as well international research projects and is leading a Action Network of the European Cancer Organization (https://www.europeancancer.org/). He was also a pioneer in the introduction since 2006 of a Pharmacogenomics and Molecular Epidemiology Course Unit in the PhD/MSc Programmes of Medicine and Molecular Oncology, Oncology and Pathology and Molecular Genetics. As PI of research projects, RM was able to raise competive FCT, and International funding and Awards in the field of Urology mainly Prostate Cancer Research publishing 77 papers in the field. Awarded with several prestigious national and International Awards and Honours namely in the field of Prostate Cancer: Astellas/Yamanouchi European Foundation Award (2005); National Health Sciences Award University of Coimbra/BluePharma (2005); National Award- Portuguese Society of Human Genetics (1999). RM has been PI or Lab supervisor of several research urology linked projects funded by FCT (PTDC/SAU-FCF/71552/2006, PTDC/MED-QUI/29800/2017) Ministry of Health, European Yamanouchi Foundation, AstraZeneca Foundation and Novartis. -Invited by 2011 A3ES-Agency for Assessment and Accreditation of Higher Education; CIMAGO- Center of Investigation in Environment, Genetics and Oncobiology; National Science Advisory Board LPCC- Portugal League Against Cancer; 2010 National Consensus Committee for HPV Vaccination Program; 2009 A3ES-Agency for Assessment and Accreditation of Higher Education of Portugal; CIMAGO- Center of Investig. Environ/ Oncobiology 2008 National Consensus Committee for HPV Vaccination Program 2006-2007; PhD Scientific Council, Faculty of Medicine, Lisbon; 2006- PhD/MSC Scientific Council, Life Sciences School, Minho University; 2004 ¿FCT-National Science and Technology Foundation of Portugal¿. Member of the Juri of the INFARMED Scientific Research Found. Member of the Juri of the Journalism Award in Oncology (Premio Jornalismo LPCC 2015,2016,2017,2018) and of the Committee of the National Science Award on Oncology (Premio Sobrinho Simoes LPCC 2017). RM has more than 10 years experience as Supervisor of PhD Projects and PhD Students (30 successful PhD Thesis concluded). http://publicationslist.org/rui.medeiros)
Identificação

Identificação pessoal

Nome completo
RUI Manuel de MEDEIROS Melo Silva MEDEIROS

Nomes de citação

  • MEDEIROS, RUI

Identificadores de autor

Ciência ID
C51F-5DBE-9C51
ORCID iD
0000-0003-3010-8373
AuthenticusID
R-000-FXC
Google Scholar ID
https://scholar.google.pt/citations?hl=pt-PT&user=m2tZ6eYAAAAJ
Researcher Id
C-7938-2009
Scopus Author Id
7006241641

Websites

  • (http://publicationslist.org/rui.medeiros) (Académico)

Domínios de atuação

  • Ciências Médicas e da Saúde

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador independente (B2) Utilizador independente (B2) Utilizador proficiente (C2) Utilizador proficiente (C1)
Formação
Grau Classificação
2006
Concluído
Fisiopatologia (Título de Agregado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Aprovado por Unanimidade
2002
Concluído
Biologia Humana (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
"Polimorfismos Genéticos, Susceptibilidade para Cancro da Próstata e Risco de Metastização" (TESE/DISSERTAÇÃO)
Muito Bom por Unanimidade
2002
Concluído
Biologia Humana (Doutoramento)
Especialização em Sem especialidade
Universidade do Porto Faculdade de Medicina, Portugal
"Polimorfismos Genéticos, Susceptibilidade para Cancro da Próstata e Risco de Metastização" (TESE/DISSERTAÇÃO)
1995
Concluído
Mestrado de Oncobiologia (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
"Papilomavírus e Cancro do Colo do Útero: Estudo da Prevalência de Diferentes Tipos de Papilomavírus Humano, da Proliferação Celular e da Expressão da Proteína p53, em Lesões Pavimentosas Cervicais" (TESE/DISSERTAÇÃO)
Muito Bom
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento
Empregador
2022/04/24 - Atual Gestão de Ciência e Tecnologia Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2006/01/01 - Atual Gestão de Ciência e Tecnologia Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2004/01/01 - Atual Investigador (Investigação) Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento
Empregador
2023/01/01 - Atual ECO BOARD MEMBER ECO, European Cancer Organization, Bélgica
ECO, European Cancer Organization, Bélgica
2020/01/01 - 2022/12/31 Presidente ECL, Association of European Cancer Leagues, Bélgica
ECL, Association of European Cancer Leagues, Bélgica
Projetos

Bolsa

Designação Financiadores
2017/09/01 - Atual Modelo biológico in vitro preditivo de resposta à radioterapia no cancro da próstata de alto risco
4209970317 CI-IPOP 69/2017
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Em curso

Projeto

Designação Financiadores
2022/06/01 - 2027/05/30 PAINLESS - “Pain relief in palliative care of cancer using home-based neuromodulation and predictive biomarkers”
Grant Agreement N°101057367; HLTH-2021-DISEASE-04-01
Investigador responsável
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Horizon 2020
Em curso
2021/01/01 - 2025/12/31 Rede de Investigação em Saúde: do Laboratório à Saúde Comunitária
LA/P/0053/2020
Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Universidade do Algarve, Portugal

Universidade do Porto Faculdade de Ciências, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade da Madeira, Portugal

Universidade de Lisboa Centro Cardiovascular da Universidade de Lisboa, Portugal

Universidade de Aveiro, Portugal

Centro de Investigação em Tecnologias e Serviços de Saúde, Portugal

Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal

Escola Superior de Enfermagem do Porto, Portugal

Universidade do Porto Faculdade de Medicina, Portugal

Universidade NOVA de Lisboa, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2021/01/01 - 2025/12/31 Health Research Network: From Lab to Community Health
Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Universidade do Algarve, Portugal

Universidade do Porto Faculdade de Ciências, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade da Madeira, Portugal

Universidade de Lisboa Centro Cardiovascular da Universidade de Lisboa, Portugal

Universidade de Aveiro, Portugal

Centro de Investigação em Tecnologias e Serviços de Saúde, Portugal

Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal

Escola Superior de Enfermagem do Porto, Portugal

Universidade do Porto Faculdade de Medicina, Portugal

Universidade NOVA de Lisboa, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2018/08/01 - 2022/01/31 Nanotecnologia sensibilizadora da terapia em tumores urológicos
PTDC/MED-QUI/29800/2017
Universidade do Porto, Portugal

Rede de Química e Tecnologia Laboratório Associado para a Química Verde, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2018/08/01 - 2021/07/31 Sensitization of urologic tumors therapy driven by nanotechnology
PTDC/MED-ONC/7325/2020
Investigador responsável
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2018/07/01 - 2020/06/30 NOVEL siRNA THERAPIES AGAINST METASTATIC COLORECTAL CANCER
NORTE-01-0247-FEDER-033399
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Agência Nacional de Inovação SA
Concluído
2019/01/01 - 2019/12/31 Centro de Investigação do Instituto Português de Oncologia do Porto
UID/DTP/00776/2019
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2019/01/01 - 2019/12/31 UFP Energy, Environment and Health Research Unit
UID/Multi/04546/2019
Fundação Ensino e Cultura Fernando Pessoa, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2011/01/01 - 2013/12/31 Projecto Estratégico - UI 776 - 2011-2012
PEst-OE/SAU/UI0776/2011
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2007/07/01 - 2010/12/31 Bone Turnover Associated-Pharmacogenomic Profile of Patients with Metastatic and Non-Metastatic Prostate Cancer: Predictive Factors for the Benefits of Bisphosphonate Treatment?
PTDC/SAU-FCF/71552/2006
Investigador responsável
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
1997/07/01 - 2000/07/31 Prostate Adenocarcinoma and Biomolecular Markers
PRAXIS/PSAU/C/SAU/0015
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
Produções

Publicações

Artigo em conferência
  1. Renato Caldevilla; Stephanie Morais; Serafim Carvalho; Rui Medeiros; Cristina Delerue-Matos; Agostinho Cruz; Marlene Santos; Maria Fátima Barroso. "Design of an Electrochemical Genosensor for BDNF Gene Polymorphism Sequence Detection Using an Enzymatically Labeled DNA Probe". 2023.
    10.3390/CSAC2023-14913
  2. Sousa, Hugo; Sousa, Ana Saraiva; Silva, Jani; Medeiros, Rui; Alves, André; Nogueira, Augusto; Alves, Maria José; Rodrigues, Andreia; Sá, Sílvia. "High prevalence of high-risk HPV infection in University students from the Northeast region of Portugal using self-sampling". 2019.
  3. Silva, RM; Sousa, E; Fonseca, P; Pinheiro, AR; Silva, C; Correia, MV; Mouta, S. "Analysis and quantification of upper-limb movement in motor rehabilitation after stroke". 2017.
    10.1007/978-3-319-46669-9_37
  4. Lima, Luís; Ferreira, José A.; Medeiros, Rui; Santos, Lúcio. "A step towards personalized medicine: establishment of a pharmacogenomics profile of response to BCG intravesical immunotherapy in bladder cancer". 2015.
  5. Santos, Marlene; Carvalho, Serafim; Lima, Luís; Mota-Pereira, Jorge; Pimentel, Paulo; Maia, Dulce; Correia, Diana; et al. "Role of pharmacogenomics in predicting antidepressant response and individualizing therapy". 2015.
  6. Santos, Marlene; Carvalho, Serafim; Lima, Luís; Nogueira, Augusto; Assis, Joana; Mota-Pereira, Jorge; Pimentel, Paulo; et al. "Influence of common ABCB1 genetic polymorphisms in the risk of Major Depressive Desorder and ntidepressant treatment phenotypes". 2013.
  7. Bicho, MC; Silva, AP; Medeiros, R; Matos, A; Fontes, G; Bicho, M. "Haptoglobin genetic polymorphism interaction with risk factors for cervix cancer and its precursor lesions". 2006.
Artigo em revista
  1. Tavares, Inês; Morais, Mariana; Dias, Francisca; Medeiros, Rui; Teixeira, Ana Luísa. "Deregulated miRNAs in enzalutamide resistant prostate cancer: A comprehensive review of key molecular alterations and clinical outcomes". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1879 2 (2024): 189067. http://dx.doi.org/10.1016/j.bbcan.2023.189067.
    Publicado • 10.1016/j.bbcan.2023.189067
  2. Tavares, Valéria; Marques, Inês Soares; Melo, Inês Guerra de; Assis, Joana; Pereira, Deolinda; Medeiros, Rui. "Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements". International Journal of Molecular Sciences 25 3 (2024): 1845. http://dx.doi.org/10.3390/ijms25031845.
    10.3390/ijms25031845
  3. Tavares, Valéria; Neto, Beatriz Vieira; Marques, Inês Soares; Assis, Joana; Pereira, Deolinda; Medeiros, Rui. "Cancer-associated thrombosis: What about microRNAs targeting the tissue factor coagulation pathway?". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1879 1 (2024): 189053. http://dx.doi.org/10.1016/j.bbcan.2023.189053.
    10.1016/j.bbcan.2023.189053
  4. Inês Soares Marques; Valéria Tavares; Joana Savva-Bordalo; Mariana Rei; Joana Liz-Pimenta; Inês Guerra de Melo; Joana Assis; Deolinda Pereira; Rui Medeiros. "Long Non-Coding RNAs: Bridging Cancer-Associated Thrombosis and Clinical Outcome of Ovarian Cancer Patients". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms25010140.
    10.3390/ijms25010140
  5. Martin-Moreno, Jose M; Yared, Wendy; Medeiros, on behalf of the ECToH 2023 Scienti, Rui. "The Madrid 2023 Declaration ‘For a Tobacco-Free Generation". Tobacco Prevention & Cessation 9 December (2023): 1-3. http://dx.doi.org/10.18332/tpc/173031.
    10.18332/tpc/173031
  6. Mariana Morais; Vera Machado; Patrícia Figueiredo; Francisca Dias; Rogéria Craveiro; Joana Lencart; Carlos Palmeira; et al. "Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma". Antioxidants (2023): https://doi.org/10.3390/antiox12122051.
    10.3390/antiox12122051
  7. Hugo-Henrique Silva; Valéria Tavares; Beatriz Neto; Fátima Cerqueira; Rui Medeiros; Maria-Raquel Silva. "FAAH rs324420 Polymorphism: Biological Pathways, Impact on Elite Athletic Performance and Insights for Sport Medicine". Genes (2023): https://doi.org/10.3390/genes14101946.
    10.3390/genes14101946
  8. Joana M. O. Santos; Valéria Tavares; Rui M. Gil da Costa; Rui Medeiros. "MiR-150 and miR-155 expression predicts survival of cervical cancer patients: a translational approach to novel prognostic biomarkers". Biomarkers (2023): https://doi.org/10.1080/1354750X.2023.2269320.
    10.1080/1354750X.2023.2269320
  9. Ângela Inácio; Laura Aguiar; Beatriz Rodrigues; Patrícia Pires; Joana Ferreira; Andreia Matos; Inês Mendonça; et al. "Genetic Modulation of HPV Infection and Cervical Lesions: Role of Oxidative Stress-Related Genes". Antioxidants (2023): https://doi.org/10.3390/antiox12101806.
    10.3390/antiox12101806
  10. Leandro Lima da Silva; Amanda Mara Teles; Joana M. O. Santos; Marcelo Souza de Andrade; Rui Medeiros; Ana I. Faustino-Rocha; Paula A. Oliveira; et al. "Malignancy Associated with Low-Risk HPV6 and HPV11: A Systematic Review and Implications for Cancer Prevention". Cancers (2023): https://doi.org/10.3390/cancers15164068.
    10.3390/cancers15164068
  11. Beatriz Almeida; Tânia R. Dias; Ana Luísa Teixeira; Francisca Dias; Rui Medeiros. "MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients?". Cancers (2023): https://doi.org/10.3390/cancers15164017.
    10.3390/cancers15164017
  12. Valéria Tavares; Joana Assis; Ricardo Pinto; Margarida Freitas-Silva; Rui Medeiros. "Venous thromboembolism-related genetic determinant F11 rs4253417 is a potential prognostic factor in ischaemic stroke". Molecular and Cellular Probes (2023): https://doi.org/10.1016/j.mcp.2023.101917.
    10.1016/j.mcp.2023.101917
  13. Inês Soares Marques; Valéria Tavares; Beatriz Vieira Neto; Inês N. R. Mota; Deolinda Pereira; Rui Medeiros. "Long Non-Coding RNAs in Venous Thromboembolism: Where Do We Stand?". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms241512103.
    10.3390/ijms241512103
  14. Pinho R; Ribeiro R; Ferrão D; Medeiros R; Lima MJ; Almeida J; Freitas-Silva M. "The platelet-to-lymphocyte ratio as an indirect outcome predictor in primary hypertension: a retrospective study.". Porto biomedical journal (2023): http://europepmc.org/abstract/med/37547703.
    10.1097/j.pbj.0000000000000220
  15. Cardoso JV; Machado DE; da Silva MC; de Mello MP; Berardo PT; Medeiros R; Perini JA. "Influence of interleukin-8 polymorphism on endometriosis-related pelvic pain.". Human immunology (2023): http://europepmc.org/abstract/med/37468423.
    10.1016/j.humimm.2023.07.004
  16. Hess T; Maj C; Gehlen J; Borisov O; Haas SL; Gockel I; Vieth M; et al. "Corrigendum to "Dissecting the genetic heterogeneity of gastric cancer".". EBioMedicine (2023): http://europepmc.org/abstract/med/37480624.
    10.1016/j.ebiom.2023.104709
  17. Joana Liz-Pimenta; Valéria Tavares; Beatriz Vieira Neto; Joana M.O. Santos; Catarina Brandão Guedes; António Araújo; Alok A. Khorana; Rui Medeiros. "Thrombosis and cachexia in cancer: Two partners in crime?". Critical Reviews in Oncology/Hematology (2023): https://doi.org/10.1016/j.critrevonc.2023.103989.
    10.1016/j.critrevonc.2023.103989
  18. Neto BV; Tavares V; da Silva JB; Liz-Pimenta J; Marques IS; Carvalho L; Salgado L; Pereira D; Medeiros R. "Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.". Scientific reports (2023): http://europepmc.org/abstract/med/37308506.
    10.1038/s41598-023-36161-w
  19. Tiago Ferreira; Adelina Gama; Fernanda Seixas; Ana I. Faustino-Rocha; Carlos Lopes; Vítor M. Gaspar; João F. Mano; Rui Medeiros; Paula A. Oliveira. "Mammary Glands of Women, Female Dogs and Female Rats: Similarities and Differences to Be Considered in Breast Cancer Research". Veterinary Sciences (2023): https://doi.org/10.3390/vetsci10060379.
    10.3390/vetsci10060379
  20. Hugo-Henrique Silva; Valéria Tavares; Maria-Raquel G. Silva; Beatriz Vieira Neto; Fátima Cerqueira; Rui Medeiros. "Association of FAAH rs324420 (C385A) Polymorphism with High-Level Performance in Volleyball Players". Genes (2023): https://doi.org/10.3390/genes14061164.
    10.3390/genes14061164
  21. Jani Silva; Valéria Tavares; Ana Afonso; Juliana Garcia; Fátima Cerqueira; Rui Medeiros. "Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms24109101.
    10.3390/ijms24109101
  22. Cristina Almeida; Ana Luísa Teixeira; Francisca Dias; Mariana Morais; Rui Medeiros. "Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management". Biology (2023): https://doi.org/10.3390/biology12050665.
    10.3390/biology12050665
  23. Yu, Manyou; Gouvinhas, Irene; Pires, Maria J.; Neuparth, Maria J.; Costa, Rui M. Gil da; Medeiros, Rui; Bastos, Margarida M.S.M.; et al. "Study on the antineoplastic and toxicological effects of pomegranate (Punica granatum L.) leaf infusion using the K14-HPV16 transgenic mouse model". (2023): http://hdl.handle.net/10400.19/8022.
    10.1016/j.fct.2023.113689
  24. Susana S. Almeida; Magda Oliveira; Rui Medeiros; Marina Prista Guerra; Carmine M. Pariante; Lia Fernandes. "Emotional, inflammatory, and genetic factors of resilience and vulnerability to depression in patients with premenopausal breast cancer: a longitudinal study protocol". (2023): https://hdl.handle.net/10216/148275.
    10.1371/journal.pone.0279344
  25. Silva, Hugo Henrique; Tavares, Valéria; Silva, Maria Raquel G.; Neto, Beatriz Vieira; Cerqueira, Fátima; Medeiros, Rui. "Association of FAAH rs324420 (C385A) Polymorphism with High-Level Performance in Volleyball Players". (2023): http://hdl.handle.net/10362/155489.
    https://doi.org/10.3390/genes14061164
  26. Caldevilla, Renato; Morais, Stephanie; Carvalho, Serafim; Medeiros, Rui; Delerue-Matos, Cristina; Cruz, Agostinho; Santos, Marlene; Barroso, M. Fátima. "Design of an electrochemical genosensor for the BDNF gene polymorphism sequence detection using an enzymatic labelled DNA probe". (2023): http://hdl.handle.net/10400.22/23787.
    10.26537/prpaeh.v1i1.5174
  27. Rosário, Andreia; Sousa, Ana Saraiva; Marinho-Dias, Joana; Medeiros, Rui; Lobo, Cláudia; Leça, Luís; Coimbra, Nuno; et al. "Impact of high-risk human papilloma virus genotyping in cervical disease in the Northern region of Portugal: real-world data from regional cervical cancer screening program". (2023): http://hdl.handle.net/10198/26394.
    10.1002/jmv.28414
  28. Santos, Marlene; Lima, Luis; Carvalho, Serafim; Mota-Pereira, Jorge; Pimentel, Paulo; Maia, Dulce; Correia, Diana; et al. "The impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 genetic polymorphisms in antidepressant treatment response phenotypes". (2023): http://hdl.handle.net/10400.22/22727.
    10.3390/ijms24076758
  29. Varandas, Tatiana; Dias, Francisca; Sousa, Ana; Sousa, Maria; Medeiros, Rui. "Characterization of genetic polymorphisms CYP2R1 rs2060793 and CYP2R1 rs12794714: potential biomarkers in endometriosis predisposition [artigo]". (2023): http://hdl.handle.net/10400.22/23663.
    10.26537/prpaeh.v1i1.5287
  30. Rosário, Andreia; Sousa, Ana Isabel; Varandas, Tatiana; Marinho-Dias, Joana; Medeiros, Rui; Martins, Gabriela; Monteiro, Paula; Sousa, Hugo. "Impact of cervicovaginal microbiome on the risk of cervical abnormalities development". (2023): http://hdl.handle.net/10198/6538.
    10.1002/jmv.28762
  31. Horta, Bruno; Freitas-Silva, Joana; Silva, Jani; Dias, Francisca; Teixeira, Ana Luísa; Medeiros, Rui; Cidade, Honorina; Pinto, Madalena; Cerqueira, Fátima. "Antitumor effect of chalcone derivatives against human prostate (LNCaP and PC-3), cervix HPV-Positive (HeLa) and lymphocyte (Jurkat) cell lines and their effect on macrophage functions". (2023): http://hdl.handle.net/10400.14/40722.
    10.3390/molecules28052159
  32. Medeiros, Catarina; Silva, Ana Rita; T. Ferreira; Barros, Lillian; Neuparth, Maria João; F. Peixoto; Bastos, M. M. S. M.; et al. "Cytinus hypocistis (L.) L. extract effects in an animal model of papillomavirus-induced neoplasia". VETERINARSKA STANICA (2023):
    Aceite para publicação
  33. Tiago Azevedo; Tiago Ferreira; João Ferreira; Filipa Teixeira; Diana Ferreira; Rita Silva-Reis; Neuparth, MJ; et al. "Supplementation of an Anthocyanin-Rich Elderberry (Sambucus nigra L.) Extract in FVB/n Mice: A Healthier Alternative to Synthetic Colorants". Applied Sciences (2022): https://www.mdpi.com/2076-3417/12/23/11928.
    10.3390/app122311928
  34. Vera Machado; Mariana Morais; Rui Medeiros. "Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?". Pharmaceutics (2022): https://doi.org/10.3390/pharmaceutics14102092.
    10.3390/pharmaceutics14102092
  35. Morais M; Machado V; Dias F; Figueiredo P; Palmeira C; Martins G; Fernandes R; et al. "Glucose-Functionalized Silver Nanoparticles as a Potential New Therapy Agent Targeting Hormone-Resistant Prostate Cancer cells.". International journal of nanomedicine (2022): http://europepmc.org/abstract/med/36147546.
    10.2147/ijn.s364862
  36. Tavares V; Neto BV; Vilas-Boas MI; Pereira D; Medeiros R. "Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: A review of existing evidence.". Biochimica et biophysica acta. Reviews on cancer (2022): http://europepmc.org/abstract/med/35963552.
    10.1016/j.bbcan.2022.188778
  37. Bruno Horta; Tomé Pereira; Rui Medeiros; Fátima Cerqueira. "Cervical Cancer Outcome and Tumor-Associated Macrophages: Research Evidence". Immuno (2022): https://doi.org/10.3390/immuno2030028.
    10.3390/immuno2030028
  38. Tânia R. Dias; Francisca Dias; Ana Luísa Teixeira; Hugo Sousa; Júlio Oliveira; Rui Medeiros. "MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response". Cells (2022): https://doi.org/10.3390/cells11152279.
    10.3390/cells11152279
  39. Hugo-Henrique Silva; Valéria Tavares; Maria-Raquel G. Silva; Beatriz Vieira Neto; Fátima Cerqueira; Rui Medeiros. "FAAH rs324420 Polymorphism Is Associated with Performance in Elite Rink-Hockey Players". Biology (2022): https://doi.org/10.3390/biology11071076.
    10.3390/biology11071076
  40. Mara Fernandes; Herlander Marques; Ana Luísa Teixeira; Rui Medeiros. "Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study". Biomedicines 10 6 (2022): 1322-1322. https://doi.org/10.3390/biomedicines10061322.
    10.3390/biomedicines10061322
  41. Dias TR; Santos JMO; Estêvão D; Costa NR; Mestre VF; Medeiros-Fonseca B; Bastos MMSM; et al. "Expression of LncRNAs in HPV-induced Carcinogenesis and Cancer Cachexia: A Study in K14-HPV16 Mice.". Anticancer research (2022): http://europepmc.org/abstract/med/35489755.
    10.21873/anticanres.15723
  42. Alexandra C. Costa; Joana M. O. Santos; Beatriz Medeiros-Fonseca; Paula A. Oliveira; Margarida M. S. M. Bastos; Haissa O. Brito; Rui M. Gil da Costa; Rui Medeiros. "Characterizing the Inflammatory Microenvironment in K14-HPV16 Transgenic Mice: Mast Cell Infiltration and MicroRNA Expression". Cancers 14 9 (2022): 2216-2216. https://doi.org/10.3390/cancers14092216.
    10.3390/cancers14092216
  43. Santos, Joana M.O.; Peixoto da Silva, Sara; Bastos, Margarida M. S. M.; Oliveira, Paula A.; Gil da Costa, R. M. ; MEDEIROS, RUI. Autor correspondente: MEDEIROS, RUI. "Decoding the role of inflammation-related microRNAs in cancer cachexia: a study using HPV16-transgenic mice and in silico approaches". Journal of Physiology and Biochemistry (2022): http://dx.doi.org/10.1007/s13105-021-00866-1.
    10.1007/s13105-021-00866-1
  44. Santos JMO; Peixoto da Silva S; Bastos MMSM; Oliveira PA; Gil da Costa RM; Medeiros R. "Decoding the role of inflammation-related microRNAs in cancer cachexia: a study using HPV16-transgenic mice and in silico approaches.". Journal of physiology and biochemistry (2022): http://europepmc.org/abstract/med/35298788.
    10.1007/s13105-021-00866-1
  45. Lima Á; Sousa H; Medeiros R; Nobre A; Machado M. "PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis.". Discover. Oncology (2022): http://europepmc.org/abstract/med/35318527.
    10.1007/s12672-022-00479-0
  46. Leitão M; Lopes S; Pereira D; Medeiros R; Vieira C. "Genetic Polymorphisms as Predictors of Survival in Breast Cancer: Future Lessons in Historical Data.". Cureus (2022): http://europepmc.org/abstract/med/35198317.
    10.7759/cureus.21410
  47. Cristina Almeida; Ana L Teixeira; Francisca Dias; Vera Machado; Mariana Gomes Morais; Gabriela Martins; Carlos Palmeira; et al. "Extracellular Vesicles Derived-LAT1 mRNA as a Powerful Inducer of Colorectal Cancer Aggressive Phenotype". Biology (2022): https://www.mdpi.com/2079-7737/11/1/145.
    10.3390/biology11010145
  48. Cochicho, Daniela; Nunes, Alexandra; Gomes, João Paulo; Martins, Luís; Cunha, Mário; Medeiros-Fonseca, Beatriz; Oliveira, Paula; et al. "Characterization of the Human Papillomavirus 16 Oncogenes in K14HPV16 Mice: Sublineage A1 Drives Multi-Organ Carcinogenesis". (2022): http://hdl.handle.net/10400.18/8481.
    10.3390/ijms232012371
  49. Silva, Hugo Henrique; Tavares, Valéria; Silva, Maria Raquel G.; Neto, Beatriz Vieira; Cerqueira, Fátima; Medeiros, Rui. "FAAH rs324420 Polymorphism Is Associated with Performance in Elite Rink-Hockey Players". (2022): http://hdl.handle.net/10362/143583.
    https://doi.org/10.3390/biology11071076
  50. Carla M. Ribeiro Silva; Ana I. Faustino Rocha; Rui M. Gil da Costa; Rui Medeiros; Maria J. Pires; Isabel Gaivão; Adelina Gama; et al. "Pulegone and Eugenol Oral Supplementation in Laboratory Animals: Results from Acute and Chronic Studies". (2022): https://hdl.handle.net/10216/152959.
    10.3390/biomedicines10102595
  51. Mara Fernandes; Herlander Marques; Ana Luísa Teixeira; Rui Medeiros. "ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort". International Journal of Molecular Sciences 23 1 (2021): 201-201. https://doi.org/10.3390/ijms23010201.
    10.3390/ijms23010201
  52. Mara Fernandes; Herlander Marques; Ana Luísa Teixeira; Rui Medeiros. "Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives". Biomedicines (2021): https://doi.org/10.3390/biomedicines9121934.
    10.3390/biomedicines9121934
  53. Mara Fernandes; Herlander Marques; Ana Luísa Teixeira; Rui Medeiros. "miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine". Cancers (2021): https://doi.org/10.3390/cancers13246324.
    10.3390/cancers13246324
  54. Brito HO; Calixto JRR; Medeiros R; da Costa RMG. "Comment on DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells.". Translational oncology (2021): http://europepmc.org/abstract/med/34974279.
    10.1016/j.tranon.2021.101326
  55. Alexandra C. Costa; Joana M.O. Santos; Rui M. Gil da Costa; Rui Medeiros. "Impact of immune cells on the hallmarks of cancer: A literature review". Critical Reviews in Oncology/Hematology (2021): https://doi.org/10.1016/j.critrevonc.2021.103541.
    10.1016/j.critrevonc.2021.103541
  56. Ana Luísa Teixeira; Ana Sofia Patrão; Francisca Dias; Carlos Silva; Isabel Vieira; José Fernando Silva; Marta Ferreira; et al. "AGO2 expression levels and related genetic polymorphisms: influence in renal cell progression and aggressive phenotypes". Pharmacogenomics 22 16 (2021): 1069-1079. https://doi.org/10.2217/pgs-2021-0072.
    10.2217/pgs-2021-0072
  57. Medeiros-Fonseca B; Abreu-Silva AL; Medeiros R; Oliveira PA; Gil da Costa RM. "Pteridium spp. and Bovine Papillomavirus: Partners in Cancer.". Frontiers in veterinary science (2021): http://europepmc.org/abstract/med/34796228.
    10.3389/fvets.2021.758720
  58. Joana M. O. Santos; Alexandra C. Costa; Tânia R. Dias; Setareh Satari; Maria Paula Costa e Silva; Rui M. Gil da Costa; Rui Medeiros. "Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates". Pharmaceuticals 14 11 (2021): 1084-1084. https://doi.org/10.3390/ph14111084.
    10.3390/ph14111084
  59. Clariano Pires de Oliveira Neto; Beatriz Medeiros-Fonseca; Estêvão D.; Verónica F. Mestre; Natália R. Costa; Fábio Evangelista de Andrade; Paula Oliveira; et al. "Differential Incidence of Tongue Base Cancer in Male and Female HPV16-Transgenic Mice: Role of Female Sex Hormone Receptors". Pathogens (2021): https://www.mdpi.com/2076-0817/10/10/1224.
    10.3390/pathogens10101224
  60. Timóteo M; Tavares A; Cruz S; Campos C; Medeiros R; Sousa H. "Association of Murine Double Minute 2 polymorphisms with gastric cancer: A systematic review with meta-analysis.". Biomedical reports (2021): http://europepmc.org/abstract/med/34257965.
    10.3892/br.2021.1445
  61. Canadas-Sousa A; Santos M; Medeiros R; Dias-Pereira P. "Single Nucleotide Polymorphism in Prolactin Gene Is Associated With Clinical Aggressiveness and Outcome of Canine Mammary Malignant Tumors.". Veterinary pathology (2021): http://europepmc.org/abstract/med/34121513.
    10.1177/03009858211022705
  62. Valéria Tavares; Ricardo Pinto; Joana Assis; Sara Coelho; Mariana Brandão; Sara Alves; Deolinda Pereira; Rui Medeiros. "Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients". The Pharmacogenomics Journal (2021): https://doi.org/10.1038/s41397-020-00201-9.
    10.1038/s41397-020-00201-9
  63. Sofia Coelho Abreu; Valéria Tavares; Filipa Carneiro; Rui Medeiros. "Venous thromboembolism and prostate cancer: what about genetic markers?". Pharmacogenomics 22 6 (2021): 365-373. https://doi.org/10.2217/pgs-2020-0094.
    10.2217/pgs-2020-0094
  64. Silva HH; Silva MG; Cerqueira F; Tavares V; Medeiros R. "Genomic profile in association with sport-type, sex, ethnicity, psychological traits and sport injuries of elite athletes: review and future perspectives.". The Journal of sports medicine and physical fitness (2021): http://europepmc.org/abstract/med/33666074.
    10.23736/s0022-4707.21.12020-1
  65. Dias TR; Santos JMO; Gil da Costa RM; Medeiros R. "Long non-coding RNAs regulate the hallmarks of cancer in HPV-induced malignancies.". Critical reviews in oncology/hematology (2021): http://europepmc.org/abstract/med/33781867.
    10.1016/j.critrevonc.2021.103310
  66. Baker P; Kelly D; Medeiros R; Morrissey M; Price R. "Eliminating HPV-caused cancers in Europe: Achieving the possible.". Journal of cancer policy (2021): http://europepmc.org/abstract/med/35559909.
    10.1016/j.jcpo.2021.100280
  67. Francisca Dias; Cristina Almeida; Ana Luísa Teixeira; Mariana Morais; Rui Medeiros. "LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression". Biomedicines 9 2 (2021): 195-195. https://doi.org/10.3390/biomedicines9020195.
    10.3390/biomedicines9020195
  68. Freitas-Silva M; Medeiros R; Nunes JPL. "Risk factors among stroke subtypes and its impact on the clinical outcome of patients of Northern Portugal under previous aspirin therapy.". Clinical neurology and neurosurgery (2021): http://europepmc.org/abstract/med/33714797.
    10.1016/j.clineuro.2021.106564
  69. Beatriz Medeiros-Fonseca; Antonio Cubilla; Haissa Brito; Tânia Martins; Rui Medeiros; Paula Oliveira; Rui M. Gil da Costa. "Experimental Models for Studying HPV-Positive and HPV-Negative Penile Cancer: New Tools for An Old Disease". Cancers 13 3 (2021): 460-460. https://doi.org/10.3390/cancers13030460.
    10.3390/cancers13030460
  70. Mariana Morais; Vera Machado; Francisca Dias; Carlos Palmeira; Gabriela Martins; Magda Fonseca; Catarina S. M. Martins; et al. "Starch-Capped AgNPs’ as Potential Cytotoxic Agents against Prostate Cancer Cells". Nanomaterials 11 2 (2021): 256-256. https://doi.org/10.3390/nano11020256.
    10.3390/nano11020256
  71. Catarina Lopes; Carina Pereira; Mónica Farinha; Rui Medeiros; Mário Dinis-Ribeiro. "Genetic Variations in Prostaglandin E2 Pathway Identified as Susceptibility Biomarkers for Gastric Cancer in an Intermediate Risk European Country". International Journal of Molecular Sciences 22 2 (2021): 648-648. https://doi.org/10.3390/ijms22020648.
    10.3390/ijms22020648
  72. Helena M. Gonçalves; Jani Silva; Inês Pintado Maury; Ana Tavares; Carla Campos; Hugo Sousa; Amado Jacinto; et al. "The prevalence and risk-factors of oral HPV DNA detection among HIV-infected men between men who have sex with men and heterosexual men". Infectious Diseases 53 1 (2021): 19-30. https://doi.org/10.1080/23744235.2020.1811373.
    10.1080/23744235.2020.1811373
  73. Catarina Lopes; Carina Pereira; Rui Medeiros. "ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation". Cancers 13 2 (2021): 203-203. https://doi.org/10.3390/cancers13020203.
    10.3390/cancers13020203
  74. Cardoso JV; Medeiros R; Dias F; Costa IA; Ferrari R; Berardo PT; Perini JA. "DROSHA rs10719 and DICER1 rs3742330 polymorphisms in endometriosis and different diseases: Case-control and review studies.". Experimental and molecular pathology (2021): http://europepmc.org/abstract/med/33535080.
    10.1016/j.yexmp.2021.104616
  75. Catarata MJ; Lourenço M; Martins MF; Frade J; Pêgo A; Cordeiro CR; Medeiros R; Ribeiro R. "Pharmacogenetics of advanced lung cancer: Predictive value of functional genetic polymorphism AGXT Pro11Leu in clinical outcome?". Pulmonology (2021): http://europepmc.org/abstract/med/33408043.
    10.1016/j.pulmoe.2020.11.007
  76. Cerqueira, Fátima; Maia, Marta; Gabriel, Carla; Medeiros, Rui; Cravo, Sara; Ribeiro, Ana Isabel; Dantas, Daniela; et al. "Mechanism of Antifungal Activity by 5-Aminoimidazole-4-Carbohydrazonamide Derivatives against Candida albicans and Candida krusei". (2021): http://hdl.handle.net/1822/72539.
    10.3390/antibiotics10020183
  77. Medeiros, Rui; Horta, Bruno; Freitas-Silva, Joana; Silva, Jani; Dias, Francisca; Sousa, Emília; Pinto, Madalena; Cerqueira, Fátima. "Effect of 1-carbaldehyde-3,4-dimethoxyxanthone on prostate and HPV-18 positive cervical cancer cell lines and on human THP-1 macrophages". (2021): http://hdl.handle.net/10400.14/34105.
    10.3390/molecules26123721
  78. Morais, Mariana; Dias, Francisca; Nogueira, Inês; Leão, Anabela; Gonçalves, Nuno; Araújo, Luís; Granja, Sara Costa; et al. "Cancer cells’ metabolism dynamics in renal cell carcinoma patients’ outcome: influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186". (2021): http://hdl.handle.net/1822/73283.
    10.3390/cancers13071733
  79. Caldas, Ana R.; Catita, José; Machado, Raul; Ribeiro, Artur; Cerqueira, Fátima; Horta, Bruno; Medeiros, Rui; Lúcio, Marlene; Lopes, Carla M.. "Omega-3- and resveratrol-loaded lipid nanosystems for potential use as topical formulations in autoimmune, inflammatory, and cancerous skin diseases". (2021): http://hdl.handle.net/1822/73868.
    10.3390/pharmaceutics13081202
  80. Catarata, Maria Joana; Lourenço, Margarida; Martins, Maria Fátima; Frade, João; Pêgo, Alice; Cordeiro, Carlos Robalo; Medeiros, Rui; Ribeiro, Ricardo. "Pharmacogenetics of advanced lung cancer: Predictive value of functional genetic polymorphism AGXT Pro11Leu in clinical outcome?". (2021): http://hdl.handle.net/10316/100782.
    https://doi.org/10.1016/j.pulmoe.2020.11.007
  81. Caldas, Ana R.; Catita, José; Machado, Raul; Ribeiro, Artur; Cerqueira, Fátima; Horta, Bruno; Medeiros, Rui; Lúcio, Marlene; Lopes, Carla M.. "Omega-3- and resveratrol-loaded lipid nanosystems for potential use as topical formulations in autoimmune, inflammatory, and cancerous skin diseases". (2021): http://hdl.handle.net/10400.14/34657.
    10.3390/pharmaceutics13081202
  82. Patwal, Tiago; Nascimento-Gonçalves, Elisabete; Macedo, Sara; Borges, Inês; Gama, Adelina; Costa, Rui Miguel Gil; Neuparth, Maria João; et al. "Toxicological and anti-tumor effects of a linden extract (Tilia platyphyllos Scop.) in a HPV16-transgenic mouse model". (2021): http://hdl.handle.net/10198/24344.
    10.1039/d1fo00225b
  83. Inês Pita; Diogo Libânio; Francisca Dias; Ana Luísa Teixeira; Inês Nogueira; Rui Medeiros; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes. "Original Article: MicroRNA Dysregulation in the Gastric Carcinogenesis Cascade: Can We Anticipate Its Role in Individualized Care?". Pathobiology 88 5 (2021): 338-350. https://doi.org/10.1159/000515548.
    10.1159/000515548
  84. Patrão, Afonso; MEDEIROS, RUI. "Despedimento coletivo - Sindicabilidade judicial da motivacao empresarial". Revista de Direito e Estudos Sociais LXII 1-4 (2021): 109-218.
    Publicado
  85. Jéssica Vilarinho Cardoso; Jamila Alessandra Perini; Daniel Escorsim Machado; Ricardo Pinto; Rui Medeiros. "Systematic review of genome-wide association studies on susceptibility to endometriosis". European Journal of Obstetrics & Gynecology and Reproductive Biology (2020): https://doi.org/10.1016/j.ejogrb.2020.10.017.
    10.1016/j.ejogrb.2020.10.017
  86. Morais M; Teixeira AL; Dias F; Machado V; Medeiros R; Prior JAV. "Cytotoxic Effect of Silver Nanoparticles Synthesized by Green Methods in Cancer.". Journal of medicinal chemistry (2020): http://europepmc.org/abstract/med/33231444.
    10.1021/acs.jmedchem.0c01055
  87. Catarina Lopes; Carina Pereira; Mónica Farinha; Rui Medeiros; Mário Dinis-Ribeiro. "Prostaglandin E2 Pathway Is Dysregulated in Gastric Adenocarcinoma in a Caucasian Population". International Journal of Molecular Sciences 21 20 (2020): 7680-7680. https://doi.org/10.3390/ijms21207680.
    10.3390/ijms21207680
  88. Petrucci G; Henriques J; Gregório H; Vicente G; Prada J; Pires I; Lobo L; Medeiros R; Queiroga F. "Metastatic feline mammary cancer: prognostic factors, outcome and comparison of different treatment modalities - a retrospective multicentre study.". Journal of feline medicine and surgery (2020): http://europepmc.org/abstract/med/33078692.
    10.1177/1098612x20964416
  89. Gonçalves, Helena M.; Silva, Jani; Pintado Maury, Inês; Tavares, Ana; Campos, Carla; Sousa, Hugo; Jacinto, Amado; et al. "The prevalence and risk-factors of oral HPV DNA detection among HIV-infected men between men who have sex with men and heterosexual men". Infectious Diseases 53 1 (2020): 19-30. http://dx.doi.org/10.1080/23744235.2020.1811373.
    10.1080/23744235.2020.1811373
  90. Ana Afonso; Jani Silva; Ana Rita Lopes; Sara Coelho; Ana Sofia Patrão; Alina Rosinha; Filipa Carneiro; et al. "YB-1 variant and androgen receptor axis-targeted agents in metastatic castration-resistant prostate cancer patients". Pharmacogenomics 21 13 (2020): 919-928. https://doi.org/10.2217/pgs-2020-0008.
    10.2217/pgs-2020-0008
  91. Sara Peixoto da Silva; Joana M. O. Santos; Verónica F. Mestre; Beatriz Medeiros-Fonseca; Paula A. Oliveira; Margarida M. S. M. Bastos; Rui M. Gil da Costa; Rui Medeiros. "Human Papillomavirus 16-Transgenic Mice as a Model to Study Cancer-Associated Cachexia". International Journal of Molecular Sciences (2020): https://doi.org/10.3390/ijms21145020.
    10.3390/ijms21145020
  92. Maria Joana Catarata; Ricardo Ribeiro; Maria José Oliveira; Carlos Robalo Cordeiro; Rui Medeiros. "Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions". Cancers 12 6 (2020): 1457-1457. https://doi.org/10.3390/cancers12061457.
    10.3390/cancers12061457
  93. Reis DRA; Medeiros-Fonseca B; Costa JM; de Oliveira Neto CP; Gil da Costa RM; Oliveira PA; Medeiros R; et al. "HPV infection as a risk factor for atherosclerosis: A connecting hypothesis.". Medical hypotheses (2020): http://europepmc.org/abstract/med/32570162.
    10.1016/j.mehy.2020.109979
  94. Sara Peixoto da Silva; Joana M.O. Santos; Maria Paula Costa e Silva; Rui M. Gil da Costa; Rui Medeiros. "Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia". Journal of Cachexia, Sarcopenia and Muscle (2020): https://doi.org/10.1002/jcsm.12528.
    10.1002/jcsm.12528
  95. Francisca Dias; Ana L Teixeira; Inês Nogueira; Mariana Gomes Morais; Joana Maia; Cristian Bodo; Marta Ferreira; et al. "Plasma Extracellular Vesicle-Derived TIMP-1 mRNA as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Pilot Study". International Journal of Molecular Sciences (2020): https://www.mdpi.com/1422-0067/21/13/4624.
    10.3390/ijms21134624
  96. Valéria Tavares; Ricardo Pinto; Joana Assis; Deolinda Pereira; Rui Medeiros. "Dataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressiveness". Data in Brief (2020): https://doi.org/10.1016/j.dib.2020.105399.
    10.1016/j.dib.2020.105399
  97. Francisca Dias; Ana Luísa Teixeira; Inês Nogueira; Mariana Morais; Joana Maia; Cristian Bodo; Marta Ferreira; et al. "Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease". Cancers (2020): https://www.mdpi.com/2072-6694/12/6/1450.
    10.3390/cancers12061450
  98. Morais M; Dias F; Resende T; Nogueira I; Oliveira J; Maurício J; Teixeira AL; Medeiros R. "Leukocyte telomere length and hTERT genetic polymorphism rs2735940 influence the renal cell carcinoma clinical outcome.". Future oncology (London, England) (2020): http://europepmc.org/abstract/med/32422075.
    10.2217/fon-2019-0795
  99. Pinto, Ana R; Silva, Jani; Pinto, Ricardo; Medeiros, Rui. "Aggressive prostate cancer phenotype and genome-wide association studies: where are we now?". Pharmacogenomics (2020): http://dx.doi.org/10.2217/pgs-2019-0123.
    Publicado • 10.2217/pgs-2019-0123
  100. Joana M. O. Santos; Sara Peixoto da Silva; Rui M. Gil da Costa; Rui Medeiros. "The Emerging Role of MicroRNAs and Other Non-Coding RNAs in Cancer Cachexia". Cancers (2020): https://doi.org/10.3390/cancers12041004.
    10.3390/cancers12041004
  101. Brausi, Maurizio; Hoskin, Peter; Andritsch, Elisabeth; Banks, Ian; Beishon, Marc; Boyle, Helen; Colecchia, Maurizio; et al. "ECCO Essential Requirements for Quality Cancer Care: Prostate cancer". Critical Reviews in Oncology/Hematology 148 (2020): 102861. http://dx.doi.org/10.1016/j.critrevonc.2019.102861.
    Publicado • 10.1016/j.critrevonc.2019.102861
  102. Mariana Morais; Francisca Dias; Ana Luísa Teixeira; Rui Medeiros. "

    Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney

    ". Cancer Management and Research (2020): https://doi.org/10.2147/CMAR.S211225.
    10.2147/CMAR.S211225
  103. MEDEIROS, RUI. "HPV16 is sufficient to induce squamous cell carcinoma specifically in the tongue base in transgenic mice". J Pathol (2020): http://www.ncbi.nlm.nih.gov/pubmed/31994197.
    10.1002/path.5387
  104. MEDEIROS, RUI. "Human papillomavirus prevalence and distribution in self-collected samples from female university students in Maputo". Int J Gynaecol Obstet (2020): http://www.ncbi.nlm.nih.gov/pubmed/32086940.
    10.1002/ijgo.13126
  105. MEDEIROS, RUI. "Low density lipoprotein cholesterol values and outcome of stroke patients: influence of previous aspirin therapy". Neurol Res (2020): 1-8. http://www.ncbi.nlm.nih.gov/pubmed/32024449.
    10.1080/01616412.2020.1724463
  106. MEDEIROS, RUI. "The emergent phenomenon of aspirin resistance: insights from genetic association studies". Pharmacogenomics 21 2 (2020): 125-140. http://www.ncbi.nlm.nih.gov/pubmed/31957546.
    10.2217/pgs-2019-0133
  107. MEDEIROS, RUI. "Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour". Biochim Biophys Acta Rev Cancer 1873 1 (2020): 188331-188331. http://www.ncbi.nlm.nih.gov/pubmed/31689458.
    10.1016/j.bbcan.2019.188331
  108. Catarata, Maria Joana; Medeiros, Rui; Oliveira, Maria José; Pêgo, Alice; Frade, João Gonçalo; Martins, Maria Fátima; Robalo Cordeiro, Carlos Robalo; et al. "Germline genetic variants of the renin-angiotensin system, hypoxia and angiogenesis in non-small cell lung cancer progression : discovery and validation studies". (2020): http://hdl.handle.net/10451/47160.
    10.3390/cancers12123834
  109. Catarata, Maria Joana; Medeiros, Rui; Oliveira, Maria José; Pêgo, Alice; Frade, João Gonçalo; Martins, Maria de Fátima; Cordeiro, Carlos Robalo; et al. "Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation Studies". (2020): http://hdl.handle.net/10316/105854.
    https://doi.org/10.3390/cancers12123834
  110. Bela Barros; Mariana Morais; Ana Luísa Teixeira; Rui Medeiros. "Loss of Chromosome Y and Its Potential Applications as Biomarker in Health and Forensic Sciences". Cytogenetic and Genome Research (2020): https://doi.org/10.1159/000508564.
    10.1159/000508564
  111. Medeiros-Fonseca, B.; Mestre, V.F.; Estêvão, D.; Sánchez, D.F.; Cañete-Portillo, S.; Fernández-Nestosa, M.J.; Casaca, F.; et al. "HPV16 induces penile intraepithelial neoplasia and squamous cell carcinoma in transgenic mice: first mouse model for HPV-related penile cancer". Journal of Pathology 251 4 (2020): 411-419. http://www.scopus.com/inward/record.url?eid=2-s2.0-85088032142&partnerID=MN8TOARS.
    10.1002/path.5475
  112. Joana Ribeiro; Mariana Malta; Ana Galaghar; Luís Pedro Afonso; Diogo Libânio; Rui Medeiros; Mario Dinis-Ribeiro; Pedro Pimentel-Nunes; Hugo Sousa. "Epstein-Barr virus is absent in gastric superficial neoplastic lesions". Virchows Archiv 475 6 (2019): 757-762. https://doi.org/10.1007/s00428-019-02670-1.
    10.1007/s00428-019-02670-1
  113. Mara Fernandes; Ana Luísa Teixeira; Rui Medeiros. "The opportunistic effect of exosomes on Non-Hodgkin Lymphoma microenvironment modulation". Critical Reviews in Oncology/Hematology 144 (2019): 102825-102825. https://doi.org/10.1016/j.critrevonc.2019.102825.
    10.1016/j.critrevonc.2019.102825
  114. Augusto Nogueira; Mara Fernandes; Raquel Catarino; Rui Medeiros. "RAD52 Functions in Homologous Recombination and Its Importance on Genomic Integrity Maintenance and Cancer Therapy". Cancers (2019): https://doi.org/10.3390/cancers11111622.
    10.3390/cancers11111622
  115. Sara Cruz; Carla Campos; Mafalda Timóteo; Ana Tavares; Maria São José Nascimento; Rui Medeiros; Hugo Sousa. "Hepatitis E virus in hematopoietic stem cell transplant recipients: A systematic review". Journal of Clinical Virology 119 (2019): 31-36. https://doi.org/10.1016/j.jcv.2019.08.002.
    10.1016/j.jcv.2019.08.002
  116. Andreia Albuquerque; Rui Medeiros. "New Insights into the Role of Human Papillomavirus in Anal Cancer and Anal Wart Development". Acta Cytologica (2019): https://doi.org/10.1159/000491815.
    10.1159/000491815
  117. Diogo Estêvão; Natália Rios Costa; Rui M. Gil da Costa; Rui Medeiros. "Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy". Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1862 2 (2019): 153-162. https://doi.org/10.1016/j.bbagrm.2019.01.001.
    10.1016/j.bbagrm.2019.01.001
  118. Vieira, CMP; Fragoso, RM; Pereira, D; Medeiros, R. "Pain polymorphisms and opioids: An evidence based review". Molecular Medicine Reports (2019):
    10.3892/mmr.2018.9792
  119. Cruz, D.; Pinto, R.; Freitas-Silva, M.; Nunes, J.P.; Medeiros, R.. "GWAS contribution to atrial fibrillation and atrial fibrillation-related stroke: Pathophysiological implications". Pharmacogenomics 20 10 (2019): 765-780. http://www.scopus.com/inward/record.url?eid=2-s2.0-85070635903&partnerID=MN8TOARS.
    10.2217/pgs-2019-0054
  120. Santos, J.M.O.; Moreira-Pais, A.; Neto, T.; Peixoto da Silva, S.; Oliveira, P.A.; Ferreira, R.; Mendes, J.; et al. "Dimethylaminoparthenolide reduces the incidence of dysplasia and ameliorates a wasting syndrome in HPV16-transgenic mice". Drug Development Research (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85069909466&partnerID=MN8TOARS.
    10.1002/ddr.21565
  121. Silva, V.; Cerqueira, F.; Nazareth, N.; Medeiros, R.; Sarmento, A.; Sousa, E.; Pinto, M.. "1,2-dihydroxyxanthone: Effect on A375-C5 melanoma cell growth associated with interference with THP-1 human macrophage activity". Pharmaceuticals 12 2 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85071929357&partnerID=MN8TOARS.
    10.3390/ph12020085
  122. Albuquerque, A; Fernandes, M; Stirrup, O; Teixeira, AL; Santos, J; Rodrigues, M; Rios, E; Macedo, G; Medeiros, R. "Expression of microRNAs 16, 20a, 150 and 155 in anal squamous intraepithelial lesions from high-risk groups". SCIENTIFIC REPORTS (2019):
    10.1038/s41598-018-38378-6
  123. Canadas-Sousa, A.; Santos, M.; Leal, B.; Medeiros, R.; Dias-Pereira, P.. "Estrogen receptors genotypes and canine mammary neoplasia". BMC Veterinary Research 15 1 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85072052308&partnerID=MN8TOARS.
    10.1186/s12917-019-2062-y
  124. Canadas, A.; Santos, M.; Medeiros, R.; Dias-Pereira, P.. "Influence of E-cadherin genetic variation in canine mammary tumour risk, clinicopathological features and prognosis". Veterinary and Comparative Oncology (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85067488397&partnerID=MN8TOARS.
    10.1111/vco.12510
  125. Sousa, H.; Tavares, A.; Campos, C.; Marinho-Dias, J.; Brito, M.; Medeiros, R.; Baldaque, I.; et al. "High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program". Papillomavirus Research 8 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85070519386&partnerID=MN8TOARS.
    10.1016/j.pvr.2019.100179
  126. Nogueira, I.; Dias, F.; Morais, M.; Teixeira, A.L.; Medeiros, R.. "Everolimus resistance in clear cell renal cell carcinoma: MiRNA-101 and HIF-2a as molecular triggers?". Future Oncology 15 20 (2019): 2361-2370. http://www.scopus.com/inward/record.url?eid=2-s2.0-85070096905&partnerID=MN8TOARS.
    10.2217/fon-2019-0067
  127. Ferreira, T.; Campos, S.; Silva, M.G.; Ribeiro, R.; Santos, S.; Almeida, J.; Pires, M.J.; et al. "The cyclooxigenase-2 inhibitor parecoxib prevents epidermal dysplasia in HPV16-transgenic mice: efficacy and safety observations". International Journal of Molecular Sciences 20 16 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85071280943&partnerID=MN8TOARS.
    10.3390/ijms20163902
  128. MEDEIROS, RUI. "Dietary Supplementation with the Red Seaweed Porphyra umbilicalis Protects against DNA Damage and Pre-Malignant Dysplastic Skin Lesions in HPV-Transgenic Mice". Mar Drugs 17 11 (2019): http://www.ncbi.nlm.nih.gov/pubmed/31671845.
    10.3390/md17110615
  129. MEDEIROS, RUI. "Pain prevalence and treatment in patients with metastatic bone disease". Oncol Lett 17 3 (2019): 3362-3370. http://www.ncbi.nlm.nih.gov/pubmed/30867771.
    10.3892/ol.2019.10013
  130. MEDEIROS, RUI. "Inhibitory Effect of 5-Aminoimidazole-4-Carbohydrazonamides Derivatives Against Candida spp. Biofilm on Nanohydroxyapatite Substrate". Mycopathologia 184 6 (2019): 775-786. http://www.ncbi.nlm.nih.gov/pubmed/31679132.
    10.1007/s11046-019-00400-4
  131. MEDEIROS, RUI. "Influence of curcumin supplementation on metabolic and lipid parameters of people living with HIV/AIDS: a randomized controlled trial". BMC Complement Altern Med 19 1 (2019): 202-202. http://www.ncbi.nlm.nih.gov/pubmed/31387592.
    10.1186/s12906-019-2620-7
  132. MEDEIROS, RUI. "Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours". J Comp Pathol 172 (2019): 72-79. http://www.ncbi.nlm.nih.gov/pubmed/31690419.
    10.1016/j.jcpa.2019.08.010
  133. Gabriel, Carla; Grenho, L.; Cerqueira, Fátima; Medeiros, Rui; Dias, Alice; Ribeiro, Ana I.; Proença, M. Fernanda R. P.; et al. "Inhibitory effect of 5-aminoimidazole-4-carbohydrazonamides derivatives against Candida spp biofilm on nanohydroxyapatite substrate". (2019): http://hdl.handle.net/1822/71006.
    10.1007/s11046-019-00400-4
  134. Ferreira, Tiago; Campos, Sandra; Silva, Mónica G; Ribeiro, Rita; Santos, Susana; Almeida, José; Pires, Maria João; et al. "The cyclooxigenase-2 Inhibitor parecoxib prevents epidermal dysplasia in HPV16-transgenic mice: efficacy and safety observations". (2019): http://hdl.handle.net/10400.11/7312.
    10.3390/ijms20163902
  135. Ferreira, Tiago; Campos, Sandra; Silva, Mónica; Ribeiro, Rita; Santos, Susana; Almeida, José L.S.; Pires, Maria João; et al. "The cyclooxigenase-2 inhibitor parecoxib prevents epidermal dysplasia in HPV16-transgenic mice: efficacy and safety observations". (2019): http://hdl.handle.net/10198/20272.
    10.3390/ijms20163902
  136. Joana M. O. Santos; Alexandra Moreira Pais; Tiago Neto; Sara Peixoto da Silva; Paula A. Oliveira; Rita Ferreira; Joaquim Mendes; et al. "Dimethylaminoparthenolide reduces the incidence of dysplasia and ameliorates a wasting syndrome in HPV16-transgenic mice". (2019): https://hdl.handle.net/10216/123404.
    10.1002/ddr.21565
  137. Ribeiro, Joana; Malta, Mariana; Galaghar, Ana; Afonso, Luís Pedro; Libânio, Diogo; Medeiros, Rui; Dinis-Ribeiro, Mario; Pimentel-Nunes, Pedro; Sousa, Hugo. "Epstein-Barr virus is absent in gastric superficial neoplastic lesions". (2019): http://hdl.handle.net/1822/67364.
    10.1007/s00428-019-02670-1
  138. Martinez, JM; Espirito Santo, Ana; Godinho, A; Azevedo, A; Felix, A; Chacim, Sérgio; Ramada, Diana; Mariz, JM; MEDEIROS, RUI. "Acute Leukemia Patients: A CLABSI Risk Special Population". Annals of Hematology & Oncology 5 2 (2018): 1-7. https://austinpublishinggroup.com/hematology/fulltext/hematology-v5-id1192.php.
    Publicado
  139. Silva, RUI. "Curcumin and Rutin Down-regulate Cyclooxygenase-2 and Reduce Tumor-associated Inflammation in HPV16-Transgenic Mice". Anticancer research (2018): https://doi.org/10.21873/anticanres.12371.
    10.21873/anticanres.12371
  140. Silva, RUI. "Relationship between clinical toxicities and ERCC1 rs3212986 and XRCC3 rs861539 polymorphisms in cervical cancer patients". The International journal of biological markers (2018): https://doi.org/10.5301/ijbm.5000279.
    10.5301/ijbm.5000279
  141. Silva, RUI. "Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice". Journal of cancer research and clinical oncology (2018): https://doi.org/10.1007/s00432-017-2549-5.
    10.1007/s00432-017-2549-5
  142. Santos, J.M.O.; da Silva, S.P.; Costa, N.R.; Gil da Costa, R.M.; Medeiros, R.. "The role of microRNAs in the metastatic process of high-risk HPV-induced cancers". Cancers 10 12 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85058471939&partnerID=MN8TOARS.
    10.3390/cancers10120493
  143. Duro, M.; Manso, M.C.; Barreira, S.; Rebelo, I.; Medeiros, R.; Almeida, C.. "Metabolic syndrome in human immunodeficiency virus-infected patients". International Journal of STD and AIDS 29 11 (2018): 1089-1097. http://www.scopus.com/inward/record.url?eid=2-s2.0-85048182910&partnerID=MN8TOARS.
    10.1177/0956462418775188
  144. Silva, RUI. "Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort". The pharmacogenomics journal (2018): https://doi.org/10.1038/s41397-018-0056-y.
    10.1038/s41397-018-0056-y
  145. Silva, RUI. "Catechol-o-methyltransferase genotypes are associated with progression and biological behaviour of canine mammary tumours". Veterinary and comparative oncology (2018): https://doi.org/10.1111/vco.12438.
    10.1111/vco.12438
  146. Silva, RUI. "CSF-1 and Ang-2 serum levels - prognostic and diagnostic partners in non-small cell lung cancer". ESMO open (2018): http://europepmc.org/articles/PMC6069916.
    10.1136/esmoopen-2018-000349
  147. Silva, RUI. "A viral map of gastrointestinal cancers". Life sciences (2018): https://doi.org/10.1016/j.lfs.2018.02.025.
    10.1016/j.lfs.2018.02.025
  148. Silva, RUI. "Canine mammary tumor risk is associated with polymorphisms in RAD51 and STK11 genes". Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc (2018): https://doi.org/10.1177/1040638718789231.
    10.1177/1040638718789231
  149. Silva, RUI. "Ozone therapy prevents the onset of dysplasia in HPV16-transgenic mice-A pre-clinical efficacy and safety analysis". Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2018): https://doi.org/10.1016/j.biopha.2018.05.018.
    10.1016/j.biopha.2018.05.018
  150. Silva, RUI. "Beyond p16 immunostaining: an overview of biomarkers in anal squamous intraepithelial lesions". Histology and histopathology (2018): https://doi.org/10.14670/HH-18-053.
    10.14670/hh-18-053
  151. Silva, RUI. "Dysregulation of cellular microRNAs by human oncogenic viruses - Implications for tumorigenesis". Biochimica et biophysica acta. Gene regulatory mechanisms (2018): https://doi.org/10.1016/j.bbagrm.2018.01.017.
    10.1016/j.bbagrm.2018.01.017
  152. Silva, RUI. "XPO5 genetic polymorphisms in cancer risk and prognosis". Pharmacogenomics (2018): https://doi.org/10.2217/pgs-2018-0018.
    10.2217/pgs-2018-0018
  153. Silva, RUI. "CRISPR-Cas9 therapies in experimental mouse models of cancer". Future oncology (London, England) (2018): https://doi.org/10.2217/fon-2018-0028.
    10.2217/fon-2018-0028
  154. Silva, RUI. "miRNAs as potential regulators of mTOR pathway in renal cell carcinoma". Pharmacogenomics (2018): https://doi.org/10.2217/pgs-2017-0160.
    10.2217/pgs-2017-0160
  155. Silva, RUI. "Genital mycoplasmas and ureaplasmas in cervicovaginal self-collected samples of reproductive-age women: prevalence and risk factors". International journal of STD & AIDS (2018): https://doi.org/10.1177/0956462418774209.
    10.1177/0956462418774209
  156. Silva, RUI. "TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer". Oncology letters (2018): http://europepmc.org/articles/PMC5921260.
    10.3892/ol.2018.8354
  157. Silva, RUI. "Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study". Veterinary pathology (2018): https://doi.org/10.1177/0300985818806968.
    10.1177/0300985818806968
  158. Silva, RUI. "Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior". Cancers (2018): http://europepmc.org/articles/PMC6210990.
    10.3390/cancers10100381
  159. Silva, RUI. "Post-transplant lymphoproliferative disorder in hematopoietic stem cell transplant patients: A single center retrospective study between 2005 and 2012". Molecular medicine reports (2018): https://doi.org/10.3892/mmr.2018.9433.
    10.3892/mmr.2018.9433
  160. Silva, RUI; B. Medeiros-Fonseca; V. F. Mestre; B. Colaço; M. J. Pires; T. Martins; R. M. Gil da Costa; et al. "Laurus nobilis (laurel) aqueous leaf extract's toxicological and anti-tumor activities in HPV16-transgenic mice". Food & function (2018): https://doi.org/10.1039/c8fo00783g.
    10.1039/c8fo00783g
  161. Marinho-Dias, J; Baldaque, I; Pinho-Vaz, C; Leite, L; Branca, R; Campilho, F; Campos, A; Medeiros, R; Sousa, H. "Association of Epstein-Barr virus infection with allogeneic hematopoietic stem cell transplantation in patients in Portugal". Molecular Medicine Reports (2018):
    10.3892/mmr.2018.9794
  162. Rita Araújo; Joana M. O. Santos; Mara Fernandes; Francisca Dias; Hugo Sousa; Joana Ribeiro; Margarida M. S. M. Bastos; et al. "Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice". (2018): https://hdl.handle.net/10216/115806.
    10.1007/s00432-017-2549-5
  163. Magda S. S. Moutinho; Sofia Aragão; Diogo Carmo; Fátima Casaca; Sandra Silva; Joana Ribeiro; Hugo Sousa; et al. "Curcumin and Rutin Down-regulate Cyclooxygenase-2 and Reduce Tumor-associated Inflammation in HPV16-Transgenic Mice". (2018): https://hdl.handle.net/10216/115857.
    10.21873/anticanres.12371
  164. Adem B; Teixeira AL; Dias F; Ruivo C; Medeiros R; Melo SA. "GE11 positive exosomes as a potential RNAi delivery system in clear cell Renal Cell Carcinoma: PS081.". Porto biomedical journal (2017): http://europepmc.org/abstract/med/32258629.
    10.1016/j.pbj.2017.07.016
  165. DA Costa RMG; Araújo R; Santos JMO; Fernandes M; Neto T; Sousa H; Ribeiro J; et al. "Regulation of miRNA-146a and miRNA-150 Levels by Celecoxib in Premalignant Lesions of K14-HPV16 Mice.". Anticancer research (2017): http://europepmc.org/abstract/med/28551628.
    10.21873/anticanres.11644
  166. Espirito Santo A; Chacim S; Ferreira I; Leite L; Moreira C; Pereira D; Dantas M; et al. "Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia.". (2017): http://europepmc.org/abstract/med/28451418.
    10.3892/mco.2017.1134
  167. Silva J; Cerqueira F; Medeiros R. "Acceptability of self-sampling in Portuguese women: the good, the bad or the ugly?". (2017): http://europepmc.org/abstract/med/28063461.
    10.1071/sh16077
  168. Santos MD; Silva C; Rocha A; Nogueira C; Castro-Poças F; Araujo A; Matos E; et al. "Prognostic and Therapeutic Potential Implications of Genetic Variability in Prostaglandin E2 Pathway Genes in Rectal Cancer.". Anticancer research (2017): http://europepmc.org/abstract/med/28011504.
    10.21873/anticanres.11319
  169. Fraga A; Ribeiro R; Coelho A; Vizcaíno JR; Coutinho H; Lopes JM; Príncipe P; et al. "Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer.". (2017): http://europepmc.org/abstract/med/28143503.
    10.1186/s12894-017-0201-y
  170. Pontes L; Sousa JC; Medeiros R. "SNPs and STRs in forensic medicine. A strategy for kinship evaluation.". Archiwum medycyny sadowej i kryminologii (2017): http://europepmc.org/abstract/med/29460612.
    10.5114/amsik.2017.73194
  171. Silva, RUI. "Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis". Urologic oncology (2017): https://doi.org/10.1016/j.urolonc.2017.04.002.
    10.1016/j.urolonc.2017.04.002
  172. Silva, RUI. "P53 deregulation in Epstein-Barr virus-associated gastric cancer". Cancer letters (2017): https://doi.org/10.1016/j.canlet.2017.07.010.
    10.1016/j.canlet.2017.07.010
  173. Coelho, A.L.; Gomes, M.P.; Catarino, R.J.; Rolfo, C.; Lopes, A.M.; Medeiros, R.M.; Araújo, A.M.. "Angiogenesis in NSCLC: Is vessel co-option the trunk that sustains the branches?". Oncotarget 8 24 (2017): 39795-39804. http://www.scopus.com/inward/record.url?eid=2-s2.0-85020668154&partnerID=MN8TOARS.
    10.18632/oncotarget.7794
  174. Silva, RUI. "Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal". World Journal of Gastroenterology (2017): http://europepmc.org/articles/PMC5677199.
    10.3748/wjg.v23.i40.7292
  175. Silva, RUI. "Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma". Oncotarget (2017): http://europepmc.org/articles/PMC5732730.
    10.18632/oncotarget.21733
  176. Silva, RUI. "Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis". Cancer treatment reviews (2017): https://doi.org/10.1016/j.ctrv.2017.10.001.
    10.1016/j.ctrv.2017.10.001
  177. Silva, RUI. "Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice". Life sciences (2017): https://doi.org/10.1016/j.lfs.2017.03.008.
    10.1016/j.lfs.2017.03.008
  178. Silva, RUI. "Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study". Antiviral research (2017): https://doi.org/10.1016/j.antiviral.2016.10.016.
    10.1016/j.antiviral.2016.10.016
  179. Silva, RUI; Nogueira, A.; Assis, J.; Faustino, I.; Pereira, D.; Catarino, R.; Medeiros, R.. "Base excision repair pathway: PARP1 genotypes as modulators of therapy response in cervical cancer patients". Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 22 1 (2017): 70-76. https://doi.org/10.1080/1354750X.2016.1204006.
    10.1080/1354750x.2016.1204006
  180. Silva, RUI. "HPV-transgenic mouse models: Tools for studying the cancer-associated immune response". Virus research (2017): https://doi.org/10.1016/j.virusres.2017.04.001.
    10.1016/j.virusres.2017.04.001
  181. Silva, RUI. "IL6-174G¿>¿C genetic polymorphism influences antidepressant treatment outcome". Nordic journal of psychiatry (2017): https://doi.org/10.1080/08039488.2016.1242650.
    10.1080/08039488.2016.1242650
  182. Silva, RUI. "HPV16 induces a wasting syndrome in transgenic mice: Amelioration by dietary polyphenols via NF-¿B inhibition". Life sciences (2017): https://doi.org/10.1016/j.lfs.2016.10.031.
    10.1016/j.lfs.2016.10.031
  183. Silva, RUI. "Predictive clinical model of tumor response after chemoradiation in rectal cancer". Oncotarget (2017): https://doi.org/10.18632/oncotarget.19651.
    10.18632/oncotarget.19651
  184. Silva, RUI. "Rethinking ovarian cancer genomics: where genome-wide association studies stand?". Pharmacogenomics (2017): https://doi.org/10.2217/pgs-2017-0108.
    10.2217/pgs-2017-0108
  185. Silva, RUI. "MicroRNAs and altered metabolism of clear cell renal cell carcinoma: Potential role as aerobic glycolysis biomarkers". Biochimica et biophysica acta. General subjects (2017): https://doi.org/10.1016/j.bbagen.2017.05.028.
    10.1016/j.bbagen.2017.05.028
  186. Silva, J.; Cerqueira, F.; Medeiros, R.. "Acceptability of self-sampling in Portuguese women: The good, the bad or the ugly?". Sexual Health 14 3 (2017): 298-300. http://www.scopus.com/inward/record.url?eid=2-s2.0-85020312588&partnerID=MN8TOARS.
    10.1071/SH16077
  187. Rui M. Gil da Costa; Rita Araújo; Joana M. O. Santos; Mara Fernandes; Tiago Neto; Hugo Sousa; Joana Ribeiro; et al. "Regulation of miRNA-146a and miRNA-150 Levels by Celecoxib in Premalignant Lesions of K14-HPV16 Mice". (2017): https://hdl.handle.net/10216/115858.
    10.21873/anticanres.11644
  188. Joana M. O. Santos; Mara Fernandes; Rita Araújo; Hugo Sousa; Joana Ribeiro; Margarida M. S. M. Bastos; Paula A. Oliveira; et al. "Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice". (2017): https://hdl.handle.net/10216/104673.
    10.1016/j.lfs.2017.03.008
  189. Carlos Santos; Manuel Vilanova; Rui Medeiros; Gil da Costa, R. M.. "HPV-transgenic mouse models: Tools for studying the cancer-associated immune response". (2017): https://repositorio-aberto.up.pt/handle/10216/117114.
    10.1016/j.virusres.2017.04.001
  190. Rui M. Gil da Costa; Sofia Aragão; Magda Moutinho; Antonieta Alvarado; Diogo Carmo; Fátima Casaca; Sandra Silva; et al. "HPV16 induces a wasting syndrome in transgenic mice: Amelioration by dietary polyphenols via NF-kappa B inhibition". (2017): https://hdl.handle.net/10216/103331.
    10.1016/j.lfs.2016.10.031
  191. Lima A; Bernardes M; Azevedo R; Seabra V; Medeiros R. "Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.". (2016): http://europepmc.org/abstract/med/27676277.
    10.2217/pgs-2016-0067
  192. Pereira C; Queirós S; Galaghar A; Sousa H; Marcos-Pinto R; Pimentel-Nunes P; Brandão C; Medeiros R; Dinis-Ribeiro M. "Influence of Genetic Polymorphisms in Prostaglandin E2 Pathway (COX-2/HPGD/SLCO2A1/ABCC4) on the Risk for Colorectal Adenoma Development and Recurrence after Polypectomy.". (2016): http://europepmc.org/abstract/med/27628421.
    10.1038/ctg.2016.47
  193. Santos C; Neto T; Ferreirinha P; Sousa H; Ribeiro J; Bastos MM; Faustino-Rocha AI; et al. "Celecoxib promotes degranulation of CD8(+) T cells in HPV-induced lesions of K14-HPV16 transgenic mice.". (2016): http://europepmc.org/abstract/med/27259813.
    10.1016/j.lfs.2016.05.040
  194. ESPíRITO Santo AE; Chacim S; Ferreira I; Leite L; Moreira C; Pereira D; Dantas Brito MD; et al. "Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia.". (2016): http://europepmc.org/abstract/med/27347135.
  195. Chambuso RS; Shadrack S; Lidenge SJ; Mwakibete N; Medeiros RM. "Influence of HIV/AIDS on Cervical Cancer: A Retrospective Study From Tanzania.". Journal of global oncology (2016): http://europepmc.org/abstract/med/28717744.
    10.1200/jgo.2015.002964
  196. DA Costa RM; Bastos MM; Medeiros R; Oliveira PA. "The NF¿B Signaling Pathway in Papillomavirus-induced Lesions: Friend or Foe?". (2016): http://europepmc.org/abstract/med/27127107.
  197. Santos M; Carvalho S; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; et al. "The role of IL18-607C>A and IL18-137G>C promoter polymorphisms in antidepressant treatment phenotypes: A preliminary report.". (2016): http://europepmc.org/abstract/med/27001087.
    10.1016/j.neulet.2016.03.026
  198. Marques H; Freitas J; Medeiros R; Longatto-Filho A. "Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability.". (2016): http://europepmc.org/abstract/med/27766139.
  199. Matos, A.; Castelão, C.; Pereira Da Silva, A.; Alho, I.; Bicho, M.; Medeiros, R.; Clara Bicho, M.. "Epistatic Interaction of CYP1A1 and COMT Polymorphisms in Cervical Cancer". Oxidative Medicine and Cellular Longevity 2016 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84954271214&partnerID=MN8TOARS.
    10.1155/2016/2769804
  200. Esp�rito Santo, A.; Chacim, S.; Ferreira, I.; Leite, L.; Moreira, C.; Pereira, D.; Dantas Brito, M.; et al. "Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia". Oncology Letters 12 1 (2016): 262-268. http://www.scopus.com/inward/record.url?eid=2-s2.0-84973494472&partnerID=MN8TOARS.
    10.3892/ol.2016.4591
  201. Silva, RUI. "Ptaquiloside from bracken (Pteridium spp.) inhibits tumour-infiltrating CD8+ T cells in HPV-16 transgenic mice". Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (2016): https://doi.org/10.1016/j.fct.2016.09.019.
    10.1016/j.fct.2016.09.019
  202. Silva, RUI. "miRNAs: mediators of ErbB family targeted therapy resistance". Pharmacogenomics (2016): https://doi.org/10.2217/pgs-2016-0038.
    10.2217/pgs-2016-0038
  203. Duro, M.; Manso, M.C.; Rebelo, I.; Medeiros, R.; Almeida, C.. "Hyperhomocysteinemia in human immunodeficiency virus-infected patients". Biomedical Research (India) 27 2 (2016): 557-562. http://www.scopus.com/inward/record.url?eid=2-s2.0-84964344261&partnerID=MN8TOARS.
  204. Da Costa, R.M.G.; Bastos, M.M.S.M.; Medeiros, R.; Oliveira, P.A.. "The NFkB signaling pathway in papillomavirus-induced lesions: Friend or foe?". Anticancer Research 36 5 (2016): 2073-2083. http://www.scopus.com/inward/record.url?eid=2-s2.0-84988310767&partnerID=MN8TOARS.
  205. Marques, H.; Freitas, J.; Medeiros, R.; Longatto-Filho, A.. "Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability". International Journal of Molecular Epidemiology and Genetics 7 3 (2016): 126-136. http://www.scopus.com/inward/record.url?eid=2-s2.0-84991649502&partnerID=MN8TOARS.
  206. Neves, M.; Ribeiro, J.; Medeiros, R.; Sousa, H.. "Genetic polymorphism in DNMTs and gastric cancer: A systematic review and meta-analysis". Porto Biomedical Journal 1 5 (2016): 164-172. http://www.scopus.com/inward/record.url?eid=2-s2.0-85043558059&partnerID=MN8TOARS.
    10.1016/j.pbj.2016.10.005
  207. Pereira, D.; Assis, J.; Gomes, M.; Nogueira, A.; Medeiros, R.. "Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: Implications of a GST activity profile". European Journal of Clinical Pharmacology 72 5 (2016): 545-553. http://www.scopus.com/inward/record.url?eid=2-s2.0-84955317254&partnerID=MN8TOARS.
    10.1007/s00228-016-2015-3
  208. Sousa, H.; Bastos, M.; Ribeiro, J.; Oliveira, S.; Breda, E.; Catarino, R.; Medeiros, R.. "5'UTR +24T>C CR2 is not associated with nasopharyngeal carcinoma development in the North Region of Portugal". Oral Diseases 22 4 (2016): 280-284. http://www.scopus.com/inward/record.url?eid=2-s2.0-84962920794&partnerID=MN8TOARS.
    10.1111/odi.12436
  209. Sousa, H.; Mesquita, L.; Ribeiro, J.; Catarino, R.; Breda, E.; Medeiros, R.. "Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal". Immunobiology 221 2 (2016): 145-152. http://www.scopus.com/inward/record.url?eid=2-s2.0-84942052730&partnerID=MN8TOARS.
    10.1016/j.imbio.2015.09.015
  210. Pontes, M.L.; Medeiros, R.. "Autosomal SNPs in different forensic applications". Australian Journal of Forensic Sciences 48 3 (2016): 248-256. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930911055&partnerID=MN8TOARS.
    10.1080/00450618.2015.1050067
  211. Marques, H; Freitas, J; Medeiros, R; Longatto Filho, A. "Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability". International Journal of Molecular Epidemiology and Genetics (2016):
  212. Rui M. Gil da Costa; Margarida M. S. M. Bastos; Rui Medeiros; Paula A. Oliveira. "The NFkB signaling pathway in papillomavirus-induced lesions: Friend or foe?". (2016): https://hdl.handle.net/10216/104671.
  213. Carvalho, Serafim; Santos, Marlene; Lima, Luís; Mota-Pereira, Jorge; Pimentel, Paulo; Maia, Dulce; Correia, Diana; et al. "IL6-174G > C genetic polymorphism influences antidepressant treatment outcome". (2016): http://hdl.handle.net/10400.22/9333.
    10.1080/08039488.2016.1242650
  214. Santos, Marlene; Carvalho, Serafim; Lima, Luís; Mota-Pereira, Jorge; Pimentel, Paulo; Maia, Dulce; Correia, Diana; et al. "The role of IL18-607C > A and IL18-137G > C promoter polymorphisms in antidepressant treatment phenotypes: A preliminary report". (2016): http://hdl.handle.net/10400.22/9332.
    10.1016/j.neulet.2016.03.026
  215. Carlos Santos; Pedro Ferreirinha; Hugo Sousa; Joana Ribeiro; Margarida M. S. M. Bastos; Tiago Neto; Paula A. Oliveira; et al. "Ptaquiloside from bracken (Pteridium spp.) inhibits tumour-infiltrating CD8(+) T cells in HPV-16 transgenic mice". (2016): https://hdl.handle.net/10216/103359.
    10.1016/j.fct.2016.09.019
  216. Carlos Santos; Tiago Neto; Pedro Ferreirinha; Hugo Sousa; Joana Ribeiro; Margarida M. S. M. Bastos; Ana I. Faustino Rocha; et al. "Celecoxib promotes degranulation of CD8(+) T cells in HPV-induced lesions of K14-HPV16 transgenic mice". (2016): https://hdl.handle.net/10216/103360.
    10.1016/j.lfs.2016.05.040
  217. Marques, Herlander; Freitas, J.; Medeiros, Rui; Longatto Filho, Adhemar. "Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability". (2016): http://hdl.handle.net/1822/45076.
  218. Margarida Freitas-Silva; Luciana Gonçalves; Rui Medeiros; José Pedro Nunes. "Can the Previous Therapeutic Control of the Main Risk Factors of Cerebrovascular Disease Influence the Acetylsalicylic Acid–Nonresponsive Status in Acute Ischemic Stroke Patients? Results from a Portuguese Prospective Cohort Study". Journal of Stroke and Cerebrovascular Diseases 24 6 (2015): 1383-1389. https://doi.org/10.1016%2Fj.jstrokecerebrovasdis.2015.02.021.
    10.1016/j.jstrokecerebrovasdis.2015.02.021
  219. Gomes, M.; Teixeira, A.L.; Coelho, A.; Medeiros, R.; Araújo, A.. "The role of biobanks in oncology research - A Portuguese perspective". Journal of Intellectual Disability - Diagnosis and Treatment 3 2 (2015): 63-69. http://www.scopus.com/inward/record.url?eid=2-s2.0-85038242311&partnerID=MN8TOARS.
    10.6000/2292-2598.2015.03.02.3
  220. Santos, M.; Carvalho, S.; Lima, L.; Mota-Pereira, J.; Pimentel, P.; Maia, D.; Correia, D.; et al. "FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression". Journal of Affective Disorders 185 (2015): 164-169. http://www.scopus.com/inward/record.url?eid=2-s2.0-84955453477&partnerID=MN8TOARS.
    10.1016/j.jad.2015.06.027
  221. Rodrigues, P.; Teixeira, A.; Kustner, E.; Medeiros, R.. "Are herpes virus associated to aggressive periodontitis? A review of literature". Journal of Oral and Maxillofacial Pathology 19 3 (2015): 348-355. http://www.scopus.com/inward/record.url?eid=2-s2.0-84957095716&partnerID=MN8TOARS.
    10.4103/0973-029X.174621
  222. Abreu, M.H.; Gomes, M.; Menezes, F.; Afonso, N.; Abreu, P.H.; Medeiros, R.; Pereira, D.; Lopes, C.. "CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer?". Breast 24 4 (2015): 481-486. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930754273&partnerID=MN8TOARS.
    10.1016/j.breast.2015.04.010
  223. Silva, S.S.; Lopes, C.; Teixeira, A.L.; Sousa, M.J.C.D.; Medeiros, R.. "Forensic miRNA: Potential biomarker for body fluids?". Forensic Science International: Genetics 14 (2015): 1-10. http://www.scopus.com/inward/record.url?eid=2-s2.0-84907843397&partnerID=MN8TOARS.
    10.1016/j.fsigen.2014.09.002
  224. Gomes, A.; Correia, G.; Coelho, M.; Araújo, J.R.; Pinho, M.J.; Teixeira, A.L.; Medeiros, R.; Ribeiro, L.. "Dietary unsaturated fatty acids differently affect catecholamine handling by adrenal chromaffin cells". Journal of Nutritional Biochemistry 26 5 (2015): 563-570. http://www.scopus.com/inward/record.url?eid=2-s2.0-84928273811&partnerID=MN8TOARS.
    10.1016/j.jnutbio.2014.12.009
  225. Silva, J.; Cerqueira, F.; Medeiros, R.. "Y chromosome DNA in cervicovaginal self-collected samples of childbearing age women: Implications for epitheliotropic sexually transmitted infections?". Life Sciences 139 (2015): 62-68. http://www.scopus.com/inward/record.url?eid=2-s2.0-84940021208&partnerID=MN8TOARS.
    10.1016/j.lfs.2015.07.027
  226. Malta, M.; Ribeiro, J.; Monteiro, P.; Loureiro, J.; Medeiros, R.; Sousa, H.. "Let-7c is a Candidate Biomarker for Cervical Intraepithelial Lesions: A Pilot Study". Molecular Diagnosis and Therapy 19 3 (2015): 191-196. http://www.scopus.com/inward/record.url?eid=2-s2.0-84931567476&partnerID=MN8TOARS.
    10.1007/s40291-015-0145-4
  227. Paiva, I.; Da Costa, R.M.G.; Ribeiro, J.; Sousa, H.; Bastos, M.; Rocha, A.F.C.; Oliveira, P.A.; Medeiros, R.. "A role for MicroRNA-155 expression in microenvironment associated to HPV-induced carcinogenesis in K14-HPV16 transgenic mice". PLoS ONE 10 1 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84921957587&partnerID=MN8TOARS.
    10.1371/journal.pone.0116868
  228. Lima, L.; Oliveira, D.; Ferreira, J.A.; Tavares, A.; Cruz, R.; Medeiros, R.; Santos, L.. "The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: Establishment of a predictive profile in a Southern Europe population". BJU International 116 5 (2015): 753-763. http://www.scopus.com/inward/record.url?eid=2-s2.0-84943581018&partnerID=MN8TOARS.
    10.1111/bju.12844
  229. Rosinha, A.; Assis, J.; Dias, F.; Nogueira, A.; Pereira, D.; Maurício, J.; Teixeira, A.L.; Medeiros, R.. "DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1". Medical Oncology 32 11 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84944723342&partnerID=MN8TOARS.
    10.1007/s12032-015-0701-0
  230. Coelho, M.; Moz, M.; Correia, G.; Teixeira, A.; Medeiros, R.; Ribeiro, L.. "Antiproliferative effects of ß-blockers on human colorectal cancer cells". Oncology Reports 33 5 (2015): 2513-2520. http://www.scopus.com/inward/record.url?eid=2-s2.0-84927125658&partnerID=MN8TOARS.
    10.3892/or.2015.3874
  231. Teixeira, A.L.; Dias, F.; Ferreira, M.; Gomes, M.; Santos, J.I.; Lobo, F.; Maurício, J.; Machado, J.C.; Medeiros, R.. "Combined influence of EGF+61G>A and TGFB+869T>C functional polymorphisms in renal cell carcinoma progression and overall survival: The link to plasma circulating MiR-7 and MiR-221/222 Expression". PLoS ONE 10 4 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84929380268&partnerID=MN8TOARS.
    10.1371/journal.pone.0103258
  232. Coelho, A.L.; Araújo, A.M.; Gomes, M.P.; Catarino, R.J.; Andrade, E.B.; Lopes, A.M.; Medeiros, R.M.. "Combined Ang-2 and VEGF serum levels: Holding hands as a new integral biomarker in non-small-cell lung cancers". Future Oncology 11 24 (2015): 3233-3242. http://www.scopus.com/inward/record.url?eid=2-s2.0-84948988367&partnerID=MN8TOARS.
    10.2217/fon.15.207
  233. Pontes, M.L.; Fondevila, M.; Laréu, M.V.; Medeiros, R.. "SNP Markers as Additional Information to Resolve Complex Kinship Cases". Transfusion Medicine and Hemotherapy 42 6 (2015): 385-388. http://www.scopus.com/inward/record.url?eid=2-s2.0-84951848578&partnerID=MN8TOARS.
    10.1159/000440832
  234. Machado, M.T.; Navega, S.; Dias, F.; De Sousa, M.J.C.; Teixeira, A.L.; Medeiros, R.. "MicroRNAs for peripheral blood fraction identification: Origin, pathways and forensic relevance". Life Sciences 143 (2015): 98-104. http://www.scopus.com/inward/record.url?eid=2-s2.0-84946545179&partnerID=MN8TOARS.
    10.1016/j.lfs.2015.10.029
  235. Paiva, I.; Gil Da Costa, R.M.; Ribeiro, J.; Sousa, H.; Bastos, M.M.S.M.; Faustino-Rocha, A.; Lopes, C.; Oliveira, P.A.; Medeiros, R.. "MicroRNA-21 expression and susceptibility to HPV-induced carcinogenesis - Role of microenvironment in K14-HPV16 mice model". Life Sciences 128 (2015): 8-14. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925071316&partnerID=MN8TOARS.
    10.1016/j.lfs.2015.02.020
  236. Ribeiro, J.; Marinho-Dias, J.; Monteiro, P.; Loureiro, J.; Baldaque, I.; Medeiros, R.; Sousa, H.. "MiR-34a and miR-125b expression in HPV infection and cervical cancer development". BioMed Research International 2015 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84934950348&partnerID=MN8TOARS.
    10.1155/2015/304584
  237. Paiva, I.; Gil da Costa, R. M.; Ribeiro, J.; Sousa, H.; Bastos, M.; Rocha, A. F.; Oliveira, P. A.; Medeiros, R.. "A role for microRNA-155 expression in microenvironment associated to HPV-induced carcinogenesis in K14-HPV16 transgenic mice". PLoS One 10 (2015): e0116868-e0116868.
    10.1371/journal.pone.011686810.1371/journal.pone.0116868. eCollection 2015.
  238. Castelao, C.; da Silva, A. P.; Matos, A.; Inacio, A.; Bicho, M.; Medeiros, R.; Bicho, M. C.. "Association of myeloperoxidase polymorphism (G463A) with cervix cancer". Mol Cell Biochem 404 (2015): 1-4.
    10.1007/s11010-015-2359-510.1007/s11010-015-2359-5. Epub 2015 Feb 21.
  239. Coelho, M.; Moz, M.; Correia, G.; Teixeira, A.; Medeiros, R.; Ribeiro, L.. "Antiproliferative effects of beta-blockers on human colorectal cancer cells". Oncol Rep 33 (2015): 2513-20.
    10.3892/or.2015.387410.3892/or.2015.3874. Epub 2015 Mar 23.
  240. Silva, S. S.; Lopes, C.; Teixeira, A. L.; Carneiro de Sousa, M. J.; Medeiros, R.. "Forensic miRNA: potential biomarker for body fluids?". Forensic Sci Int Genet 14 (2015): 1-10.
    10.1016/j.fsigen.2014.09.00210.1016/j.fsigen.2014.09.002. Epub 2014 Sep 10.
  241. Santos, M.; Carvalho, S.; Lima, L.; Mota-Pereira, J.; Pimentel, P.; Maia, D.; Correia, D.; et al. "FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression". J Affect Disord 185 (2015): 164-9.
    10.1016/j.jad.2015.06.02710.1016/j.jad.2015.06.027. Epub 2015 Jun 24.
  242. Gomes, M.; Coelho, A.; Araujo, A.; Azevedo, A.; Teixeira, A. L.; Catarino, R.; Medeiros, R.. "IL-6 polymorphism in non-small cell lung cancer: a prognostic value?". Tumour Biol 36 (2015): 3679-84.
    10.1007/s13277-014-3006-610.1007/s13277-014-3006-6. Epub 2015 Jan 9.
  243. Fraga, A.; Ribeiro, R.; Principe, P.; Lopes, C.; Medeiros, R.. "Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings". Clin Genitourin Cancer 13 (2015): 295-301.
    10.1016/j.clgc.2015.03.00610.1016/j.clgc.2015.03.006. Epub 2015 Mar 28.
  244. Neves, M.; Marinho-Dias, J.; Ribeiro, J.; Esteves, M.; Maltez, E.; Baldaque, I.; Breda, E.; et al. "Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal". J Med Virol 87 (2015): 1382-8.
    10.1002/jmv.2419010.1002/jmv.24190. Epub 2015 Apr 16.
  245. Freitas-Silva, M.; Goncalves, L.; Medeiros, R.; Nunes, J. P.. "Can the previous therapeutic control of the main risk factors of cerebrovascular disease influence the acetylsalicylic Acid-nonresponsive status in acute ischemic stroke patients? Results from a portuguese prospective cohort study". J Stroke Cerebrovasc Dis 24 (2015): 1383-9.
    10.1016/j.jstrokecerebrovasdis.2015.02.02110.1016/j.jstrokecerebrovasdis.2015.02.021. Epub 2015 Apr 7.
  246. Gomes, A.; Correia, G.; Coelho, M.; Araujo, J. R.; Pinho, M. J.; Teixeira, A. L.; Medeiros, R.; Ribeiro, L.. "Dietary unsaturated fatty acids differently affect catecholamine handling by adrenal chromaffin cells". J Nutr Biochem 26 (2015): 563-70.
    10.1016/j.jnutbio.2014.12.00910.1016/j.jnutbio.2014.12.009. Epub 2015 Feb 12.
  247. Abreu, M. H.; Gomes, M.; Menezes, F.; Afonso, N.; Abreu, P. H.; Medeiros, R.; Pereira, D.; Lopes, C.. "CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer?". Breast 24 (2015): 481-6.
    10.1016/j.breast.2015.04.01010.1016/j.breast.2015.04.010. Epub 2015 May 8.
  248. Silva, J.; Cerqueira, F.; Medeiros, R.. "Y chromosome DNA in cervicovaginal self-collected samples of childbearing age women: Implications for epitheliotropic sexually transmitted infections?". Life Sci (2015):
    10.1016/j.lfs.2015.07.02710.1016/j.lfs.2015.07.027.
  249. Castaldo, S. A.; da Silva, A. P.; Matos, A.; Inacio, A.; Bicho, M.; Medeiros, R.; Alho, I.; Bicho, M. C.. "The role of CYBA (p22phox) and catalase genetic polymorphisms and their possible epistatic interaction in cervical cancer". Tumour Biol 36 (2015): 909-14.
    10.1007/s13277-014-2714-210.1007/s13277-014-2714-2. Epub 2014 Oct 12.
  250. Paiva, I.; Gil da Costa, R. M.; Ribeiro, J.; Sousa, H.; Bastos, M. M.; Faustino-Rocha, A.; Lopes, C.; Oliveira, P. A.; Medeiros, R.. "MicroRNA-21 expression and susceptibility to HPV-induced carcinogenesis - role of microenvironment in K14-HPV16 mice model". Life Sci 128 (2015): 8-14.
    10.1016/j.lfs.2015.02.02010.1016/j.lfs.2015.02.020. Epub 2015 Mar 12.
  251. Malta, M.; Ribeiro, J.; Monteiro, P.; Loureiro, J.; Medeiros, R.; Sousa, H.. "Let-7c is a Candidate Biomarker for Cervical Intraepithelial Lesions: A Pilot Study". Mol Diagn Ther 19 (2015): 191-6.
    10.1007/s40291-015-0145-410.1007/s40291-015-0145-4.
  252. Lima, A.; Bernardes, M.; Azevedo, R.; Medeiros, R.; Seabra, V.. "Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?". Int J Mol Sci 16 (2015): 13760-80.
    10.3390/ijms16061376010.3390/ijms160613760.
  253. Ribeiro, J.; Marinho-Dias, J.; Monteiro, P.; Loureiro, J.; Baldaque, I.; Medeiros, R.; Sousa, H.. "miR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development". Biomed Res Int 2015 (2015): 304584-304584.
    10.1155/2015/30458410.1155/2015/304584. Epub 2015 Jun 9.
  254. Gomes, M; Coelho, A; Araujo, A; Azevedo, A; Teixeira, AL; Catarino, R; Rui Medeiros. "IL-6 polymorphism in non-small cell lung cancer: a prognostic value?". (2015): https://hdl.handle.net/10216/117737.
    10.1007/s13277-014-3006-6
  255. Isabel Paiva; Rui M. Gil da Costa; Joana Ribeiro; Hugo Sousa; Margarida M. S. M. Bastos; Ana Faustino Carlos Rocha; Paula A. Oliveira; Rui Medeiros. "A Role for MicroRNA-155 Expression in Microenvironment Associated to HPV-Induced Carcinogenesis in K14-HPV16 Transgenic Mice". (2015): https://hdl.handle.net/10216/103353.
    10.1371/journal.pone.0116868
  256. Silva, T; Martins, HC; Coutinho, R; Leitao, E; Silva, R; Padua, E. "Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV". JOURNAL OF MEDICAL VIROLOGY (2015):
    10.1002/jmv.24213
  257. Aurea Lima; Vítor Seabra; Miguel Bernardes; Rita Azevedo; Hugo Sousa; Rui Medeiros; Yue Wang. "Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients". PLoS ONE 9 10 (2014): e108165-e108165. http://dx.doi.org/10.1371/journal.pone.0108165.
    10.1371/journal.pone.0108165
  258. Aurea Lima; Hugo Sousa; Joaquim Monteiro; Rita Azevedo; Rui Medeiros; Vitor Seabra. "Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers". Pharmacogenomics 15 12 (2014): 1611-1635. http://dx.doi.org/10.2217/pgs.14.116.
    10.2217/pgs.14.116
  259. Ana Oliveira; Dora Pinho; António Albino-Teixeira; Rui Medeiros; Ricardo Dinis-Oliveira; Félix Carvalho. "Effects of modulating morphine metabolism on its pharmacological action in guinea pigs". Toxicology Letters 229 (2014): S96-S96. http://dx.doi.org/10.1016/j.toxlet.2014.06.355.
    10.1016/j.toxlet.2014.06.355
  260. Ana Oliveira; Dora Pinho; António Albino-Teixeira; Rui Medeiros; Ricardo Jorge Dinis-Oliveira; Félix Carvalho. "Morphine glucuronidation increases its analgesic effect in guinea pigs". Life Sciences 109 2 (2014): 104-110. http://dx.doi.org/10.1016/j.lfs.2014.06.010.
    10.1016/j.lfs.2014.06.010
  261. Jani Silva; Fátima Cerqueira; Rui Medeiros. "Response to: Chlamydia trachomatis, human papillomavirus, bacterial vaginosis and cervical neoplasia". Arch Gynecol Obstet 289 6 (2014): 1157-1158. http://dx.doi.org/10.1007/s00404-014-3215-7.
    10.1007/s00404-014-3215-7
  262. Carina Pereira; Sara Queirós; Ana Galaghar; Hugo Sousa; Pedro Pimentel-Nunes; Catarina Brandão; Luís Moreira-Dias; et al. "Genetic Variability in Key Genes in Prostaglandin E2 Pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and Their Involvement in Colorectal Cancer Development". PLoS ONE 9 4 (2014): e92000-e92000. http://dx.doi.org/10.1371/journal.pone.0092000.
    10.1371/journal.pone.0092000
  263. Juliana Inês Santos; Ana Luísa Teixeira; Francisca Dias; Mónica Gomes; Augusto Nogueira; Joana Assis; Rui Medeiros. "Restoring TGFß1 pathway-related microRNAs: possible impact in metastatic prostate cancer development". Tumor Biol. 35 7 (2014): 6245-6253. http://dx.doi.org/10.1007/s13277-014-1887-z.
    10.1007/s13277-014-1887-z
  264. Gérard Siest; Rui Medeiros; Bohuslav Melichar; Maria Stathopoulou; Ron HN Van Schaik; Ramon Cacabelos; Peter Meier Abt; et al. "Conference Scene: Pharmacogenomics: from cell to clinic (Part 1)". Pharmacogenomics 15 5 (2014): 593-599. http://dx.doi.org/10.2217/pgs.14.35.
    10.2217/pgs.14.35
  265. Ana L Teixeira; Francisca Dias; Mónica Gomes; Mara Fernandes; Rui Medeiros. "Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?". jkcvhl 1 8 (2014): 84-84. http://dx.doi.org/10.15586/jkcvhl.2014.19.
    10.15586/jkcvhl.2014.19
  266. Hugo Sousa; David Boutolleau; Joana Ribeiro; Ana L. Teixeira; Carlos Pinho Vaz; Fernando Campilho; Rosa Branca; et al. "Cytomegalovirus Infection in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation in Portugal: A Five-Year Retrospective Review". Biology of Blood and Marrow Transplantation 20 12 (2014): 1958-1967. http://dx.doi.org/10.1016/j.bbmt.2014.08.010.
    10.1016/j.bbmt.2014.08.010
  267. Oliveira, A.; Carvalho, F.; Pinho, P.G.; Remião, F.; Medeiros, R.; Dinis-Oliveira, R.J.. "Quantification of morphine and its major metabolites M3G and M6G in antemortem and postmortem samples". Biomedical Chromatography 28 9 (2014): 1263-1270. http://www.scopus.com/inward/record.url?eid=2-s2.0-84905570766&partnerID=MN8TOARS.
    10.1002/bmc.3158
  268. Ribeiro, A.I.; Gabriel, C.; Cerqueira, F.; Maia, M.; Pinto, E.; Sousa, J.C.; Medeiros, R.; Proença, M.F.; Dias, A.M.. "Synthesis and antimicrobial activity of novel 5-aminoimidazole-4-carboxamidrazones". Bioorganic and Medicinal Chemistry Letters 24 19 (2014): 4699-4702. http://www.scopus.com/inward/record.url?eid=2-s2.0-84907210331&partnerID=MN8TOARS.
    10.1016/j.bmcl.2014.08.025
  269. Oliveira, A.; Dinis-Oliveira, R.J.; Nogueira, A.; Gonçalves, F.; Silva, P.; Vieira, C.; Silvestre, R.; Carvalho, F.; Medeiros, R.. "Interleukin-1ß genotype and circulating levels in cancer patients: Metastatic status and pain perception". Clinical Biochemistry 47 13-14 (2014): 1209-1213. http://www.scopus.com/inward/record.url?eid=2-s2.0-84899467319&partnerID=MN8TOARS.
    10.1016/j.clinbiochem.2014.04.009
  270. Lima, A.; Bernardes, M.; Sousa, H.; Azevedo, R.; Costa, L.; Ventura, F.; Seabra, V.; Medeiros, R.. "SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients". Pharmacogenomics 15 6 (2014): 807-820. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896373858&partnerID=MN8TOARS.
    10.2217/pgs.13.244
  271. Soares, S.; Craveiro, R.; Catarino, R.; Breda, E.; Medeiros, R.; Bravo, I.. "The role of nt590 P21 gene polymorphism in the susceptibility to nasopharyngeal cancer". Experimental Oncology 36 1 (2014): 44-47. http://www.scopus.com/inward/record.url?eid=2-s2.0-84901217980&partnerID=MN8TOARS.
  272. Oliveira, A.; Dinis-Oliveira, R.J.; Nogueira, A.; Azevedo, A.S.; Gonçalves, F.; Silva, P.; Carvalho, F.; Medeiros, R.. "Genetic profile and cancer-related pain: A tale from two outlier cases with bone metastatic disease". Pain Medicine (United States) 15 4 (2014): 710-712. http://www.scopus.com/inward/record.url?eid=2-s2.0-84898041413&partnerID=MN8TOARS.
    10.1111/pme.12314
  273. Soares, S.; Craveiro, R.; Catarino, R.; Breda, E.; Medeiros, R.; Bravo, I.. "The role of nt590 P21 gene polymorphism in the susceptibility to nasopharyngeal cancer". Exp Oncol 36 (2014): 44-7. http://www.ncbi.nlm.nih.gov/pubmed/24691284.
  274. Coelho, A.L.; Araú Jo, A.; Gomes, M.; Catarino, R.; Marques, A.; Medeiros, R.. "Circulating ang-2 mrna expression levels: Looking ahead to a new prognostic factor for NSCLC". PLoS ONE 9 2 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84896532455&partnerID=MN8TOARS.
    10.1371/journal.pone.0090009
  275. Siest, G.; Medeiros, R.; Melichar, B.; Stathopoulou, M.; Van Schaik, R.H.N.; Cacabelos, R.; Abt, P.M.; et al. "Conference Scene: Pharmacogenomics: from cell to clinic (Part 2)". Pharmacogenomics 15 6 (2014): 739-744. http://www.scopus.com/inward/record.url?eid=2-s2.0-84922393876&partnerID=MN8TOARS.
    10.2217/PGS.14.36
  276. Ribeiro, J.; Teixeira, D.; Marinho-Dias, J.; Monteiro, P.; Loureiro, J.; Baldaque, I.; Medeiros, R.; Sousa, H.. "Characterization of human papillomavirus genotypes and HPV-16 physical status in cervical neoplasias of women from northern Portugal". International Journal of Gynecology and Obstetrics 125 2 (2014): 107-110. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897572092&partnerID=MN8TOARS.
    10.1016/j.ijgo.2013.10.011
  277. Silva, J.; Cerqueira, F.; Medeiros, R.. "Chlamydia trachomatis infection: Implications for HPV status and cervical cancer". Archives of Gynecology and Obstetrics 289 4 (2014): 715-723. http://www.scopus.com/inward/record.url?eid=2-s2.0-84899005736&partnerID=MN8TOARS.
    10.1007/s00404-013-3122-3
  278. Lima, A.; Monteiro, J.; Bernardes, M.; Sousa, H.; Azevedo, R.; Seabra, V.; Medeiros, R.. "Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: Implication of MTHFR RS1801133 and ATIC RS4673993 polymorphisms". BioMed Research International 2014 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84902174947&partnerID=MN8TOARS.
    10.1155/2014/368681
  279. Lima, A.; Bernardes, M.; Azevedo, R.; Monteiro, J.; Sousa, H.; Medeiros, R.; Seabra, V.. "SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients". Toxicological Sciences 142 1 (2014): 196-209. http://www.scopus.com/inward/record.url?eid=2-s2.0-84934993519&partnerID=MN8TOARS.
    10.1093/toxsci/kfu162
  280. Lima, A.; Seabra, V.; Martins, S.; Coelho, A.; Araújo, A.; Medeiros, R.. "Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy". Molecular Biology Reports 41 5 (2014): 3349-3357. http://www.scopus.com/inward/record.url?eid=2-s2.0-84905716777&partnerID=MN8TOARS.
    10.1007/s11033-014-3197-3
  281. Santos, J.I.; Teixeira, A.L.; Dias, F.; Maurício, J.; Lobo, F.; Morais, A.; Medeiros, R.. "Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: Evidences from in vitro and in vivo studies". Tumor Biology 35 7 (2014): 7105-7113. http://www.scopus.com/inward/record.url?eid=2-s2.0-84905044659&partnerID=MN8TOARS.
    10.1007/s13277-014-1918-9
  282. Siest, G.; Medeiros, R.; Melichar, B.; Stathopoulou, M.; Van Schaik, R. H.; Cacabelos, R.; Abt, P. M.; et al. "Conference scene: pharmacogenomics: from cell to clinic (part 2)". Pharmacogenomics 15 (2014): 739-44.
    10.2217/pgs.14.3610.2217/pgs.14.36.
  283. Santos, M.; Carvalho, S.; Lima, L.; Nogueira, A.; Assis, J.; Mota-Pereira, J.; Pimentel, P.; et al. "Common genetic polymorphisms in the ABCB1 gene are associated with risk of major depressive disorder in male Portuguese individuals". Genet Test Mol Biomarkers 18 (2014): 12-9.
    10.1089/gtmb.2013.019710.1089/gtmb.2013.0197. Epub 2013 Nov 7.
  284. Lima, L.; Ferreira, J. A.; Tavares, A.; Oliveira, D.; Morais, A.; Videira, P. A.; Medeiros, R.; Santos, L.. "FASL polymorphism is associated with response to bacillus Calmette-Guerin immunotherapy in bladder cancer". Urol Oncol 32 (2014): 44 e1-7.
    10.1016/j.urolonc.2013.05.00910.1016/j.urolonc.2013.05.009. Epub 2013 Aug 12.
  285. Sousa, H.; Boutolleau, D.; Ribeiro, J.; Teixeira, A. L.; Pinho Vaz, C.; Campilho, F.; Branca, R.; et al. "Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: a five-year retrospective review". Biol Blood Marrow Transplant 20 (2014): 1958-67.
    10.1016/j.bbmt.2014.08.01010.1016/j.bbmt.2014.08.010. Epub 2014 Aug 17.
  286. Silva, J.; Cerqueira, F.; Medeiros, R.. "Chlamydia trachomatis infection: implications for HPV status and cervical cancer". Arch Gynecol Obstet 289 (2014): 715-23.
    10.1007/s00404-013-3122-310.1007/s00404-013-3122-3. Epub 2013 Dec 18.
  287. Costa, M. L.; Lima-Junior, R. C.; Aragao, K. S.; Medeiros, R. P.; Marques-Neto, R. D.; de Sa Grassi, L.; Leite, L. L.; et al. "Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal model". Cancer Chemother Pharmacol 74 (2014): 711-20.
    10.1007/s00280-014-2434-810.1007/s00280-014-2434-8. Epub 2014 Aug 1.
  288. Teixeira, A. L.; Dias, F.; Ferreira, M.; Gomes, M.; Santos, J. I.; Lobo, F.; Mauricio, J.; Machado, J. C.; Medeiros, R.. "Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression". PLoS One 10 (2014): e0103258-e0103258.
    10.1371/journal.pone.010325810.1371/journal.pone.0103258. eCollection 2014.
  289. Coelho, A. L.; Araujo, A.; Gomes, M.; Catarino, R.; Marques, A.; Medeiros, R.. "Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected]". PLoS One 9 (2014): e90009-e90009.
    10.1371/journal.pone.009000910.1371/journal.pone.0090009. eCollection 2014.
  290. Santos, J. I.; Teixeira, A. L.; Dias, F.; Mauricio, J.; Lobo, F.; Morais, A.; Medeiros, R.. "Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies". Tumour Biol 35 (2014): 7105-13.
    10.1007/s13277-014-1918-910.1007/s13277-014-1918-9. Epub 2014 Apr 24.
  291. Teixeira, A. L.; Ferreira, M.; Silva, J.; Gomes, M.; Dias, F.; Santos, J. I.; Mauricio, J.; Lobo, F.; Medeiros, R.. "Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients". Tumour Biol 35 (2014): 4057-66.
    10.1007/s13277-013-1531-310.1007/s13277-013-1531-3. Epub 2013 Dec 31.
  292. Oliveira, A.; Pinho, D.; Albino-Teixeira, A.; Medeiros, R.; Dinis-Oliveira, R. J.; Carvalho, F.. "Morphine glucuronidation increases its analgesic effect in guinea pigs". Life Sci 109 (2014): 104-10.
    10.1016/j.lfs.2014.06.01010.1016/j.lfs.2014.06.010. Epub 2014 Jun 24.
  293. Oliveira, A.; Dinis-Oliveira, R. J.; Nogueira, A.; Goncalves, F.; Silva, P.; Vieira, C.; Silvestre, R.; Carvalho, F.; Medeiros, R.. "Interleukin-1beta genotype and circulating levels in cancer patients: metastatic status and pain perception". Clin Biochem 47 (2014): 1209-13.
    10.1016/j.clinbiochem.2014.04.00910.1016/j.clinbiochem.2014.04.009. Epub 2014 Apr 18.
  294. Oliveira, A.; Dinis-Oliveira, R. J.; Nogueira, A.; Azevedo, A. S.; Goncalves, F.; Silva, P.; Carvalho, F.; Medeiros, R.. "Genetic profile and cancer-related pain: a tale from two outlier cases with bone metastatic disease". Pain Med 15 (2014): 710-2.
    10.1111/pme.1231410.1111/pme.12314. Epub 2013 Dec 11.
  295. Lima, A.; Sousa, H.; Monteiro, J.; Azevedo, R.; Medeiros, R.; Seabra, V.. "Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers". Pharmacogenomics 15 (2014): 1611-35.
    10.2217/pgs.14.11610.2217/pgs.14.116.
  296. Duro, M.; Rebelo, I.; Barreira, S.; Sarmento-Castro, R.; Medeiros, R.; Almeida, C.. "Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients". Int J STD AIDS (2014):
    10.1177/0956462414554814
  297. Pereira, C.; Queiros, S.; Galaghar, A.; Sousa, H.; Pimentel-Nunes, P.; Brandao, C.; Moreira-Dias, L.; Medeiros, R.; Dinis-Ribeiro, M.. "Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development". PLoS One 9 (2014): e92000-e92000.
    10.1371/journal.pone.009200010.1371/journal.pone.0092000. eCollection 2014.
  298. Ribeiro, J.; Teixeira, D.; Marinho-Dias, J.; Monteiro, P.; Loureiro, J.; Baldaque, I.; Medeiros, R.; Sousa, H.. "Characterization of human papillomavirus genotypes and HPV-16 physical status in cervical neoplasias of women from northern Portugal". Int J Gynaecol Obstet 125 (2014): 107-10.
    10.1016/j.ijgo.2013.10.01110.1016/j.ijgo.2013.10.011. Epub 2014 Jan 15.
  299. Gil da Costa, R. M.; Medeiros, R.. "Bovine papillomavirus: opening new trends for comparative pathology". Arch Virol 159 (2014): 191-8.
    10.1007/s00705-013-1801-910.1007/s00705-013-1801-9. Epub 2013 Aug 9.
  300. Soares, S.; Craveiro, R.; Catarino, R.; Breda, E.; Medeiros, R.; Bravo, I.. "The role of nt590 P21 gene polymorphism in the susceptibility to nasopharyngeal cancer". Exp Oncol 36 (2014): 44-7.
  301. Lima, A.; Bernardes, M.; Sousa, H.; Azevedo, R.; Costa, L.; Ventura, F.; Seabra, V.; Medeiros, R.. "SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients". Pharmacogenomics 15 (2014): 807-20.
    10.2217/pgs.13.24410.2217/pgs.13.244. Epub 2013 Dec 18.
  302. Lima, A.; Seabra, V.; Bernardes, M.; Azevedo, R.; Sousa, H.; Medeiros, R.. "Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients". PLoS One 9 (2014): e108165-e108165.
    10.1371/journal.pone.010816510.1371/journal.pone.0108165. eCollection 2014.
  303. Ribeiro, A. I.; Gabriel, C.; Cerqueira, F.; Maia, M.; Pinto, E.; Sousa, J. C.; Medeiros, R.; Proenca, M. F.; Dias, A. M.. "Synthesis and antimicrobial activity of novel 5-aminoimidazole-4-carboxamidrazones". Bioorg Med Chem Lett 24 (2014): 4699-702.
    10.1016/j.bmcl.2014.08.02510.1016/j.bmcl.2014.08.025. Epub 2014 Aug 17.
  304. Lima, A.; Bernardes, M.; Azevedo, R.; Monteiro, J.; Sousa, H.; Medeiros, R.; Seabra, V.. "SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients". Toxicol Sci 142 (2014): 196-209.
    10.1093/toxsci/kfu16210.1093/toxsci/kfu162. Epub 2014 Aug 14.
  305. Lima, A.; Monteiro, J.; Bernardes, M.; Sousa, H.; Azevedo, R.; Seabra, V.; Medeiros, R.. "Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms". Biomed Res Int 2014 (2014): 368681-368681.
    10.1155/2014/36868110.1155/2014/368681. Epub 2014 May 21.
  306. Siest, G.; Medeiros, R.; Melichar, B.; Stathopoulou, M.; Van Schaik, R. H.; Cacabelos, R.; Abt, P. M.; et al. "Pharmacogenomics: from cell to clinic (Part 1)". Pharmacogenomics 15 (2014): 593-9.
    10.2217/pgs.14.3510.2217/pgs.14.35.
  307. Santos, J. I.; Teixeira, A. L.; Dias, F.; Gomes, M.; Nogueira, A.; Assis, J.; Medeiros, R.. "Restoring TGFbeta1 pathway-related microRNAs: possible impact in metastatic prostate cancer development". Tumour Biol 35 (2014): 6245-53.
    10.1007/s13277-014-1887-z10.1007/s13277-014-1887-z. Epub 2014 Apr 25.
  308. Silva, J.; Cerqueira, F.; Medeiros, R.. "Response to: Chlamydia trachomatis, human papillomavirus, bacterial vaginosis and cervical neoplasia". Arch Gynecol Obstet 289 (2014): 1157-8.
    10.1007/s00404-014-3215-710.1007/s00404-014-3215-7.
  309. Lima, A.; Seabra, V.; Martins, S.; Coelho, A.; Araujo, A.; Medeiros, R.. "Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy". Mol Biol Rep 41 (2014): 3349-57.
    10.1007/s11033-014-3197-310.1007/s11033-014-3197-3. Epub 2014 Feb 20.
  310. Soares, S.; Craveiro, R.; Catarino, R.; Breda, E.; Medeiros, R.; Bravo, I.. "The role of nt590 P21 gene polymorphism in the susceptibility to nasopharyngeal cancer". Exp Oncol 36 (2014): 44-7.
  311. Sousa, H.; Oliveira, S.; Santos, A. M.; Catarino, R.; Moutinho, J.; Medeiros, R.. "Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer". Tumour Biol 35 (2014): 2561-4.
    10.1007/s13277-013-1337-310.1007/s13277-013-1337-3. Epub 2013 Nov 7.
  312. Fraga, A.; Ribeiro, R.; Principe, P.; Lobato, C.; Pina, F.; Mauricio, J.; Monteiro, C.; et al. "The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration". Eur J Cancer 50 (2014): 359-65.
    10.1016/j.ejca.2013.09.00110.1016/j.ejca.2013.09.001. Epub 2013 Sep 30.
  313. Pereira, C.; Sousa, H.; Silva, J.; Brandao, C.; Elgueta-Karstegl, C.; Farrell, P. J.; Medeiros, R.; Dinis-Ribeiro, M.. "The -1195G allele increases the transcriptional activity of cyclooxygenase-2 gene (COX-2) in colon cancer cell lines". Mol Carcinog 53 Suppl 1 (2014): E92-5.
    10.1002/mc.2204910.1002/mc.22049. Epub 2013 Jun 18.
  314. Gomes, M.; Teixeira, A. L.; Coelho, A.; Araujo, A.; Medeiros, R.. "The role of inflammation in lung cancer". Adv Exp Med Biol 816 (2014): 1-23.
    10.1007/978-3-0348-0837-8_110.1007/978-3-0348-0837-8_1.
  315. Lima, L.; Oliveira, D.; Ferreira, J. A.; Tavares, A.; Cruz, R.; Medeiros, R.; Santos, L.. "The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guerin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population". BJU Int (2014):
    10.1111/bju.1284410.1111/bju.12844.
  316. Rui M. Gil da Costa; Rui Medeiros. "Bovine papillomavirus: opening new trends for comparative pathology". (2014): https://hdl.handle.net/10216/103330.
    10.1007/s00705-013-1801-9
  317. Santos, Marlene; Carvalho, Serafim; Lima, Luís; Nogueira, Augusto; Assis, Joana; Mota-Pereira, Jorge; Pimentel, Paulo; et al. "Common genetic polymorphisms in the ABCB1 gene are associated with risk of major depressive disorder in male Portuguese individuals". (2014): http://hdl.handle.net/10400.22/3269.
    10.1089/gtmb.2013.0197
  318. Lima, Luís; Oliveira, Daniela; Ferreira, José Alexandre; Tavares, Ana; Cruz, Ricardo; Medeiros, Rui; Santos, Lúcio. "The role of functional polymorphisms in immune response genes as biomarkers of BCG Immunotherapy outcome in bladder cancer: Establishment of a predictive profile in a Southern Europe population". (2014): http://hdl.handle.net/10400.22/5489.
    10.1111/bju.12844
  319. Lima, Luís; Ferreira, José Alexandre; Tavares, Ana; Oliveira, Daniela; Morais, António; Videira, Paula; Medeiros, Rui; Santos, Lúcio. "FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer". (2014): http://hdl.handle.net/10400.22/3170.
    10.1016/j.urolonc.2013.05.009
  320. Santos, Marlene; Carvalho, Serafim; Lima, Luís; Mota-Pereira, Jorge; Pimentel, Paulo; Maia, Dulce; Correia, Diana; et al. "Influence of il6-174g>c, il6-6331t>c and il6r d358a a>c il-6 genetic polymorphisms in antidepressant treatment phenotypes". (2014): http://hdl.handle.net/10400.22/23539.
    10.1016/S0924-9338(14)78532-3
  321. Dias F; Teixeira AL; Santos JI; Gomes M; Nogueira A; Assis J; Medeiros R. "Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway.". (2013): http://europepmc.org/abstract/med/24192126.
    10.2217/pgs.13.184
  322. Espirito Santo A; Medeiros R. "Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy.". (2013): http://europepmc.org/abstract/med/24053936.
    10.1517/17425255.2013.835803
  323. Santos M; Carvalho S; Lima L; Nogueira A; Assis J; Mota-Pereira J; Pimentel P; et al. "Common Genetic Polymorphisms in the ABCB1 Gene Are Associated with Risk of Major Depressive Disorder in Male Portuguese Individuals.". (2013): http://europepmc.org/abstract/med/24200053.
    10.1089/gtmb.2013.0197
  324. Sousa H; Oliveira S; Santos AM; Catarino R; Moutinho J; Medeiros R. "Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer.". (2013): http://europepmc.org/abstract/med/24197984.
    10.1007/s13277-013-1337-3
  325. Fraga A; Ribeiro R; Príncipe P; Lobato C; Pina F; Maurício J; Monteiro C; et al. "The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration.". (2013): http://europepmc.org/abstract/med/24090974.
    10.1016/j.ejca.2013.09.001
  326. Marques I; Teixeira AL; Ferreira M; Assis J; Lobo F; Maurício J; Medeiros R. "Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population.". (2013): http://europepmc.org/abstract/med/23645041.
    10.1007/s11033-013-2578-3
  327. Sousa H; Breda E; Santos AM; Catarino R; Pinto D; Canedo P; Machado JC; Medeiros R. "IL-1RN VNTR polymorphism as a susceptibility marker for nasopharyngeal carcinoma in Portugal.". (2013): http://europepmc.org/abstract/med/23562526.
    10.1016/j.archoralbio.2013.02.004
  328. Gil da Costa RM; Medeiros R. "Bovine papillomavirus: opening new trends for comparative pathology.". (2013): http://europepmc.org/abstract/med/23929231.
    10.1007/s00705-013-1801-9
  329. Marinho-Dias J; Ribeiro J; Monteiro P; Loureiro J; Baldaque I; Medeiros R; Sousa H. "Characterization of cytomegalovirus and epstein-barr virus infection in cervical lesions in Portugal.". (2013): http://europepmc.org/abstract/med/23765777.
    10.1002/jmv.23596
  330. Lima A; Azevedo R; Sousa H; Seabra V; Medeiros R. "Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics.". (2013): http://europepmc.org/abstract/med/23930679.
    10.2217/pgs.13.118
  331. Lima L; Ferreira JA; Tavares A; Oliveira D; Morais A; Videira PA; Medeiros R; Santos L. "FASL polymorphism is associated with response to bacillus Calmette-Guerin immunotherapy in bladder cancer.". (2013): http://europepmc.org/abstract/med/23948181.
    10.1016/j.urolonc.2013.05.009
  332. Pereira C; Sousa H; Silva J; Brandão C; Elgueta-Karstegl C; Farrell PJ; Medeiros R; Dinis-Ribeiro M. "The -1195G allele increases the transcriptional activity of cyclooxygenase-2 gene (COX-2) in colon cancer cell lines.". (2013): http://europepmc.org/abstract/med/23776069.
    10.1002/mc.22049
  333. Duro M; Sarmento-Castro R; Almeida C; Medeiros R; Rebelo I. "Lipid profile changes by high activity anti-retroviral therapy.". (2013): http://europepmc.org/abstract/med/23295258.
    10.1016/j.clinbiochem.2012.12.017
  334. Nogueira A; Assis J; Catarino R; Medeiros R. "DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients.". (2013): http://europepmc.org/abstract/med/23570471.
    10.2217/pgs.13.48
  335. Assis J; Pereira D; Medeiros R. "Ovarian cancer and DNA repair: DNA ligase IV as a potential key.". (2013): http://europepmc.org/abstract/med/23538968.
    10.5306/wjco.v4.i1.14
  336. Assis J; Pereira D; Gomes M; Marques D; Marques I; Nogueira A; Catarino R; Medeiros R. "Influence of CYP3A4 genotypes in the outcome of serous ovarian cancer patients treated with first-line chemotherapy: implication of a CYP3A4 activity profile.". (2013): http://europepmc.org/abstract/med/23936594.
  337. Teixeira AL; Gomes M; Nogueira A; Azevedo AS; Assis J; Dias F; Santos JI; et al. "Improvement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFß1 signaling pathway modulation.". (2013): http://europepmc.org/abstract/med/23951322.
    10.1371/journal.pone.0072419
  338. Silva, I.H.; Nogueira-Silva, C.; Figueiredo, T.; Lombo, L.; Faustino, I.; Catarino, R.; Nogueira, A.; Pereira, D.; Medeiros, R.. "The impact of GGH -401C>T polymorphism on cisplatin-based chemoradiotherapy response and survival in cervical cancer". Gene 512 2 (2013): 247-250. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870386199&partnerID=MN8TOARS.
    10.1016/j.gene.2012.10.038
  339. Silva, J.. "Is Chlamydia trachomatis related to human papillomavirus infection in young women of southern European population? A self-sampling study". Archives of Gynecology and Obstetrics (2013): 1-7. http://www.scopus.com/inward/record.url?eid=2-s2.0-84874793544&partnerID=MN8TOARS.
    10.1007/s00404-013-2771-6
  340. Pimentel-Nunes, P.. "Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans". Digestive and Liver Disease 45 1 (2013): 63-69. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871617221&partnerID=MN8TOARS.
    10.1016/j.dld.2012.08.006
  341. Monteiro, C.. "Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer". Medical Oncology 30 1 (2013): 1-5. http://www.scopus.com/inward/record.url?eid=2-s2.0-84873349067&partnerID=MN8TOARS.
    10.1007/s12032-013-0490-2
  342. Nogueira, A.; Assis, J.; Catarino, R.; Medeiros, R.. "DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients". Pharmacogenomics 14 (2013): 689-700.
    10.2217/pgs.13.4810.2217/pgs.13.48.
  343. Junqueira, D. M.; Medeiros, R. M.; Leite, T. C.; Guimaraes, M. L.; Graf, T.; Pinto, A. R.; Almeida, S. E.. "Detection of the B"-GWGR variant in the southernmost region of Brazil: unveiling the complexity of the human immunodeficiency virus-1 subtype B epidemic". Mem Inst Oswaldo Cruz 108 (2013): 735-40.
    10.1590/0074-027610806201301010.1590/0074-0276108062013010.
  344. Sousa, H.; Breda, E.; Santos, A. M.; Catarino, R.; Pinto, D.; Canedo, P.; Machado, J. C.; Medeiros, R.. "IL-1RN VNTR polymorphism as a susceptibility marker for nasopharyngeal carcinoma in Portugal". Arch Oral Biol 58 (2013): 1040-6.
    10.1016/j.archoralbio.2013.02.00410.1016/j.archoralbio.2013.02.004. Epub 2013 Apr 3.
  345. Monteiro, C.; Sousa, M. V.; Ribeiro, R.; Mauricio, J.; Fraga, A.; Medeiros, R.. "Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer". Med Oncol 30 (2013): 490-490.
    10.1007/s12032-013-0490-210.1007/s12032-013-0490-2. Epub 2013 Feb 10.
  346. Lima, A.; Azevedo, R.; Sousa, H.; Seabra, V.; Medeiros, R.. "Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics". Pharmacogenomics 14 (2013): 1337-51.
    10.2217/pgs.13.11810.2217/pgs.13.118.
  347. Marinho-Dias, J.; Ribeiro, J.; Monteiro, P.; Loureiro, J.; Baldaque, I.; Medeiros, R.; Sousa, H.. "Characterization of cytomegalovirus and epstein-barr virus infection in cervical lesions in Portugal". J Med Virol 85 (2013): 1409-13.
    10.1002/jmv.2359610.1002/jmv.23596.
  348. Assis, J.; Pereira, D.; Gomes, M.; Marques, D.; Marques, I.; Nogueira, A.; Catarino, R.; Medeiros, R.. "Influence of CYP3A4 genotypes in the outcome of serous ovarian cancer patients treated with first-line chemotherapy: Implication of a CYP3A4 activity profile". International Journal of Clinical and Experimental Medicine 6 7 (2013): 552-561. http://www.scopus.com/inward/record.url?eid=2-s2.0-84881039079&partnerID=MN8TOARS.
  349. Assis, J.; Pereira, D.; Medeiros, R.. "Ovarian cancer and DNA repair: DNA ligase IV as a potential key". World J Clin Oncol 4 (2013): 14-24.
    10.5306/wjco.v4.i1.1410.5306/wjco.v4.i1.14.
  350. Duro, M.; Sarmento-Castro, R.; Almeida, C.; Medeiros, R.; Rebelo, I.. "Lipid profile changes by high activity anti-retroviral therapy". Clin Biochem (2013):
    S0009-9120(12)00710-2 [pii] 10.1016/j.clinbiochem.2012.12.01710.1016/j.clinbiochem.2012.12.017.
  351. Dias, F.; Teixeira, A. L.; Santos, J. I.; Gomes, M.; Nogueira, A.; Assis, J.; Medeiros, R.. "Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway". Pharmacogenomics 14 (2013): 1793-803.
    10.2217/pgs.13.18410.2217/pgs.13.184.
  352. Espirito Santo, A.; Medeiros, R.. "Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy". Expert Opin Drug Metab Toxicol 9 (2013): 1625-34.
    10.1517/17425255.2013.83580310.1517/17425255.2013.835803. Epub 2013 Sep 22.
  353. Assis, J.; Pereira, D.; Gomes, M.; Marques, D.; Marques, I.; Nogueira, A.; Catarino, R.; Medeiros, R.. "Influence of CYP3A4 genotypes in the outcome of serous ovarian cancer patients treated with first-line chemotherapy: implication of a CYP3A4 activity profile". Int J Clin Exp Med 6 (2013): 552-61.
  354. Teixeira, A. L.; Gomes, M.; Nogueira, A.; Azevedo, A. S.; Assis, J.; Dias, F.; Santos, J. I.; et al. "Improvement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFbeta1 signaling pathway modulation". PLoS One 8 (2013): e72419-e72419.
    10.1371/journal.pone.007241910.1371/journal.pone.0072419. eCollection 2013.
  355. Assis, J.; Pereira, D.; Gomes, M.; Marques, D.; Marques, I.; Nogueira, A.; Catarino, R.; Medeiros, R.. "Influence of CYP3A4 genotypes in the outcome of serous ovarian cancer patients treated with first-line chemotherapy: implication of a CYP3A4 activity profile". Int J Clin Exp Med 6 (2013): 552-61. http://www.ncbi.nlm.nih.gov/pubmed/23936594.
  356. Silva, J.; Cerqueira, F.; Ribeiro, J.; Sousa, H.; Osorio, T.; Medeiros, R.. "Is Chlamydia trachomatis related to human papillomavirus infection in young women of southern European population? A self-sampling study". Arch Gynecol Obstet 288 (2013): 627-33.
    10.1007/s00404-013-2771-610.1007/s00404-013-2771-6. Epub 2013 Mar 15.
  357. Marques, I.; Teixeira, A. L.; Ferreira, M.; Assis, J.; Lobo, F.; Mauricio, J.; Medeiros, R.. "Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population". Mol Biol Rep 40 (2013): 4819-26.
    10.1007/s11033-013-2578-310.1007/s11033-013-2578-3. Epub 2013 May 5.
  358. Silva, Inês Hilário; Silva, Cristina Nogueira; Figueiredo, Tiago; Lombo, Liliana; Faustino, Ilda; Catarino, Raquel; Nogueira, Augusto; Pereira, Deolinda; Medeiros, Rui. "The impact of GGH -401C>T polymorphism on cisplatin-based chemoradiotherapy response and survival in cervical cancer". (2013): http://hdl.handle.net/1822/28252.
    10.1016/j.gene.2012.10.038
  359. Goncalves, F; Almeida, A; Antunes, C; Cardoso, M; Carvalho, M; Claro, M; Coimbra, F; et al. "A cross-sectional survey of pain in palliative care in Portugal". SUPPORTIVE CARE IN CANCER (2013):
    10.1007/s00520-013-1746-2
  360. Nogueira A; Catarino R; Faustino I; Nogueira-Silva C; Figueiredo T; Lombo L; Hilário-Silva I; Pereira D; Medeiros R. "Role of the RAD51 G172T polymorphism in the clinical outcome of cervical cancer patients under concomitant chemoradiotherapy.". (2012): http://europepmc.org/abstract/med/22634097.
    10.1016/j.gene.2012.05.037
  361. Ribeiro R; Monteiro C; Cunha V; Oliveira MJ; Freitas M; Fraga A; Príncipe P; et al. "Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro.". (2012): http://europepmc.org/abstract/med/22469146.
    10.1186/1756-9966-31-32
  362. Teixeira AL; Gomes M; Medeiros R. "EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222.". (2012): http://europepmc.org/abstract/med/23233863.
    10.3389/fgene.2012.00286
  363. Ribeiro, R.J.T.. "Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction". PLoS ONE 7 6 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84863092426&partnerID=MN8TOARS.
    10.1371/journal.pone.0039236
  364. Carvalho, A.. "The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma". Genes and Immunity 13 2 (2012): 197-201. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857787435&partnerID=MN8TOARS.
    10.1038/gene.2011.59
  365. Ribeiro, R.J.T.. "Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profile". Cellular Physiology and Biochemistry 29 1-2 (2012): 233-240. http://www.scopus.com/inward/record.url?eid=2-s2.0-84859829669&partnerID=MN8TOARS.
    10.1159/000337604
  366. Gomes, M.. "Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: The paradoxal role of IL-4". Gene 504 1 (2012): 111-115. http://www.scopus.com/inward/record.url?eid=2-s2.0-84862309386&partnerID=MN8TOARS.
    10.1016/j.gene.2012.05.008
  367. Botelho, M.C.. "Inactivation of estrogen receptor by Schistosoma haematobium total antigen in bladder urothelial cells". Oncology Reports 27 2 (2012): 356-362. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855754142&partnerID=MN8TOARS.
    10.3892/or.2011.1552
  368. Ribeiro, R.. "Obesity and prostate cancer: Gene expression signature of human periprostatic adipose tissue". BMC Medicine 10 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84866532210&partnerID=MN8TOARS.
    10.1186/1741-7015-10-108
  369. Fontenete, S.; Nogueira, A.; Pina, F.; Lobo, F.; Fraga, A.; Calais Da Silva, F.; Medeiros, R.. "Molecular study of the PCA3 Gene: Genotypic analysis of PCA3 polymorphism-845G>A and metastatic prostate cancer". Genetic Testing and Molecular Biomarkers 16 5 (2012): 418-422. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861509800&partnerID=MN8TOARS.
    10.1089/gtmb.2011.0160
  370. Oliveira, S.. "Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G". Oncology Reports 27 4 (2012): 1188-1192. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856560326&partnerID=MN8TOARS.
    10.3892/or.2011.1609
  371. Araújo, A.P.. "Epidermal growth factor genetic variation associated with advanced cervical cancer in younger women". American Journal of Clinical Oncology: Cancer Clinical Trials 35 3 (2012): 247-250. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861529358&partnerID=MN8TOARS.
    10.1097/COC.0b013e31820dbbf5
  372. Sousa, H.; Santos, A.M.; Catarino, R.; Pinto, D.; Moutinho, J.; Canedo, P.; Machado, J.C.; Medeiros, R.. "IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal.". Molecular biology reports 39 12 (2012): 10837-10842. http://www.scopus.com/inward/record.url?eid=2-s2.0-85027950740&partnerID=MN8TOARS.
    10.1007/s11033-012-1979-z
  373. Ribeiro, R.; Monteiro, C.; Cunha, V.; Oliveira, M.; Freitas, M.; Fraga, A.; Príncipe, P.; et al. "Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro". Journal of Experimental and Clinical Cancer Research 31 1 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-85027938362&partnerID=MN8TOARS.
    10.1186/1756-9966-31-3222469146
  374. Ribeiro, R.. "Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma". Experimental Biology and Medicine 237 10 (2012): 1155-1162. http://www.scopus.com/inward/record.url?eid=2-s2.0-84868224535&partnerID=MN8TOARS.
    10.1258/ebm.2012.012131
  375. Marques, H.. "Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin's lymphoma is not associated with prognosis". Oncology Letters 4 6 (2012): 1285-1289. http://www.scopus.com/inward/record.url?eid=2-s2.0-84867240731&partnerID=MN8TOARS.
    10.3892/ol.2012.913
  376. Castela, Â.. "Differentially expressed angiogenic genes in diabetic erectile tissue - Results from a microarray screening". Molecular Genetics and Metabolism 105 2 (2012): 255-262. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856080147&partnerID=MN8TOARS.
    10.1016/j.ymgme.2011.11.002
  377. Silva, J.. "DNA repair system and prostate cancer progression: The role of NBS1 polymorphism (rs1805794)". DNA and Cell Biology 31 7 (2012): 1182-1186. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863922114&partnerID=MN8TOARS.
    10.1089/dna.2011.1562
  378. Catarino, R.. "Cyclin D1 polymorphism in non-small cell lung cancer in a Portuguese population". Cancer Biomarkers 12 2 (2012): 65-72. http://www.scopus.com/inward/record.url?eid=2-s2.0-84874312952&partnerID=MN8TOARS.
    10.3233/CBM-130294
  379. Catarino, R.. "Circulating DNA and NSCLC: Old findings with new perspectives". Journal of Thoracic Disease 4 5 (2012): 442-443. http://www.scopus.com/inward/record.url?eid=2-s2.0-84868271361&partnerID=MN8TOARS.
    10.3978/j.issn.2072-1439.2012.08.09
  380. Catarino, R.. "Circulating DNA: Diagnostic tool and predictive marker for overall survival of NSCLC patients". PLoS ONE 7 6 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84862177008&partnerID=MN8TOARS.
    10.1371/journal.pone.0038559
  381. Pimentel-Nunes, P.; Teixeira, A. L.; Pereira, C.; Gomes, M.; Brandao, C.; Rodrigues, C.; Goncalves, N.; et al. "Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans". Dig Liver Dis 45 (2012): 63-9.
    S1590-8658(12)00295-2 [pii] 10.1016/j.dld.2012.08.00610.1016/j.dld.2012.08.006. Epub 2012 Sep 19.
  382. Sousa, H.; Silva, J.; Azevedo, L.; Pinto-Correia, A. L.; Catarino, R.; Pinto, D.; Lopes, C.; Medeiros, R.. "Epstein-Barr virus in healthy individuals from Portugal". Acta Med Port 24 (2012): 707-12.
  383. Silva, J.; Teixeira, A. L.; Lobo, F.; Mauricio, J.; Medeiros, R.. "DNA repair system and prostate cancer progression: the role of NBS1 polymorphism (rs1805794)". DNA Cell Biol 31 (2012): 1182-6.
    10.1089/dna.2011.156210.1089/dna.2011.1562. Epub 2012 Mar 13.
  384. Marques, H.; Catarino, R.; Domingues, N.; Barros, E.; Portela, C.; Almeida, M. I.; Costa, S.; et al. "Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non-Hodgkin's lymphoma is not associated with prognosis". Oncol Lett 4 (2012): 1285-1289.
    10.3892/ol.2012.913 ol-04-06-1285 [pii]
  385. Teixeira, A. L.; Gomes, M.; Medeiros, R.. "EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222". Front Genet 3 (2012): 286-286.
    10.3389/fgene.2012.0028610.3389/fgene.2012.00286. Epub 2012 Dec 7.
  386. Sousa, H.; Silva, J.; Azevedo, L.; Pinto-Correia, A. L.; Catarino, R.; Pinto, D.; Lopes, C.; Medeiros, R.. "Epstein-Barr virus in healthy individuals from Portugal". Acta Med Port 24 (2012): 707-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22525621.
  387. Sousa, H.; Santos, A. M.; Catarino, R.; Pinto, D.; Moutinho, J.; Canedo, P.; Machado, J. C.; Medeiros, R.. "IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal". Mol Biol Rep 39 (2012): 10837-42.
    10.1007/s11033-012-1979-z10.1007/s11033-012-1979-z. Epub 2012 Oct 10.
  388. Ribeiro, R.; Monteiro, C.; Cunha, V.; Oliveira, M. J.; Freitas, M.; Fraga, A.; Principe, P.; et al. "Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro". J Exp Clin Cancer Res 31 (2012): 32-32.
    1756-9966-31-32 [pii] 10.1186/1756-9966-31-3210.1186/1756-9966-31-32.
  389. Ribeiro, R.; Monteiro, C.; Silvestre, R.; Castela, A.; Coutinho, H.; Fraga, A.; Principe, P.; et al. "Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma". Exp Biol Med (Maywood) 237 (2012): 1155-62.
    ebm.2012.012131 [pii] 10.1258/ebm.2012.01213110.1258/ebm.2012.012131. Epub 2012 Oct 4.
  390. Coelho, A.; Araujo, A. M. F.; Catarino, R.; Gomes, M.; Marques, A.; Medeiros, R.. "CLINICAL SIGNIFICANCE OF ANGIOPOIETIN-2 SERUM LEVELS IN NON-SMALL CELL LUNG CANCER". Annals of Oncology 23 (2012): 78-78. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000309409000180&KeyUID=WOS:000309409000180.
  391. Fontenete, S.; Silva, J.; Teixeira, A. L.; Ribeiro, R.; Bastos, E.; Pina, F.; Medeiros, R.. "Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis". Int Braz J Urol 37 (2012): 719-26.
    IBJUv37n6a5 [pii]
  392. Catarino, R.; Coelho, A.; Medeiros, R.. "Circulating DNA and NSCLC: old findings with new perspectives". J Thorac Dis 4 (2012): 442-3.
    10.3978/j.issn.2072-1439.2012.08.09 jtd-04-05-442 [pii]10.3978/j.issn.2072-1439.2012.08.09.
  393. Catarino, R.; Coelho, A.; Araujo, A.; Gomes, M.; Nogueira, A.; Lopes, C.; Medeiros, R.. "Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients". PLoS One 7 (2012): e38559-e38559.
    10.1371/journal.pone.0038559 PONE-D-12-09738 [pii]10.1371/journal.pone.0038559. Epub 2012 Jun 12.
  394. Ribeiro, R. J.; Monteiro, C. P.; Cunha, V. F.; Azevedo, A. S.; Oliveira, M. J.; Monteiro, R.; Fraga, A. M.; et al. "Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profile". Cell Physiol Biochem 29 (2012): 233-40.
    000337604 [pii] 10.1159/00033760410.1159/000337604. Epub 2012 Mar 1.
  395. Silva, I. H.; Nogueira-Silva, C.; Figueiredo, T.; Lombo, L.; Faustino, I.; Catarino, R.; Nogueira, A.; Pereira, D.; Medeiros, R.. "The impact of GGH -401C>T polymorphism on cisplatin-based chemoradiotherapy response and survival in cervical cancer". Gene 512 (2012): 247-50.
    S0378-1119(12)01316-9 [pii] 10.1016/j.gene.2012.10.03810.1016/j.gene.2012.10.038. Epub 2012 Oct 26.
  396. Ribeiro, R.; Monteiro, C.; Catalan, V.; Hu, P.; Cunha, V.; Rodriguez, A.; Gomez-Ambrosi, J.; et al. "Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue". BMC Med 10 (2012): 108-108.
    1741-7015-10-108 [pii] 10.1186/1741-7015-10-10810.1186/1741-7015-10-108.
  397. Ribeiro, R. J.; Monteiro, C. P.; Azevedo, A. S.; Cunha, V. F.; Ramanakumar, A. V.; Fraga, A. M.; Pina, F. M.; et al. "Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction". PLoS One 7 (2012): e39236-e39236.
    10.1371/journal.pone.0039236 PONE-D-12-05862 [pii]10.1371/journal.pone.0039236. Epub 2012 Jun 29.
  398. Gomes, M.; Coelho, A.; Araujo, A.; Teixeira, A. L.; Catarino, R.; Medeiros, R.. "Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4". Gene 504 (2012): 111-5.
    S0378-1119(12)00571-9 [pii] 10.1016/j.gene.2012.05.00810.1016/j.gene.2012.05.008. Epub 2012 May 11.
  399. Fontenete, S.; Nogueira, A.; Pina, F.; Lobo, F.; Fraga, A.; Calais da Silva, F.; Medeiros, R.. "Molecular study of the PCA3 gene: genotypic analysis of PCA3 polymorphism -845G>A and metastatic prostate cancer". Genet Test Mol Biomarkers 16 (2012): 418-22.
    10.1089/gtmb.2011.016010.1089/gtmb.2011.0160. Epub 2012 Jan 30.
  400. Nogueira, A.; Catarino, R.; Faustino, I.; Nogueira-Silva, C.; Figueiredo, T.; Lombo, L.; Hilario-Silva, I.; Pereira, D.; Medeiros, R.. "Role of the RAD51 G172T polymorphism in the clinical outcome of cervical cancer patients under concomitant chemoradiotherapy". Gene 504 (2012): 279-83.
    S0378-1119(12)00625-7 [pii] 10.1016/j.gene.2012.05.03710.1016/j.gene.2012.05.037. Epub 2012 May 24.
  401. Oliveira, A.; Dinis-Oliveira, R.; Nogueira, A.; Azevedo, A.; Goncalves, F.; Silva, P.; Carvalho, F.; Medeiros, R.. "COMT Genetic Variation May Influence Opioid Dosing Requirements in the Treatment of Cancer-related Pain". European Journal of Cancer 48 (2012): S235-S235. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000313036501437&KeyUID=WOS:000313036501437.
    10.1016/s0959-8049(12)71593-9
  402. Catarino, R.; Faustino, I.; Nogueira-Silva, C.; Figueiredo, T.; Lombo, L.; Hilario-Silva, I.; Pereira, D.; Medeiros, R.. "RAD51 G172T Polymorphism - a Prognostic Value in Cervical Cancer?". European Journal of Cancer 48 (2012): S198-S198. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000313036501303&KeyUID=WOS:000313036501303.
    10.1016/s0959-8049(12)71459-4
  403. Marques, Herlander; Catarino, Raquel; Domingues, Nelson; Barros, Eliane; Portela, Catarina; Almeida, Maria Inês; Costa, Sandra; et al. "Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non Hodgkin's lymphoma is not associated with prognosis". (2012): http://hdl.handle.net/1822/23822.
    10.3892/ol.2012.913
  404. Carvalho, Agostinho; Cunha, Cristina; Almeida, A. J.; Osório, Nuno S.; Saraiva, Margarida; Coelho, Maria Teixeira; Pedreiro, Susana; et al. "The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma". (2012): http://hdl.handle.net/1822/23858.
    10.1038/gene.2011.59
  405. de Mello RA; Marques DS; Medeiros R; Araújo AM. "Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies.". (2011): http://europepmc.org/abstract/med/22087435.
    10.5306/wjco.v2.i11.367
  406. Couto Mdo R; Pinto D; Oliveira J; Monteiro A; Pereira D; Medeiros R; Rodrigues H. "[The predictive and monitoring value of serum HER2/NEU in breast cancer under trastuzumab therapy].". (2011): http://europepmc.org/abstract/med/21672436.
  407. Sousa H; Silva J; Azevedo L; Pinto-Correia AL; Catarino R; Pinto D; Lopes C; Medeiros R. "Epstein-Barr virus in healthy individuals from Portugal.". (2011): http://europepmc.org/abstract/med/22525621.
  408. Sousa H; Santos AM; Pinto D; Medeiros R. "Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?". (2011): http://europepmc.org/abstract/med/21672450.
  409. Couto, Maria do Rosario; Pinto, Daniela; Oliveira, Julio; Monteiro, Alice; Pereira, Deolinda; Medeiros, Rui; Rodrigues, Helena. "THE PREDICTIVE AND MONITORING VALUE OF SERUM HER2/NEU In Breast Cancer Under Trastuzumab Therapy". Acta Medica Portuguesa 24 1 (2011): 5-16. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288765900001&KeyUID=WOS:000288765900001.
  410. Couto Mdo, R.; Pinto, D.; Oliveira, J.; Monteiro, A.; Pereira, D.; Medeiros, R.; Rodrigues, H.. "[The predictive and monitoring value of serum HER2/NEU in breast cancer under trastuzumab therapy]". Acta Med Port 24 (2011): 5-16.
  411. Botelho, M. C.; Ribeiro, R.; Vale, N.; Oliveira, P.; Medeiros, R.; Lopes, C.; Machado, J. C.; Correia da Costa, J. M.. "Inactivation of estrogen receptor by Schistosoma haematobium total antigen in bladder urothelial cells". Oncol Rep 27 (2011): 356-62.
    10.3892/or.2011.155210.3892/or.2011.1552. Epub 2011 Nov 15.
  412. Azevedo, A.; Cunha, V.; Teixeira, A. L.; Medeiros, R.. "IL-6/IL-6R as a potential key signaling pathway in prostate cancer development". World J Clin Oncol 2 (2011): 384-96.
    10.5306/wjco.v2.i12.38410.5306/wjco.v2.i12.384.
  413. Oliveira, S.; Ribeiro, J.; Sousa, H.; Pinto, D.; Baldaque, I.; Medeiros, R.. "Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G". Oncol Rep 27 (2011): 1188-92.
    10.3892/or.2011.160910.3892/or.2011.1609. Epub 2011 Dec 22.
  414. Lima, L.; Silva, J.; Amaro, T.; Morais, A.; Lopes, C.; Medeiros, R.; Videira, P. A.; Santos, L.. "IL-4 and TNF-alpha polymorphisms are associated with risk of multiple superficial tumors or carcinoma in situ development". Urol Int 87 (2011): 457-63.
    000331882 [pii] 10.1159/00033188210.1159/000331882. Epub 2011 Nov 18.
  415. Leite-Pereira, F.; Medeiros, R.; Dinis-Ribeiro, M.. "Overweight and obese patients do not seem to adequately recognize their own risk for colorectal cancer". J Cancer Educ 26 (2011): 767-73.
    10.1007/s13187-011-0231-110.1007/s13187-011-0231-1.
  416. Silva, J.; Ribeiro, J.; Sousa, H.; Cerqueira, F.; Teixeira, A. L.; Baldaque, I.; Osorio, T.; Medeiros, R.. "Oncogenic HPV Types Infection in Adolescents and University Women from North Portugal: From Self-Sampling to Cancer Prevention". J Oncol 2011 (2011): 953469-953469.
    10.1155/2011/95346910.1155/2011/953469. Epub 2011 Nov 28.
  417. Sousa, H.; Santos, A. M.; Pinto, D.; Medeiros, R.. "Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?". Acta Med Port 24 (2011): 127-34.
  418. Sousa, Hugo; Santos, Alexandra M.; Pinto, Daniela; Medeiros, Rui. "IS THERE A BIOLOGICAL PLAUSABILITY FOR P53 CODON 72 POLYMORPHISM INFLUENCE On Cervical Cancer Development?". Acta Medica Portuguesa 24 1 (2011): 127-134. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288765900015&KeyUID=WOS:000288765900015.
  419. Sousa, H.. "Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma". Molecular Carcinogenesis 50 2 (2011): 73-79. http://www.scopus.com/inward/record.url?eid=2-s2.0-78651458053&partnerID=MN8TOARS.
    10.1002/mc.20689
  420. Couto, M.D.R.. "The predictive and monitoring value of serum HER2/neu in breast cancer under trastuzumab therapy | Papel do HER2/neu sérico como factor preditivo e de monitorização no cancro da mama sob terapêutica com trastuzumab". Acta Medica Portuguesa 24 1 (2011): 5-16. http://www.scopus.com/inward/record.url?eid=2-s2.0-79953244751&partnerID=MN8TOARS.
  421. Sousa, H.. "Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development? | Existem evidências biológicas do papel do poliforfismo no codão 72 da p53 na suscepstibilidade para cancro do colo do útero". Acta Medica Portuguesa 24 1 (2011): 127-134. http://www.scopus.com/inward/record.url?eid=2-s2.0-79953276262&partnerID=MN8TOARS.
  422. Teixeira, A.L.; Araújo, A.; Coelho, A.; Ribeiro, R.; Gomes, M.; Pereira, C.; Medeiros, R.. "Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk". Journal of Cancer Research and Clinical Oncology 137 3 (2011): 435-439. http://www.scopus.com/inward/record.url?eid=2-s2.0-79954437963&partnerID=MN8TOARS.
    10.1007/s00432-010-0896-6
  423. Leite-Pereira, F.. "Overweight and obese patients do not seem to adequately recognize their own risk for colorectal cancer". Journal of Cancer Education 26 4 (2011): 767-773. http://www.scopus.com/inward/record.url?eid=2-s2.0-84859911266&partnerID=MN8TOARS.
    10.1007/s13187-011-0231-1
  424. Sousa, H.; Santos, A. M.; Pinto, D.; Medeiros, R.. "Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?". Acta Med Port 24 (2011): 127-34.
  425. Silva, J.. "Oncogenic HPV types infection in adolescents and university women from North Portugal: From self-sampling to cancer prevention". Journal of Oncology (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-84855577698&partnerID=MN8TOARS.
    10.1155/2011/953469
  426. Couto Mdo, R.; Pinto, D.; Oliveira, J.; Monteiro, A.; Pereira, D.; Medeiros, R.; Rodrigues, H.. "[The predictive and monitoring value of serum HER2/NEU in breast cancer under trastuzumab therapy]". Acta Med Port 24 (2011): 5-16.
  427. Sousa, H.. "Epstein-Barr virus in healthy individuals from Portugal | Caracterização da frequência do vírus de Epstein-Barr em dadores saudáveis de Portugal". Acta Medica Portuguesa 24 5 (2011): 707-712. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857146134&partnerID=MN8TOARS.
  428. Lima, L.. "IL-4 and TNF-a polymorphisms are associated with risk of multiple superficial tumors or carcinoma in situ development". Urologia Internationalis 87 4 (2011): 457-463. http://www.scopus.com/inward/record.url?eid=2-s2.0-84355162794&partnerID=MN8TOARS.
    10.1159/000331882
  429. Sousa, H.; Breda, E.; Santos, A.M.; Catarino, R.; Pinto, D.; Medeiros, R.. "Genetic risk markers for nasopharyngeal carcinoma in Portugal: Tumor necrosis factor alpha-308G>A polymorphism". DNA and Cell Biology 30 2 (2011): 99-103. http://www.scopus.com/inward/record.url?eid=2-s2.0-79551624285&partnerID=MN8TOARS.
    10.1089/dna.2010.1086
  430. Araújo, A.P.. "Association between EGF +61A/G polymorphism and gastric cancer in caucasians". World Journal of Gastroenterology 17 4 (2011): 488-492. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955930685&partnerID=MN8TOARS.
    10.3748/wjg.v17.i4.488
  431. Fontenete, S.; Silva, J.; Teixeira, A.L.; Ribeiro, R.; Bastos, E.; Pina, F.; Medeiros, R.. "Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis". International Braz J Urol 37 6 (2011): 719-726. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861008474&partnerID=MN8TOARS.
    10.1590/S1677-55382011000600006
  432. Castela, A.; Soares, R.; Rocha, F.; Medeiros, R.; Ribeiro, R.; Monteiro, C.; Gomes, P.; et al. "Differentially expressed angiogenic genes in diabetic erectile tissue - results from a microarray screening". Mol Genet Metab 105 (2011): 255-62.
    S1096-7192(11)00419-7 [pii] 10.1016/j.ymgme.2011.11.00210.1016/j.ymgme.2011.11.002. Epub 2011 Nov 10.
  433. de Mello, R. A.; Marques, D. S.; Medeiros, R.; Araujo, A. M.. "Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies". World J Clin Oncol 2 (2011): 367-76.
    10.5306/wjco.v2.i11.36710.5306/wjco.v2.i11.367.
  434. Araujo, A. P.; Catarino, R.; Ribeiro, R.; Pereira, D.; Pinto, D.; Medeiros, R.. "Epidermal growth factor genetic variation associated with advanced cervical cancer in younger women". Am J Clin Oncol 35 (2011): 247-50.
    10.1097/COC.0b013e31820dbbf510.1097/COC.0b013e31820dbbf5.
  435. Araujo, A. P.; Costa, B. M.; Pinto-Correia, A. L.; Fragoso, M.; Ferreira, P.; Dinis-Ribeiro, M.; Costa, S.; Reis, R. M.; Medeiros, R.. "Association between EGF +61A/G polymorphism and gastric cancer in Caucasians". World J Gastroenterol 17 (2011): 488-92.
    10.3748/wjg.v17.i4.48810.3748/wjg.v17.i4.488.
  436. Fontenete, S.; Silva, J.; Teixeira, A. L.; Ribeiro, R.; Bastos, E.; Pina, F.; Medeiros, R.. "Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis". International Braz J Urol 37 6 (2011): 719-726. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000300370000006&KeyUID=WOS:000300370000006.
  437. Sousa, H.; Santos, A. M.; Pinto, D.; Medeiros, R.. "Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?". Acta Med Port 24 (2011): 127-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21672450.
  438. Couto Mdo, R.; Pinto, D.; Oliveira, J.; Monteiro, A.; Pereira, D.; Medeiros, R.; Rodrigues, H.. "[The predictive and monitoring value of serum HER2/NEU in breast cancer under trastuzumab therapy]". Acta Med Port 24 (2011): 5-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21672436.
  439. Assis, J.; Gomes, M.; Marques, D.; Marques, I.; Catarino, R.; Pereira, D.; Medeiros, R.. "CYP3A4*1B Polymorphism - a Prognostic Value in Ovarian Cancer?". European Journal of Cancer 47 (2011): S139-S139. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000295752800489&KeyUID=WOS:000295752800489.
    10.1016/s0959-8049(11)70795-x
  440. Hilario Silva, I.; Nogueira-Silva, C.; Figueiredo, T.; Lombo, L.; Faustino, I.; Catarino, R.; Nogueira, A.; Pereira, D.; Medeiros, R.. "Linking XRCC1 Arg399GIn and GGH-401C > T Polymorphisms to Cervical Cancer Risk". European Journal of Cancer 47 (2011): S538-S538. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000295752801851&KeyUID=WOS:000295752801851.
    10.1016/s0959-8049(11)72125-6
  441. Gomes, M.; Coelho, A.; Araujo, A.; Catarino, R.; Medeiros, R.. "Is MMP-9 Q279R a Possible Marker of Prognostic in Non Small Cell Lung Cancer?". European Journal of Cancer 47 (2011): S134-S135. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000295752800474&KeyUID=WOS:000295752800474.
    10.1016/s0959-8049(11)70780-8
  442. Couto, Maria do Rosário; Pinto, Daniela; Oliveira, Júlio; Monteiro, Alice; Pereira, Deolinda; Medeiros, Rui; Rodrigues, Helena. "The predictive and monitoring value of serum HER2/NEU in breast cancer under trastuzumab therapy.". (2011): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/349.
  443. Sousa, Hugo; Santos, Alexandra M; Pinto, Daniela; Medeiros, Rui. "Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?". (2011): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/335.
  444. Sousa, Hugo; Silva, João; Azevedo, Luís; Pinto-Correia, Ana L; Catarino, Raquel; Pinto, Daniela; Lopes, Carlos; Medeiros, Rui. "Epstein-Barr virus in healthy individuals from Portugal.". (2011): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/517.
  445. Araújo, Ana Paula; Costa, Bruno Marques; Correia, Ana L. Pinto; Fragoso, Maria; Ferreira, Paula; Ribeiro, Mário Dinis; Costa, Sandra Maria Araújo da; Reis, R. M.; Medeiros, Rui. "Association between EGF +61A/G polymorphism and gastric cancer in Caucasians". (2011): http://hdl.handle.net/1822/15059.
    10.3748/wjg.v17.i4.488
  446. Azevedo, A.; Ribeiro, R.; Cunha, V.; Monteiro, C.; Pina, F.; Fraga, A.; Calais da Silva, F.; Lobo, F.; Medeiros, R. U. I.. "Combined analysis of SNPs in IL-6/IL-6R pathway predict prostate cancer aggressiveness and development of resistance to hormonal castration". Ejc Supplements 8 5 (2010): 97-97. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288603100363&KeyUID=WOS:000288603100363.
  447. Pereira, P. D.; Lopes, C. C.; Matos, A. J.; Cortez, P. P.; Gartner, F.; Medeiros, R.; Lopes, C.. "Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems". J Comp Pathol 143 (2010): 87-93.
    S0021-9975(10)00010-1 [pii] 10.1016/j.jcpa.2010.01.00210.1016/j.jcpa.2010.01.002. Epub 2010 Feb 13.
  448. Botelho, M. C.; Soares, R.; Vale, N.; Ribeiro, R.; Camilo, V.; Almeida, R.; Medeiros, R.; et al. "Schistosoma haematobium: identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells". Exp Parasitol 126 (2010): 526-35.
    S0014-4894(10)00207-9 [pii] 10.1016/j.exppara.2010.06.01210.1016/j.exppara.2010.06.012. Epub 2010 Jun 12.
  449. Assis, J.; Gomes, M.; Marques, D.; Pereira, D.; Medeiros, R.. "INFLUENCE OF LIG4 1977 T/C POLYMORPHISM IN OVARIAN CANCER (OC) SUSCEPTIBILITY". Annals of Oncology 21 (2010): 59-59. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000283115900162&KeyUID=WOS:000283115900162.
  450. Santos, D. S. N. M.; Assis, J.; Gomes, M.; Rodrigues, A. C. F.; Oliveira, J.; Pereira, D.; Medeiros, R.. "CYP3A4(star)1B (RS2740574) GENE POLYMORPHISM HAS PROGNOSTIC VALUE IN OVARIAN CANCER". Annals of Oncology 21 (2010): 310-310. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000284592300192&KeyUID=WOS:000284592300192.
  451. Breda, E.; Catarino, R. J.; Azevedo, I.; Lobao, M.; Monteiro, E.; Medeiros, R.. "Epstein-Barr virus detection in nasopharyngeal carcinoma: implications in a low-risk area". Braz J Otorhinolaryngol 76 (2010): 310-5.
    S1808-86942010000300007 [pii]
  452. Eduardo, B.; Raquel, C.; Rui, M.. "Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal". Eur Arch Otorhinolaryngol 267 (2010): 1607-12.
    10.1007/s00405-010-1258-310.1007/s00405-010-1258-3. Epub 2010 May 8.
  453. Catarino, R.; Araujo, A.; Coelho, A.; Gomes, M.; Nogueira, A.; Lopes, C.; Medeiros, R. M.. "Prognostic significance of telomerase polymorphism in non-small cell lung cancer". Clin Cancer Res 16 (2010): 3706-12.
    1078-0432.CCR-09-3030 [pii] 10.1158/1078-0432.CCR-09-303010.1158/1078-0432.CCR-09-3030. Epub 2010 Jul 6.
  454. Sousa, M.; Ribeiro, R.; Mauricio, M. J.; Begonha, R.; Monteiro, C.; Cunha, V.; Morais, A.; Lobo, F.; Medeiros, R.. "PHARMACOGENOMIC PROFILE OF CASTRATION-RESISTANT PROSTATE CANCER: THE INFLUENCE OF AR+1733 G > A AND SHBG+5790 G > A POLYMORPHISMS". Annals of Oncology 21 (2010): 280-280. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000284592300097&KeyUID=WOS:000284592300097.
  455. Medeiros, R.; Ramada, D.. "Knowledge differences between male and female university students about human papillomavirus (HPV) and cervical cancer: Implications for health strategies and vaccination". Vaccine 29 (2010): 153-60.
    S0264-410X(10)01569-0 [pii] 10.1016/j.vaccine.2010.10.06810.1016/j.vaccine.2010.10.068. Epub 2010 Nov 4.
  456. Botelho, M.C.; Soares, R.; Vale, N.; Ribeiro, R.; Camilo, V.; Almeida, R.; Medeiros, R.; et al. "Schistosoma haematobium: Identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells". Experimental Parasitology 126 4 (2010): 526-535. http://www.scopus.com/inward/record.url?eid=2-s2.0-79960934913&partnerID=MN8TOARS.
    10.1016/j.exppara.2010.06.012
  457. Catarino, R.; Araújo, A.; Coelho, A.; Gomes, M.; Nogueira, A.; Lopes, C.; Medeiros, R.M.. "Prognostic significance of telomerase polymorphism in non-small cell lung cancer". Clinical Cancer Research 16 14 (2010): 3706-3712. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954700718&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-09-3030
  458. Medeiros, R.; Ramada, D.. "Knowledge differences between male and female university students about human papillomavirus (HPV) and cervical cancer: Implications for health strategies and vaccination". Vaccine 29 2 (2010): 153-160. http://www.scopus.com/inward/record.url?eid=2-s2.0-78649705897&partnerID=MN8TOARS.
    10.1016/j.vaccine.2010.10.068
  459. Nogueira, A.; Catarino, R.; Coelho, A.; Araújo, A.; Gomes, M.; Medeiros, R.. "Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy". Cancer Chemotherapy and Pharmacology 66 3 (2010): 501-506. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954680606&partnerID=MN8TOARS.
    10.1007/s00280-009-1187-2
  460. Carvalho, R.; Pinheiro, M.F.; Medeiros, R.. "Localization of candidate genes in a region of high frequency of microvariant alleles for prostate cancer susceptibility: The chromosome region yp11.2 genetic variation". DNA and Cell Biology 29 1 (2010): 3-7. http://www.scopus.com/inward/record.url?eid=2-s2.0-74049123438&partnerID=MN8TOARS.
    10.1089/dna.2009.0905
  461. Breda, E.; Catarino, R.J.F.; Azevedo, I.; Lobão, M.; Monteiro, E.; Medeiros, R.. "Epstein-barr virus detection in nasopharyngeal carcinoma - Implications in a low-risk area". Brazilian Journal of Otorhinolaryngology 76 3 (2010): 310-315. http://www.scopus.com/inward/record.url?eid=2-s2.0-79952110143&partnerID=MN8TOARS.
    10.1590/S1808-86942010000300007
  462. Dias Pereira, P.; Lopes, C.C.; Matos, A.J.F.; Cortez, P.P.; Gärtner, F.; Medeiros, R.; Lopes, C.. "Caveolin-1 in diagnosis and prognosis of canine mammary tumours: Comparison of evaluation systems". Journal of Comparative Pathology 143 2-3 (2010): 87-93. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954897337&partnerID=MN8TOARS.
    10.1016/j.jcpa.2010.01.002
  463. Pereira, C.; Pimentel-Nunes, P.; Brandão, C.; Moreira-Dias, L.; Medeiros, R.; Dinis-Ribeiro, M.. "COX-2 polymorphisms and colorectal cancer risk: A strategy for chemoprevention". European Journal of Gastroenterology and Hepatology 22 5 (2010): 607-613. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951282598&partnerID=MN8TOARS.
    10.1097/MEG.0b013e3283352cbb
  464. Lima, L.; Pereira, D.; Gomes, A. M.; Pinto, D.; Medeiros, R.. "Association between FAS-670A/G polymorphism and ovarian cancer development". Ejc Supplements 8 5 (2010): 28-28. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288603100105&KeyUID=WOS:000288603100105.
    10.1016/s1359-6349(10)70916-2
  465. Cunha, V.; Ribeiro, R.; Azevedo, A.; Monteiro, C.; Pina, F.; Fraga, A.; da Silva, F. Calais; Lobo, F.; Medeiros, R.. "Adiponectin functional polymorphisms and haplotype are associated with prostate cancer aggressiveness and to hormonal castration resistance". Ejc Supplements 8 5 (2010): 25-25. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288603100093&KeyUID=WOS:000288603100093.
    10.1016/s1359-6349(10)70904-6
  466. Teixeira, A. L.; Ribeiro, R.; Gomes, M.; Pereira, C.; Lobo, F.; Fraga, A.; Calais-da-Silva, F.; Pina, F.; Medeiros, R.. "Influence of functional genetic variants of TGF beta 1/TGF beta R2 pathway in prostate cancer development". Ejc Supplements 8 5 (2010): 23-24. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288603100087&KeyUID=WOS:000288603100087.
    10.1016/s1359-6349(10)70898-3
  467. Monteiro, C.; Ribeiro, R.; Azevedo, A.; Cunha, V.; Fraga, A.; Pina, F.; Calais da Silva, F.; Lobo, F.; Medeiros, R.. "Non-synonym leptin receptor genetic variants, prostate cancer susceptibility and aggressiveness". Ejc Supplements 8 5 (2010): 25-26. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288603100094&KeyUID=WOS:000288603100094.
    10.1016/s1359-6349(10)70905-8
  468. Nogueira, A.; Catarino, R.; Pereira, D.; Coelho, A.; Medeiros, R.. "Is there a role for RAD51 genetic variants in cervical cancer development?". Ejc Supplements 8 5 (2010): 193-193. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000288603100740&KeyUID=WOS:000288603100740.
    10.1016/s1359-6349(10)71562-7
  469. Rodrigues, Catarina; Pereira, Carina; Medeiros, Rui; Dinis-Ribeiro, Mário. "Predictive factors of chemotherapy-induced oral mucositis in colorectal cancer: role of polymorphisms in genes mediating the inflammatory response". (2010): https://doi.org/10.31877/on.2010.14.02.
    https://doi.org/10.31877/on.2010.14.02
  470. Coelho A; Pereira D; Nogal A; Pinto D; Catarino R; Araújo A; Medeiros R. "CXCL12 chemokine genotypes as predictive biomarkers of ovarian cancer outcome.". (2009): http://europepmc.org/abstract/med/21475798.
    10.3892/mmr_00000069
  471. Pereira, A.; Machado, P.; Araujo, A.; Coelho, A.; Teixeira, A. L.; Medeiros, R.. "8473T > C COX-2 polymorphism and susceptibility for lung cancer: a strategy for individualised chemoprevention". Ejc Supplements 7 2 (2009): 523-523. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000270645902404&KeyUID=WOS:000270645902404.
    10.1016/s1359-6349(09)71772-0
  472. Dias Pereira, P.; Lopes, C. C.; Matos, A. J.; Pinto, D.; Gartner, F.; Lopes, C.; Medeiros, R.. "Influence of catechol-O-methyltransferase (COMT) genotypes on the prognosis of canine mammary tumors". Vet Pathol 46 (2009): 1270-4.
    vp.08-VP-0298-D-FL [pii] 10.1354/vp.08-VP-0298-D-FL10.1354/vp.08-VP-0298-D-FL. Epub 2009 Jul 15.
  473. Carvalho, R.; Pinheiro, M. F.; Medeiros, R.. "Localization of candidate genes in a region of high frequency of microvariant alleles for prostate cancer susceptibility: the chromosome region Yp11.2 genetic variation". DNA Cell Biol 29 (2009): 3-7.
    10.1089/dna.2009.090510.1089/dna.2009.0905.
  474. Nogueira, A.; Catarino, R.; Coelho, A.; Araujo, A.; Gomes, M.; Medeiros, R.. "Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy". Cancer Chemother Pharmacol 66 (2009): 501-6.
    10.1007/s00280-009-1187-210.1007/s00280-009-1187-2. Epub 2009 Dec 4.
  475. Teixeira, A. L.; Araujo, A.; Coelho, A.; Gomes, M.; Pereira, C.; Ribeiro, R.; Medeiros, R.. "Influence of TGFB1+869T > c polymorphism in non-small cell lung cancer (NSCLC) risk". Ejc Supplements 7 2 (2009): 113-113. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000270645900378&KeyUID=WOS:000270645900378.
    10.1016/s1359-6349(09)70387-8
  476. Bicho, M. C.; Pereira da Silva, A.; Matos, A.; Silva, R. M.; Bicho, M. D.. "Sex steroid hormones influence the risk for cervical cancer: modulation by haptoglobin genetic polymorphism". Cancer Genet Cytogenet 191 (2009): 85-9.
    S0165-4608(09)00093-4 [pii] 10.1016/j.cancergencyto.2009.02.005
  477. Fraga, A.; Ribeiro, R.; Medeiros, R.. "[Tumor hypoxia: the role of HIF]". Actas Urol Esp 33 (2009): 941-51.
    13145076 [pii]
  478. Coelho, Ana P.; Araujo, Antonio Manuel; Gomes, Monica; Ribeiro, Ricardo; Teixeira, Ana L.; Catarino, Raquel; Nogal, Ana; Medeiros, Rui. "VEGF genotypes as a prognostic factors in non-small cell lung cancer patients". Journal of Thoracic Oncology 4 9 (2009): S609-S610. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000269496001587&KeyUID=WOS:000269496001587.
  479. Fraga, A.; Ribeiro, R.; Medeiros, R.. "Tumor hypoxia: The role of HIF,Hipoxia tumoral. Papel del factor inducible por hipoxia". Actas Urologicas Espanolas 33 9 (2009): 941-951. http://www.scopus.com/inward/record.url?eid=2-s2.0-75649133242&partnerID=MN8TOARS.
    10.1016/S0210-4806(09)72891-8
  480. Dias Pereira, P.; Lopes, C.C.; Matos, A.J.F.; Pinto, D.; Gärtner, F.; Lopes, C.; Medeiros, R.. "Influence of catechol-O-methyltransferase (COMT) genotypes on the prognosis of canine mammary tumors". Veterinary Pathology 46 6 (2009): 1270-1274. http://www.scopus.com/inward/record.url?eid=2-s2.0-75649140581&partnerID=MN8TOARS.
    10.1354/vp.08-vp-0298-d-fl
  481. Araújo, A.P.. "Ovarian cancer and genetic susceptibility: Association of A61G polymorphism in the EGF gene". Experimental Biology and Medicine 234 3 (2009): 241-245. http://www.scopus.com/inward/record.url?eid=2-s2.0-63349107870&partnerID=MN8TOARS.
    10.3181/0805-RM-146
  482. Araüjo, A.P.. "Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease". DNA and Cell Biology 28 5 (2009): 265-269. http://www.scopus.com/inward/record.url?eid=2-s2.0-65549171488&partnerID=MN8TOARS.
    10.1089/dna.2008.0823
  483. Coelho, A.; Pereira, D.; Nogal, A.; Pinto, D.; Catarino, R.; Araújo, A.; Medeiros, R.. "CXCL12 chemokine genotypes as predictive biomarkers of ovarian cancer outcome". Molecular Medicine Reports 2 1 (2009): 103-106. http://www.scopus.com/inward/record.url?eid=2-s2.0-69249152606&partnerID=MN8TOARS.
    10.3892/mmr-00000069
  484. Dias Pereira, P.. "COX-2 Expression in Canine Normal and Neoplastic Mammary Gland". Journal of Comparative Pathology 140 4 (2009): 247-253. http://www.scopus.com/inward/record.url?eid=2-s2.0-63349110467&partnerID=MN8TOARS.
    10.1016/j.jcpa.2008.12.005
  485. Pereira, C.. "Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: Are conclusive results available?". European Journal of Gastroenterology and Hepatology 21 1 (2009): 76-91. http://www.scopus.com/inward/record.url?eid=2-s2.0-58149215969&partnerID=MN8TOARS.
    10.1097/MEG.0b013e32830ce7ba
  486. Teixeira, A.L.; Ribeiro, R.; Morais, A.; Lobo, F.; Fraga, A.; Pina, F.; Calais-da-Silva, F.M.; Calais-da-Silva, F.E.; Medeiros, R.. "Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility". Pharmacogenomics Journal 9 5 (2009): 341-346. http://www.scopus.com/inward/record.url?eid=2-s2.0-70349694553&partnerID=MN8TOARS.
    10.1038/tpj.2009.20
  487. Bicho, MC; da Silva, AP; Matos, A; Silva, RM; Bicho, MD. "Sex steroid hormones influence the risk for cervical cancer: modulation by haptoglobin genetic polymorphism". CANCER GENETICS AND CYTOGENETICS (2009):
    10.1016/j.cancergencyto.2009.02.005
  488. Azevedo, A.; Ribeiro, R.; Monteiro, C.; Cunha, V.; Francisco, N.; Fraga, A.; Pina, F.; et al. "Genetic profile of IL-6/IL6R pathway predicts susceptibility, agressiveness and response to hormonal treatment in prostate cancer patients". Ejc Supplements 7 2 (2009): 413-413. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000270645902032&KeyUID=WOS:000270645902032.
    10.1016/s1359-6349(09)71400-4
  489. Catarino, R.; Coelho, A.; Araujo, A.; Nogal, A.; Gomes, M.; Nogueira, A.; Medeiros, R.. "Cyclin D1 and Non-Small cell lung cancer - a role of CCND1 gene variants in lung carcinogenesis". Ejc Supplements 7 2 (2009): 523-523. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000270645902405&KeyUID=WOS:000270645902405.
    10.1016/s1359-6349(09)71773-2
  490. Ribeiro, R.; Azevedo, A.; Francisco, N.; Monteiro, C.; Cunha, V.; Fraga, A.; Pina, F.; et al. "Osteopontin functional genetic polymorphism is associated with prostate cancer biochemical recurrence and androgen independence". Ejc Supplements 7 2 (2009): 413-413. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000270645902033&KeyUID=WOS:000270645902033.
    10.1016/s1359-6349(09)71401-6
  491. Lima, L.; Gomes, A. M.; Ribeiro, R.; Fraga, A.; Pina, F.; Lobo, F.; Calais-da-Silva, F.; Medeiros, R.. "Prostate cancer and apoptosis: An insight of FAS-670A/G polymorphism role in tumor development". Ejc Supplements 7 2 (2009): 115-115. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000270645900385&KeyUID=WOS:000270645900385.
    10.1016/s1359-6349(09)70394-5
  492. Gomes, M.; Coelho, A.; Araujo, A.; Catarino, R.; Nogal, A.; Teixeira, A. L.; Medeiros, R.. "Influence of IL-4-590C/T polymorphism in Non-Small Cell Lung Cancer (NSCLC) susceptibility". Ejc Supplements 7 2 (2009): 114-114. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000270645900382&KeyUID=WOS:000270645900382.
    10.1016/s1359-6349(09)70391-x
  493. Monteiro, C.; Ribeiro, R.; Azevedo, A.; Cunha, V.; Francisco, N.; Fraga, A.; Pina, F.; et al. "Leptin receptor genetic variants are associated with prostate cancer development, aggressiveness and the time to biochemical relapse". Ejc Supplements 7 2 (2009): 412-413. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000270645902031&KeyUID=WOS:000270645902031.
    10.1016/s1359-6349(09)71399-0
  494. Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN. "Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.". (2008): http://europepmc.org/abstract/med/18191900.
    10.1016/j.neuroscience.2007.11.009
  495. Breda E; Catarino R; Coelho A; Sousa H; Medeiros R. "[Nasopharyngeal carcinoma study: introduction and multidisciplinary perspective].". (2008): http://europepmc.org/abstract/med/18674419.
  496. Breda, E.; Catarino, R.; Coelho, A.; Sousa, H.; Medeiros, R.. "[Nasopharyngeal carcinoma study: introduction and multidisciplinary perspective]". Acta Med Port 21 (2008): 273-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18674419.
  497. Sousa, H.; Pinto-Correia, A. L.; Medeiros, R.; Dinis-Ribeiro, M.. "Epstein-Barr virus is associated with gastric carcinoma: the question is what is the significance?". World J Gastroenterol 14 (2008): 4347-51.
  498. Lima, L. C.; Catarino, R. J.; Gomes, M.; Magalhaes, S.; Medeiros, R.; Santos, L.. "CYCLIN D1 AND BLADDER CANCER-CCND1 POLYMORPHISM IN BLADDER CARCINOGENESIS AND BCG IMMUNOTHERAPY". Annals of Oncology 19 (2008): 188-188. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000259973300580&KeyUID=WOS:000259973300580.
  499. Nogal, Aria; Gomes, Monica; Ribeiro, Ricardo; Coelho, Ana; Catarino, Raquel; Medeiros, Rui. "CYP3A4 and CYP3A5 genotypes: Molecular markers for prostate cancer aggressiveness?". Cellular Oncology 30 2 (2008): 151-151. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000254301100115&KeyUID=WOS:000254301100115.
  500. Pereira, A.; Lima, L.; Magalhaees, S.; Santos, L.; Medeiros, R.. "-765G > C COX2 polymorphism and bladder cancer onset: implications for chemoprevention in a Portuguese population". Ejc Supplements 6 12 (2008): 35-36. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000261221200104&KeyUID=WOS:000261221200104.
    10.1016/s1359-6349(08)72038-x
  501. Coelho, A.; Catarino, R. J.; Gomes, M.; Nogal, A.; Araujo, A.; Medeiros, R.. "-592 IL10 POLYMORPHISM AS A PROGNOSTIC FACTOR IN LUNG CANCER PATIENTS". Annals of Oncology 19 (2008): 114-114. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000259973300315&KeyUID=WOS:000259973300315.
  502. Lima, Luis; Morais, Antnio; Lobo, Francisco; Calais da Silva, Fernando Manuel; Calais da Silva, Fernando Eduardo; Medeiros, Rui. "Apoptosis and Fas/FasL pathway: Role of FASL functional polymorphism in prostate cancer development". Cellular Oncology 30 2 (2008): 131-132. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000254301100079&KeyUID=WOS:000254301100079.
  503. Carvalho, R.; Pinheiro, M.F.; Medeiros, R.. "Study of 16 X-STRs in a prostate cancer population sample (preliminary results)". Forensic Science International: Genetics Supplement Series 1 1 (2008): 142-144. http://www.scopus.com/inward/record.url?eid=2-s2.0-50649098046&partnerID=MN8TOARS.
    10.1016/j.fsigss.2007.10.168
  504. Catarino, R.. "Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer". DNA and Cell Biology 27 8 (2008): 415-421. http://www.scopus.com/inward/record.url?eid=2-s2.0-51649092604&partnerID=MN8TOARS.
    10.1089/dna.2008.0744
  505. Costa, S.. "XRCC1 Arg399Gln and RAD51 5'UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients". Breast Cancer Research and Treatment 109 1 (2008): 183-185. http://www.scopus.com/inward/record.url?eid=2-s2.0-42149147370&partnerID=MN8TOARS.
    10.1007/s10549-007-9637-1
  506. Oliveira, S.. "The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: A study in exfoliated cervical cells". Journal of Medical Virology 80 3 (2008): 424-429. http://www.scopus.com/inward/record.url?eid=2-s2.0-38849102428&partnerID=MN8TOARS.
    10.1002/jmv.21103
  507. Pinto-Correia, A.L.. "Overall survival in women with breast cancer: The influence of Pepsinogen C gene polymorphism". DNA and Cell Biology 27 6 (2008): 333-336. http://www.scopus.com/inward/record.url?eid=2-s2.0-45149098701&partnerID=MN8TOARS.
    10.1089/dna.2007.0713
  508. Catarino, R.. "Oncogenic virus-associated neoplasia: A role for cyclin D1 genotypes influencing the age of onset of disease?". Biochemical and Biophysical Research Communications 370 1 (2008): 118-122. http://www.scopus.com/inward/record.url?eid=2-s2.0-41849123799&partnerID=MN8TOARS.
    10.1016/j.bbrc.2008.03.039
  509. Sousa, H.; Pinto-Correia, A. L.; Medeiros, R.; Dinis-Ribeiro, M.. "Epstein-Barr virus is associated with gastric carcinoma: the question is what is the significance?". World J Gastroenterol 14 (2008): 4347-51.
  510. Breda, E.. "Nasopharyngeal carcinoma study: Introduction and multidisciplinary perspective | Estudo do carcinoma de tipo nasofaringeo: Introdução e perspectiva multidisciplinar". Acta Medica Portuguesa 21 1-3 (2008): 273-284. http://www.scopus.com/inward/record.url?eid=2-s2.0-51349083239&partnerID=MN8TOARS.
  511. Teixeira, A.L.. "Genetic polymorphism in EGF Is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients". Clinical Cancer Research 14 11 (2008): 3367-3371. http://www.scopus.com/inward/record.url?eid=2-s2.0-50349084344&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-07-5119
  512. Paiva, M.. "Fc¿RIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients". Cancer Genetics and Cytogenetics 183 1 (2008): 35-40. http://www.scopus.com/inward/record.url?eid=2-s2.0-43149113005&partnerID=MN8TOARS.
    10.1016/j.cancergencyto.2008.02.001
  513. Dias Pereira, P.. "Estrogens metabolism associated with polymorphisms: Influence of COMT G482a genotype on age at onset of canine mammary tumors". Veterinary Pathology 45 2 (2008): 124-130. http://www.scopus.com/inward/record.url?eid=2-s2.0-42449131781&partnerID=MN8TOARS.
    10.1354/vp.45-2-124
  514. Sousa, H.. "Epstein-Barr virus is associated with gastric carcinoma: The question is what is the significance?". World Journal of Gastroenterology 14 27 (2008): 4347-4351. http://www.scopus.com/inward/record.url?eid=2-s2.0-55949084952&partnerID=MN8TOARS.
    10.3748/wjg.14.4347
  515. Costa, S.. "Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer". BMC Cancer 8 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-39849089291&partnerID=MN8TOARS.
    10.1186/1471-2407-8-32
  516. Lima, L.; Morais, A.; Lobo, F.; Calais-da-Silva, F.M.; Calais-da-Silva, F.E.; Medeiros, R.. "Association between FAS polymorphism and prostate cancer development". Prostate Cancer and Prostatic Diseases 11 1 (2008): 94-98. http://www.scopus.com/inward/record.url?eid=2-s2.0-39149123190&partnerID=MN8TOARS.
    10.1038/sj.pcan.4501002
  517. Sousa, H.; Pinto-Correia, A. L.; Medeiros, R.; Dinis-Ribeiro, M.. "Epstein-Barr virus is associated with gastric carcinoma: the question is what is the significance?". World J Gastroenterol 14 (2008): 4347-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18666324.
  518. Sousa H; Santos AM; Pinto D; Medeiros R. "Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations.". (2007): http://europepmc.org/abstract/med/17912468.
  519. Ramada, Diana; MEDEIROS, RUI. "HPV e cancro do colo do útero: Intervenção Urgente". onco.news 2 (2007): 4-7.
    Publicado
  520. Breda E; Catarino R; Azevedo I; Fernandes T; Barreira da Costa C; Medeiros R. "[Characterization of the clinical evolution of nasopharyngeal carcinoma in Portuguese population].". (2007): http://europepmc.org/abstract/med/17498470.
  521. Ribeiro R; Araújo A; Lopes C; Medeiros R. "Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator?". (2007): http://europepmc.org/abstract/med/17410023.
  522. Araújo A; Ribeiro R; Azevedo I; Coelho A; Soares M; Sousa B; Pinto D; et al. "Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.". (2007): http://europepmc.org/abstract/med/17296816.
  523. Breda, E.; Catarino, R.; Azevedo, I.; Fernandes, T.; Barreira da Costa, C.; Medeiros, R.. "[Characterization of the clinical evolution of nasopharyngeal carcinoma in Portuguese population]". Acta Otorrinolaringol Esp 58 (2007): 191-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17498470.
    13102205 [pii]
  524. Breda E; Catarino R; Azevedo I; Fernandes T; Barreira da Costa C; Medeiros R. "[Characterization of the clinical evolution of nasopharyngeal carcinoma in Portuguese population].". (2007): http://europepmc.org/abstract/med/17498470.
  525. Nogal, A.; Coelho, A.; Catarino, R.; Morais, A.; Lobo, F.; Medeiros, R.. "The CYP3A4*1B polymorphism and prostate cancer susceptibility in a Portuguese population". Cancer Genetics and Cytogenetics 177 2 (2007): 149-152. http://www.scopus.com/inward/record.url?eid=2-s2.0-34548473119&partnerID=MN8TOARS.
    10.1016/j.cancergencyto.2007.06.011
  526. Coelho, A.. "The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis". Gynecologic and Obstetric Investigation 64 4 (2007): 208-212. http://www.scopus.com/inward/record.url?eid=2-s2.0-36048932962&partnerID=MN8TOARS.
    10.1159/000106492
  527. Sousa, H.. "Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations". International Journal of Molecular Medicine 20 5 (2007): 731-741. http://www.scopus.com/inward/record.url?eid=2-s2.0-38449109353&partnerID=MN8TOARS.
  528. Costa, S.. "Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer". Cancer Letters 246 1-2 (2007): 324-330. http://www.scopus.com/inward/record.url?eid=2-s2.0-33845623812&partnerID=MN8TOARS.
    10.1016/j.canlet.2006.03.014
  529. Ribeiro, R.; Araujo, A.; Lopes, C.; Medeiros, R.. "Immunoinflammatory mechanisms in lung cancer development: is leptin a mediator?". J Thorac Oncol 2 (2007): 105-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17410023.
    01243894-200702000-00002 [pii]
  530. Sousa, H.; Santos, A. M.; Pinto, D.; Medeiros, R.. "Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations". Int J Mol Med 20 (2007): 731-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17912468.
  531. Rodrigues, C.. "Molecular epidemiology characterization of the urinary excretion of polyomavirus in healthy individuals from Portugal - A southern European population". Journal of Medical Virology 79 8 (2007): 1194-1198. http://www.scopus.com/inward/record.url?eid=2-s2.0-34347361499&partnerID=MN8TOARS.
    10.1002/jmv.20907
  532. Araújo, A.; Ribeiro, R.; Azevedo, I.; Coelho, A.; Soares, M.; Sousa, B.; Pinto, D.; et al. "Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer - A review of the literature". Oncologist 12 2 (2007): 201-210. http://www.scopus.com/inward/record.url?eid=2-s2.0-33847056277&partnerID=MN8TOARS.
    10.1634/theoncologist.12-2-201
  533. Ribeiro, R.. "Immunoinflammatory mechanisms in lung cancer development: Is leptin a mediator?". Journal of Thoracic Oncology 2 2 (2007): 105-108. http://www.scopus.com/inward/record.url?eid=2-s2.0-34247104585&partnerID=MN8TOARS.
  534. Breda E; Catarino R; Azevedo I; Fernandes T; Barreira da Costa C; Medeiros R. "[Characterization of the clinical evolution of nasopharyngeal carcinoma in Portuguese population].". (2007): http://europepmc.org/abstract/med/17498470.
  535. Sousa, H.; Santos, A. M.; Pinto, D.; Medeiros, R.. "Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations". Int J Mol Med 20 (2007): 731-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17912468.
  536. Ribeiro, R.. "EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients". Journal of Neuro-Oncology 81 3 (2007): 225-229. http://www.scopus.com/inward/record.url?eid=2-s2.0-33846553750&partnerID=MN8TOARS.
    10.1007/s11060-006-9224-z
  537. Costa, S.. "DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: A study on a Portuguese population". Breast Cancer Research and Treatment 103 2 (2007): 209-217. http://www.scopus.com/inward/record.url?eid=2-s2.0-34249074107&partnerID=MN8TOARS.
    10.1007/s10549-006-9364-z
  538. Pereira C; Sousa H; Ferreira P; Fragoso M; Moreira-Dias L; Lopes C; Medeiros R; Dinis-Ribeiro M. "-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia.". (2006): http://europepmc.org/abstract/med/17006983.
  539. Pinto-Correia AL; Sousa H; Fragoso M; Moreira-Dias L; Lopes C; Medeiros R; Dinis-Ribeiro M. "Gastric cancer in a Caucasian population: role of pepsinogen C genetic variants.". (2006): http://europepmc.org/abstract/med/16937501.
  540. Santos, A.M.. "TP53 and P21 polymorphisms: Response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer". Biochemical and Biophysical Research Communications 340 1 (2006): 256-262. http://www.scopus.com/inward/record.url?eid=2-s2.0-29244474068&partnerID=MN8TOARS.
    10.1016/j.bbrc.2005.11.176
  541. Ribeiro, R.. "A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer". European Journal of Cancer 42 8 (2006): 1188-1193. http://www.scopus.com/inward/record.url?eid=2-s2.0-33646414773&partnerID=MN8TOARS.
    10.1016/j.ejca.2006.02.004
  542. Pereira, C.. "-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia". World Journal of Gastroenterology 12 34 (2006): 5473-5478. http://www.scopus.com/inward/record.url?eid=2-s2.0-33749371902&partnerID=MN8TOARS.
  543. Ribeiro, R.; Lopes, C.; Medeiros, R.. "The link between obesity and prostate cancer: The leptin pathway and therapeutic perspectives". Prostate Cancer and Prostatic Diseases 9 1 (2006): 19-24. http://www.scopus.com/inward/record.url?eid=2-s2.0-33644887167&partnerID=MN8TOARS.
    10.1038/sj.pcan.4500844
  544. Sousa, H.. "Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development". European Journal of Cancer Prevention 15 4 (2006): 362-366. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745964407&partnerID=MN8TOARS.
    10.1097/00008469-200608000-00010
  545. Pereira, C.; Sousa, H.; Ferreira, P.; Fragoso, M.; Moreira-Dias, L.; Lopes, C.; Medeiros, R.; Dinis-Ribeiro, M.. "-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia". World J Gastroenterol 12 (2006): 5473-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17006983.
  546. Santos, A.M.. "Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer". European Journal of Cancer 42 7 (2006): 958-963. http://www.scopus.com/inward/record.url?eid=2-s2.0-33646172093&partnerID=MN8TOARS.
    10.1016/j.ejca.2006.01.015
  547. Pinto-Correia, A.L.. "Gastric cancer in a Caucasian population: Role of pepsinogen C genetic variants". World Journal of Gastroenterology 12 31 (2006): 5033-5036. http://www.scopus.com/inward/record.url?eid=2-s2.0-33748312255&partnerID=MN8TOARS.
  548. Sousa, H.; Santos, A. M.; Catarino, R.; Pinto, D.; Vasconcelos, A.; Lopes, C.; Breda, E.; Medeiros, R.. "Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development". Eur J Cancer Prev 15 (2006): 362-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16835507.
    00008469-200608000-00010 [pii]
  549. Cardoso, C.S.. "Haemochromatosis gene (HFE) mutations in viral-associated neoplasia: Linkage to cervical cancer". Biochemical and Biophysical Research Communications 341 1 (2006): 232-238. http://www.scopus.com/inward/record.url?eid=2-s2.0-30944448597&partnerID=MN8TOARS.
    10.1016/j.bbrc.2005.12.174
  550. Pereira, C.; Sousa, H.; Ferreira, P.; Fragoso, M.; Moreira-Dias, L.; Lopes, C.; Medeiros, R.; Dinis-Ribeiro, M.. "-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia". World J Gastroenterol 12 (2006): 5473-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17006983.
  551. Pinto-Correia, A. L.; Sousa, H.; Fragoso, M.; Moreira-Dias, L.; Lopes, C.; Medeiros, R.; Dinis-Ribeiro, M.. "Gastric cancer in a Caucasian population: role of pepsinogen C genetic variants". World J Gastroenterol 12 (2006): 5033-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16937501.
  552. Coelho, A.. "CXCL12-3' A polymorphism and lung cancer metastases protection: New perspectives in immunotherapy?". Cancer Immunology, Immunotherapy 55 6 (2006): 639-643. http://www.scopus.com/inward/record.url?eid=2-s2.0-33644591597&partnerID=MN8TOARS.
    10.1007/s00262-005-0062-1
  553. Catarino, R.J.. "Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma". Head and Neck 28 7 (2006): 603-608. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745786796&partnerID=MN8TOARS.
    10.1002/hed.20377
  554. Magro, F.; Cunha, E.; Araujo, F.; Meireles, E.; Pereira, P.; Dinis-Ribeiro, M.; Veloso, F.T.; Medeiros, R.; Soares-Da-Silva, P.. "Dopamine D2receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment". Digestive Diseases and Sciences 51 11 (2006): 2039-2044. http://www.scopus.com/inward/record.url?eid=2-s2.0-33751531923&partnerID=MN8TOARS.
    10.1007/s10620-006-9168-3
  555. Ferreira, P.M.. "Cervical cancer and CYP2E1 polymorphisms: Implications for molecular epidemiology". European Journal of Clinical Pharmacology 62 1 (2006): 15-21. http://www.scopus.com/inward/record.url?eid=2-s2.0-30844456881&partnerID=MN8TOARS.
    10.1007/s00228-005-0066-y
  556. Coelho, AP; Pereira, DP; Catarino, RJ; Nogal, AB; Portela, CM; Medeiros, RM. "CXCL12 chemokine genotypes as predictive biomarkers of ovarian cancer outcome". Annals of Oncology 17 (2006): 44-44. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000237800900082&KeyUID=WOS:000237800900082.
  557. Santos, A.M.. "TP53 codon 72 polymorphism and risk for cervical cancer in Portugal". Cancer Genetics and Cytogenetics 159 2 (2005): 143-147. http://www.scopus.com/inward/record.url?eid=2-s2.0-19344362729&partnerID=MN8TOARS.
    10.1016/j.cancergencyto.2004.10.005
  558. Coelho, A.. "Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma". Gynecologic Oncology 96 3 (2005): 760-764. http://www.scopus.com/inward/record.url?eid=2-s2.0-13844266786&partnerID=MN8TOARS.
    10.1016/j.ygyno.2004.11.028
  559. Matos, A.; Moutinho, J.; Pinto, D.; Medeiros, R.. "The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population". European Journal of Cancer Prevention 14 5 (2005): 485-491. http://www.scopus.com/inward/record.url?eid=2-s2.0-26444545415&partnerID=MN8TOARS.
    10.1097/01.cej.0000174780.44260.32
  560. Pinto, D.. "The influence of HER2 genotypes as molecular markers in ovarian cancer outcome". Biochemical and Biophysical Research Communications 335 4 (2005): 1173-1178. http://www.scopus.com/inward/record.url?eid=2-s2.0-24044527478&partnerID=MN8TOARS.
    10.1016/j.bbrc.2005.08.012
  561. Catarino, R.. "Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism". Cancer Genetics and Cytogenetics 160 1 (2005): 49-54. http://www.scopus.com/inward/record.url?eid=2-s2.0-20444427987&partnerID=MN8TOARS.
    10.1016/j.cancergencyto.2004.11.017
  562. Duarte, I.. "G-308A TNF-a polymorphism is associated with an increased risk of invasive cervical cancer". Biochemical and Biophysical Research Communications 334 2 (2005): 588-592. http://www.scopus.com/inward/record.url?eid=2-s2.0-22144439398&partnerID=MN8TOARS.
    10.1016/j.bbrc.2005.06.137
  563. Medeiros, R.; Prazeres, H.; Pinto, D.; Macedo-Pinto, I.; Lacerda, M.; Lopes, C.; Cruz, E.. "Characterization of HPV genotype profile in squamous cervical lesions in Portugal, a southern European population at high risk of cervical cancer". Eur J Cancer Prev 14 (2005): 467-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16175051.
    00008469-200510000-00004 [pii]
  564. Costa, S.. "Acetylation genotype and the genetic susceptibility to prostate cancer in a Southern European population". Prostate 64 3 (2005): 246-252. http://www.scopus.com/inward/record.url?eid=2-s2.0-22144462833&partnerID=MN8TOARS.
    10.1002/pros.20241
  565. Matos, A.; Moutinho, J.; Pinto, D.; Medeiros, R.. "The influence of smoking and other cofactors on the time to onset to cervical cancer in a southern European population". Eur J Cancer Prev 14 (2005): 485-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16175054.
    00008469-200510000-00007 [pii]
  566. Medeiros, R.; Prazeres, H.; Pinto, D.; Macedo-Pinto, I.; Lacerda, M.; Lopes, C.; Cruz, E.. "Characterization of HPV genotype profile in squamous cervical lesions in Portugal, a southern European population at high risk of cervical cancer". European Journal of Cancer Prevention 14 5 (2005): 467-471. http://www.scopus.com/inward/record.url?eid=2-s2.0-26444584346&partnerID=MN8TOARS.
    10.1097/01.cej.0000178079.29533.1e
  567. Craveiro, R.. "TP73 alterations in cervical carcinoma". Cancer Genetics and Cytogenetics 150 2 (2004): 116-121. http://www.scopus.com/inward/record.url?eid=2-s2.0-11144357830&partnerID=MN8TOARS.
    10.1016/j.cancergencyto.2003.08.020
  568. Medeiros, R.. "Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer". Journal of Pathology 202 3 (2004): 330-335. http://www.scopus.com/inward/record.url?eid=2-s2.0-1542375102&partnerID=MN8TOARS.
    10.1002/path.1529
  569. Ribeiro, R.; Lopes, C.; Medeiros, R.. "Leptin and prostate: Implications for cancer prevention - Overview of genetics and molecular interactions". European Journal of Cancer Prevention 13 5 (2004): 359-368. http://www.scopus.com/inward/record.url?eid=2-s2.0-5044230358&partnerID=MN8TOARS.
    10.1097/00008469-200410000-00002
  570. Ribeiro, R.. "Overexpressing Leptin Genetic Polymorphism (-2548 G/A) Is Associated with Susceptibility to Prostate Cancer and Risk of Advanced Disease". Prostate 59 3 (2004): 268-274. http://www.scopus.com/inward/record.url?eid=2-s2.0-1942507889&partnerID=MN8TOARS.
    10.1002/pros.20004
  571. Medeiros, R.. "Metabolic Susceptibility Genes and Prostate Cancer Risk in a Southern European Population: The Role of Glutathione S-Transferases GSTM1, GSTM3, and GSTT1 Genetic Polymorphisms". Prostate 58 4 (2004): 414-420. http://www.scopus.com/inward/record.url?eid=2-s2.0-1542377512&partnerID=MN8TOARS.
    10.1002/pros.10348
  572. Pinto, D.; Vasconcelos, A.; Costa, S.; Pereira, D.; Rodrigues, H.; Lopes, C.; Medeiros, R.. "HER2 polymorphism and breast cancer risk in Portugal". European Journal of Cancer Prevention 13 3 (2004): 177-181. http://www.scopus.com/inward/record.url?eid=2-s2.0-2942666198&partnerID=MN8TOARS.
    10.1097/01.cej.0000130015.91525.c7
  573. Ribeiro, R.; Lopes, C.; Medeiros, R.. "Leptin and prostate: implications for cancer prevention--overview of genetics and molecular interactions". Eur J Cancer Prev 13 (2004): 359-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15452447.
    00008469-200410000-00002 [pii]
  574. Pinto, D.; Vasconcelos, A.; Costa, S.; Pereira, D.; Rodrigues, H.; Lopes, C.; Medeiros, R.. "HER2 polymorphism and breast cancer risk in Portugal". Eur J Cancer Prev 13 (2004): 177-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15167216.
    00008469-200406000-00005 [pii]
  575. Freitas-Silva, M.. "Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women". Cancer Genetics and Cytogenetics 155 1 (2004): 42-46. http://www.scopus.com/inward/record.url?eid=2-s2.0-7444253343&partnerID=MN8TOARS.
    10.1016/j.cancergencyto.2004.03.020
  576. Medeiros, R.. "Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer". Cancer Genetics and Cytogenetics 141 2 (2003): 91-96. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037373237&partnerID=MN8TOARS.
    10.1016/S0165-4608(02)00660-X
  577. Medeiros, R.. "Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: Glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome". International Journal of Clinical Oncology 8 3 (2003): 156-161. http://www.scopus.com/inward/record.url?eid=2-s2.0-0042305238&partnerID=MN8TOARS.
    10.1007/s10147-003-0318-8
  578. Medeiros, R.; Vasconcelos, A.; Costa, S.; Pinto, D.; Morais, A.; Oliveira, J.; Lopees, C.. "Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer". Cancer Genet Cytogenet 141 (2003): 91-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12606125.
    S016546080200660X [pii]
  579. Medeiros, R.. "Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients". Cancer Letters 189 1 (2003): 85-90. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037427566&partnerID=MN8TOARS.
    10.1016/S0304-3835(02)00118-0
  580. Ferreira, P.M.; Medeiros, R.; Vasconcelos, A.; Costa, S.; Pinto, D.; Morais, A.; Oliveira, J.; Lopes, C.. "Association between CYP2E1 polymorphisms and susceptibility to prostate cancer". European Journal of Cancer Prevention 12 3 (2003): 205-211. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037502788&partnerID=MN8TOARS.
    10.1097/00008469-200306000-00007
  581. Medeiros RM; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Ferreira P; Lopes C. "Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7.". (2002): http://europepmc.org/abstract/med/12429631.
  582. Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C. "The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.". (2002): http://europepmc.org/abstract/med/12181642.
    10.1007/s100380200060
  583. Costa, S.. "A slow acetylator genotype associated with an increased risk of advanced cervical cancer". Journal of Cancer Research and Clinical Oncology 128 12 (2002): 678-682. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036458259&partnerID=MN8TOARS.
    10.1007/s00432-002-0391-9
  584. Vasconcelos, A.; Medeiros, R.; Veiga, I.; Pereira, D.; Carrilho, S.; Palmeira, C.; Azevedo, C.; Lopes, C. S.. "Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: association with lymph node metastasis". Breast J 8 (2002): 226-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12100115.
    tbj08407 [pii]
  585. Medeiros, R.. "The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population". Journal of Human Genetics 47 8 (2002): 413-418. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036336854&partnerID=MN8TOARS.
  586. Medeiros, R.. "Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells". Prostate 53 1 (2002): 88-94. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037106039&partnerID=MN8TOARS.
    10.1002/pros.10135
  587. Medeiros, R.M.. "Outcome in prostate cancer: Association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at Exon 7". Clinical Cancer Research 8 11 (2002): 3433-3437. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036850208&partnerID=MN8TOARS.
  588. Medeiros, R.; Morais, A.; Vasconcelos, A.; Costa, S.; Pinto, D.; Oliveira, J.; Lopes, C.. "Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer". European Journal of Cancer Prevention 11 4 (2002): 343-350. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036685839&partnerID=MN8TOARS.
    10.1097/00008469-200208000-00005
  589. Afonso, N.. "Hepatocellular cancer | Carcinoma hepatocelular". Arquivos de Medicina 16 4-6 (2002): 241-248. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036666946&partnerID=MN8TOARS.
  590. Vasconcelos, A.. "Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: Association with lymph node metastasis". Breast Journal 8 4 (2002): 226-229. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036324563&partnerID=MN8TOARS.
    10.1046/j.1524-4741.2002.08407.x
  591. Pinto, D.. "HLA-DRB1 and susceptibility/ resistence to cervical Neoplasia in Portuguese women". European Journal of Immunogenetics 28 2 (2001): http://www.scopus.com/inward/record.url?eid=2-s2.0-33749100150&partnerID=MN8TOARS.
Edição de número de revista
  1. Dias, Francisca; Teixeira, Ana Luísa; MEDEIROS, RUI. "Special Issue "Noncoding RNAs in Renal Cell Carcinoma Landscape"". Cancers (2021): https://www.mdpi.com/journal/cancers/special_issues/Noncoding_RNAs_RCC.
    Em revisão
  2. Dias, Francisca; Teixeira, Ana Luísa; MEDEIROS, RUI. ""Noncoding RNAs in Renal Cell Carcinoma Landscape"". Cancers (2021): https://www.mdpi.com/journal/cancers/special_issues/Noncoding_RNAs_RCC.
    Publicado
Livro
  1. Gomes, M.; Teixeira, A.L.; Coelho, A.; Araújo, A.; Medeiros, R.. Inflammation and lung cancer: Oxidative stress, ROS, and DNA damage. 2017.
  2. Silva, J.; Cerqueira, F.; Medeiros, R.. Chlamydia silent epidemic disease: From research evidence to prevention. 2014.
  3. Gomes, M.; Teixeira, A.L.; Coelho, A.; Araújo, A.; Medeiros, R.. The role of inflammation in lung cancer. 2014.
    10.1007/978-3-348-837-8_1
  4. Gomes, M.; Teixeira, A.L.; Coelho, A.; Araújo, A.; Medeiros, R.. The role of inflammation in lung cancer. 2014.
    10.1007/978-3-0348-0837-8-1
  5. Silva, J.; Cerqueira, F.; Medeiros, R.. Chlamydia silent epidemic disease: From research evidence to prevention. 2014.
Poster em conferência
  1. Tavares, Inês; Morais, Mariana; Dias, Francisca; Bidarra, Silvia; MEDEIROS, RUI; Teixeira, Ana Luísa. "Extracellular vesicles-derived microRNAs: mediators of enzalutamide resistance in Prostate Cancer". Trabalho apresentado em 1st Young Researchers Symposium - Portuguese Oncology Institute of Oncology of Porto Research Center, 2023.
  2. Venancio, Patricia; Dias, Francisca; MEDEIROS, RUI; Teixeira, Ana Luísa. "Extracellular Vesicles derived-microRNAs and renal cell carcinoma phenotype modulation". Trabalho apresentado em 1st Young Researchers Symposium - Portuguese Oncology Institute of Oncology of Porto Research Center, 2023.
  3. Dias, Francisca; Teixeira, Ana Luísa; Mirjam Mastik; Isabel Vieira; José Silva; Maria Joaquina Maurício; António Joaquim de Pinho Morais; et al. "Plasma EV-derived hsa-miR-4521 as a potential biomarker of clear cell Renal Cell Carcinoma aggressiveness¿". Trabalho apresentado em EACR 2023 Conference, 2023.
  4. Morais, Mariana; Figueiredo, Patrícia; Dias, Francisca; Tavares, Inês; Mikkonen, KS; Teixeira, Ana Luísa; MEDEIROS, RUI. "Caveolae-dependent endocytosis is responsible for the selective effect of Silver Nanoparticles in Prostate Cancer Sensitive and Resistant to Androgen Deprivation Therapy". Trabalho apresentado em EACR 2023 Conference, 2023.
  5. Almeida, Cristina; Teixeira, Ana Luísa; Machado, Vera; Dias, Francisca; MEDEIROS, RUI. "MicroRNA-122-5p inhibits cell proliferation of colorectal cancer cells through downregulation of LAT1 and ASCT2". Trabalho apresentado em 4th National Meeting of Young Investigators in Oncology, 2022.
  6. Medeiros-Fonseca, B; Pires, Maria João; MEDEIROS, RUI; Rui Miguel Gil da Costa Oliveira; Paula Alexandra Martins de Oliveira. "APLICAÇÃO DA ESCALA MOUSE GRIMACE EM MURGANHOS K14HPV16 DURANTE A EXPOSIÇÃO À INFUSÃO DE LÚCIA-LIMA". Trabalho apresentado em XIV Jornadas de Bioquímica, 2022.
  7. Almeida, Cristina; Dias, Francisca; Machado, Vera; Carlos Palmeira; Gabriela Martins; Costa-Silva, Bruno; Ana Luísa Teixeira; MEDEIROS, RUI. "LAT1 mRNA as a potential therapeutic target in colorectal cancer". Trabalho apresentado em 3rd National Meeting of Young Investigators in Oncology, 2021.
  8. Almeida, Cristina; Dias, Francisca; Machado, Vera; Palmeira, Carlos; Martins, Gabriela; Costa-Silva, Bruno; Teixeira, Ana Luísa; MEDEIROS, RUI. "LAT1 mRNA como potencial alvo terapêutico no cancro colorretal". Trabalho apresentado em 3º Encontro Nacional de Jovens Investigadores em Oncologia, 2021.
  9. Morais, Mariana; Machado, Vera; Figueiredo, Patrícia; Dias, Francisca; Mikkonen, KS; Teixeira, Ana Luísa; MEDEIROS, RUI. "Nanopartículas de prata funcionalizadas com glucose como potenciais agentes terapêuticos em Cancro de Próstata resistente à Terapia de Bloqueio Androgénico". Trabalho apresentado em 3º Encontro Nacional de Jovens Investigadores em Oncologia, 2021.
  10. Tavares, Inês ; Morais, Mariana; Dias, Francisca; Teixeira, Ana Luísa; MEDEIROS, RUI. "O efeito de Warburg no processo de aquisição de resistência à Terapia de Bloqueio Androgénico". Trabalho apresentado em 3º Encontro Nacional de Jovens Investigadores em Oncologia, 2021.
  11. Almeida, Cristina; Dias, Francisca; Teixeira, Ana Luísa; Machado, Vera; Palmeira, Carlos; Martins, Gabriela; MEDEIROS, RUI. "LAT1 mRNA derived from extracellular vesicles of colorectal cancer alter the phenotype of recipient cells". Trabalho apresentado em 1st Meeting of the Portuguese Network on Extracellular vesicles, 2021.
  12. Medeiros-Fonseca, B; Olga Segurado; Diana Costa; Catarina Medeiros; MEDEIROS, RUI; Pires, Maria João; BASTOS, MARGARIDA M.S.M.; et al. "Efeito da aplicação repetida de Cytinus hypocistis em murganhos transgénicos (K14HPV16): avaliação de humane endpoints.". 2021.
  13. Almeida, Cristina; Teixeira, Ana Luísa; Dias, Francisca; Nogueira, Inês; Machado, Vera; Barbosa, Inês; Palmeira, Carlos; Martins, Gabriela; MEDEIROS, RUI. "Influência de mRNA LAT1 derivado de vesículas extracelulares na progressão do cancro colorretal". Trabalho apresentado em 2º Encontro Nacional de Jovens Investigadores em Oncologia., 2020.
  14. Timóteo, Mafalda; Ribeiro, Joana; Malta, Mariana; Medeiros, Rui; Sousa, Hugo; Malta, Mariana D.; MEDEIROS, RUI. "MDM2 REGULATION OF P53 IN EPSTEIN-BARR VIRUS ASSOCIATED GASTRIC CANCER (PRELIMINAR STUDY)". Trabalho apresentado em 22nd European Society for Clinical Virology's Annual Meeting, 2019.
  15. Timóteo, Mafalda; Ribeiro, Joana; Malta, Mariana D.; MEDEIROS, RUI; Sousa, Hugo. "MDM2 Regulation of p53 in Epstein-Barr associated Gastric Cancer (preliminary study).". Trabalho apresentado em 22nd European Society for Clinical Virology's Annual Meeting, 2019.
  16. Malta, Mariana D.; Ribeiro, Joana; Monteiro, Paula; Loureiro, Joana; MEDEIROS, RUI; Sousa, Hugo. "Let-7c is a candidate biomarker for HPV-associated cervical intraepithelial lesions.". Trabalho apresentado em 30th International Papillomavirus Conference, 2015.
Pré-impressão
  1. Silva, Jani; Cerqueira, Fátima; Teixeira, Ana Luísa; Campainha, Rui; Amorim, José; Medeiros, R.. "Prevalence of Neisseria gonorrhoeae and Trichomonas vaginalis in portuguese women of childbearing age". 2021. http://hdl.handle.net/10284/10172.
    10.1080/01443615.2020.1736014
Resumo em conferência
  1. Kochuparambil, ST; Zhang, BY; Riska, SM; Mahoney, DW; McDonnell, S; Lee, AM; Quevedo, F; et al. "Association of germline variation with androgen ablation (AA) failure in advanced hormone-sensitive prostate cancer (HSPC).". 2015.
  2. Zhang, BYM; Riska, SM; Mahoney, DW; Teixeira Ribeiro, RJT; Medeiros, R; Monteiro, C; Cerhan, JR; et al. "Variation in TRMT11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (CRPC) patients.". 2015.
  3. Lima, A; Azevedo, AR; Sousa, H; Bernardes, M; Medeiros, R; Seabra, V. "SLC19A1, SLCO1B1 AND ABCG2 POLYMORPHISMS ARE ASSOCIATED WITH METHOTREXATE-RELATED GASTROINTESTINAL TOXICITY IN PORTUGUESE RHEUMATOID ARTHRITIS PATIENTS". 2014.
    10.1136/annrheumdis-2014-eular.4711
  4. Oliveira, A; Dinis Oliveira, RJ; Pinho, PG; Remiao, F; Carvalho, F; Medeiros, R. "Quantification of morphine and metabolites in antemortem and postmortem human samples". 2012.
    10.1016/j.toxlet.2012.03.551
  5. Ramada, Diana; MEDEIROS, RUI. "Does university students knowledge influence hpv vaccination? Implications in health care programs". Trabalho apresentado em Eurogin 2011, Lisboa, 2011.
    Publicado
  6. Pereira, AC; Sousa, H; Pinto Correia, AL; Teixeira, AL; Fragoso, M; Moreira Dias, L; Medeiros, R; Dinis Ribeiro, M. "Gastric adenocarcinoma development in patients with atrophy or/and intestinal metaplasia: the role of COX-2 polymorphisms in a Northern Portuguese population". 2010.
    10.1016/s1359-6349(10)70918-6
  7. Pereira, C; Pimentel Nunes, P; Brandao, C; Moreira Dias, L; Medeiros, RM; Dinis Ribeiro, MJ. "COX-2 Polymorphisms in Colorectal Carcinogenesis: A Strategy for Individualized Chemoprevention". 2009.
    10.1016/s0016-5085(09)62074-6
  8. Pinto, D; Faustino, C; Pinto Correia, AL; Ferreira, P; Machado, M; Raimundo, AC; Fragoso, RM; Medeiros, R. "INFLUENCE OF GSTT1 GENOTYPES IN THE SURVIVAL OF WOMEN WITH METASTATIC GASTRIC CANCER". 2008.
  9. Pinto Correia, AL; Parente, M; Pinto, D; Pereira, D; Couto, R; Sousa, B; Medeiros, R. "PEPSINOGEN C POLYMORPHISM IS ASSOCIATED WITH OVARIAN CANCER RISK IN A SOUTHERN EUROPEAN POPULATION". 2008.
  10. Teixeira, A; Ribeiro, R; Coelho, A; Araujo, A; Medeiros, R. "TGFB1 +29T > C genetic polymorphism is associated with non-small cell lung cancer". 2008.
  11. Oliveira, S; Sousa, H; Pinto, D; Pinto Correia, AL; Moutinho, J; Medeiros, R. "The influence of the Ataxia-Telangiectasia mutated G5557A polymorphism on cervical cancer development". 2008.
    10.1016/S1359-6349(08)71368-5
  12. Azevedo, A; Ribeiro, R; Fraga, A; Pina, F; Lobo, F; Morais, A; da Silva, FEC; da Silva, FMC; Medeiros, R. "Interleukin-6 functional polymorphism influences susceptibility and has a predictive factor in prostate cancer patients receiving androgen blockade therapy". 2008.
    10.1016/S1359-6349(08)71346-6
  13. Ribeiro, R; Teixeira, AL; Pinto, D; Pereira, D; Medeiros, R. "Functional genetic polymorphisms in the leptin pathway are associated with progression free interval and overall survival in ovarian cancer patients". 2008.
    10.1016/s1359-6349(08)71568-4
  14. Lima, A; Araujo, A; Coelho, A; Ribeiro, R; Seabra, V; Medeiros, R. "Thymidylate synthase genotypes as a prognostic factor in non-small cell lung cancer patients". 2008.
    10.1016/S1359-6349(08)71567-2
  15. Oliveira, S; Sousa, H; Pinto, D; Pinto Correia, AL; Moutinho, J; Medeiros, R. "THE ROLE OF P53BP1 C1236G POLYMORPHISM ON CERVICAL CANCER DEVELOPMENT". 2008.
  16. Lima, AN; Araujo, A; Coelho, A; Seabra, V; Medeiros, R. "Thymidylate synthase gene polymorphosms and lung cancer susceptibility". 2008.
    10.1200/jco.2008.26.15_suppl.22168
  17. Teixeira, AL; Ribeiro, R; Morajs, A; Lobo, F; Fraga, A; Calais Da Silva, FM; Calais Da Silva, FE; Pina, F; Medeiros, R. "Proliferative/angiogenic genetic profile is associated with progression-free-interval in androgen blockade treated prostate cancer patients". 2008.
    10.1016/S1359-6349(08)71763-4
  18. Rodrigues, C; Pinto, D; Catarino, R; Pereira, D; Moutinho, J; Medeiros, R. "Genetic background and cervical development: the influence of cytochromes P4501ID6 genotypes". 2007.
    10.1016/s1359-6349(07)70369-5
  19. Dinis Ribeiro, M; Sousa, H; Oliveira, S; Pinto Correia, AL; Faustino, C; Perreira, P; Fragoso, M; Medeiros, R. "P53 codon 72 PRO/PRO genotype is a genetic susceptibility maker for gastric adenocarcinoma development". 2007.
    10.1016/s1359-6349(07)70360-9
  20. Teixeira, AL; Ribeiro, R; Cardoso, D; Pinto, D; Morais, A; Lobo, F; Calais da Silva, FM; Calais da Silva, FE; Medeiros, R. "Epidermal growth factor (EGF)+61 A/G functional genetic polymorphism influences disease-free interval in androgen blockade treated prostate cancer patients". 2007.
    10.1016/S1359-6349(07)70448-2
  21. Correia, AP; Pinto, D; Pereira, D; Rodrigues, H; de Sousa, JA; Sousa, H; Sousa, B; et al. "Pepsinogen C gene polymorphism and breast cancer: Influence on the overall survival". 2007.
  22. Craveiro, R; Pinto, D; Bravo, I; Catarino, R; Pereira, D; Matos, A; Pereira, H; Medeiros, R. "TP73 polymorphism in cervical cancer". 2007.
    10.1016/S1359-6349(07)70349-X
  23. Pinto, D; Faustino, C; Ferreira, P; Teixeira, AL; Pinto Correia, AL; Sousa, H; Dinis Ribeiro, M; Fragoso, M; Medeiros, R. "HER2 polymorphism is associated with gastric cancer risk". 2007.
    10.1016/s1359-6349(07)70344-0
  24. Araujo, A; Araujo, AP; Teixeira, AL; Coelho, A; Ribeiro, R; Azevedo, I; Catarino, R; et al. "Genetic polymorphism of the epidermal growth factor gene-value for the treatment of non-small cell lung cancer (NSCLC)". 2007.
    10.1016/S1359-6349(07)71369-1
  25. Nogal, A; Coelho, A; Araujo, A; Catarino, R; Medeiros, R. "CYP3A5 polymorphism and NSCLC - a role for genetic variation as a protective factor in lung cancer susceptibility". 2007.
    10.1016/s1359-6349(07)71364-2
  26. Sousa, H; Breda, E; Catarino, R; Pinto, D; Canedo, R; Machado, JC; Medeiros, R. "-308G > A TNF-alpha polymorphism is a genetic susceptibility marker for nasopharyngeal carcinoma development". 2007.
    10.1016/s1359-6349(07)70359-2
  27. Ferreira, M; Catarino, R; Sousa, A; Rodrigues, H; Medeiros, R. "Quantification of free circulating tumor DNA in plasma as a diagnostic marker for breast cancer". 2007.
    10.1016/s1359-6349(07)70762-0
  28. Lima, L; Morais, A; Lobo, F; Calais da Silva, FM; Calais da Silva, FE; Santos, L; Medeiros, R. "Apoptosis in Bladder and prostate cancer: The role of FAS and FASL polymorphisms". 2007.
    10.1016/s1359-6349(07)70475-5
  29. Bravo, I; Craveiro, R; Salgado, L; Carvalho, L; Catarino, R; Pereira, H; Medeiros, R. "TP21 genetic polymorphism in cervical cancer and radiotherapy response". 2007.
    10.1016/S1359-6349(07)71196-5
  30. Pereira, C; Pinto, D; Catarino, R; Nogal, A; Pereira, D; Sousa, B; Medeiros, R. "COX-2 polymorphism and susceptibility to gynaecological malignancies: -765C allele confers increased risk for ovarian cancer". 2007.
    10.1016/S1359-6349(07)71183-7
  31. Catarino, RJ; Araujo, A; Coelho, A; Nogal, A; Medeiros, R. "Cyclin D1 and non-small cell lung cancer - A role of CCND1 polymorphism in NSCLC carcinogenesis". 2007.
  32. Calais Da Silva, FM; Sousa, H; Coelho, A; Calais Da Silva, FE; Medeiros, R. "The relationship between biochemical failure and TP53 genetic polymorphism in patient with prostate cancer". 2007.
    10.1016/S1569-9056(07)60669-1
  33. Nogal, AB; Coelho, A; Pereira, D; Catarino, R; Pinto, D; Sousa, H; Lopes, C; Medeiros, R; Dinis, J. "CYP3A4 genotypes as predictive biomarkers of ovarian cancer outcome". 2006.
  34. Coelho, AP; Pereira, DP; Catarino, RJ; Nogal, AB; Portela, CM; Medeiros, RM. "CXCL12 chemokine genotypes as predictive biomarkers of non-small-cell lung cancer outcome". 2006.
  35. Portela, C; Pinto, D; Pereira, D; Afonso, N; Leal da Silva, J; Medeiros, R. "GSTM1 genotypes as predictive biomarkers in ovarian cancer". 2005.
  36. Catarino, R; Pereira, D; Pinto, D; Matos, A; Craveiro, R; Lopes, C; Medeiros, R. "Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism". 2005.
  37. Rodrigues, C; Pinto, D; Sousa, S; Catarinol, R; Leal da Silva, J; Lopes, C; Rodrigues, H; Medeiros, R. "Cytochromes P450IID6 genotypes and its influence on the behavior of breast cancer in women under forty years". 2005.
  38. Costa, S; Pinto, D; Pereira, D; Rodrigues, H; Carvalho, S; Portela, C; Medeiros, R; Schmitt, F. "Importance of XRCC1 Arg399GIn polymorphism in the development of breast carcinoma in women with and without breast cancer family history". 2005.
  39. Coelho, A; Calgada, C; Catarino, R; Pinto, D; Fonseca, G; Araujo, A; Medeiros, R. "CXCL12-3'A polymorphism and Lung Cancer metastases protection: new perspectives in immunotherapy?". 2005.
  40. Costa, M; Ferreira, P; Catarino, R; Pereira, D; Matos, A; Coelho, A; Lopes, C; Medeiros, R. "CYP2E1 polymorphism and susceptibility to cervical cancer". 2005.
  41. Ribeiro, R; Araujo, AP; Catarino, R; Pinto, D; Araujo, A; Calcada, C; Medeiros, R. "Increased risk for non-small cell lung cancer in carriers of a genetic functional variant in leptin gene". 2005.
  42. Pinto, D; Vasconcelos, A; Costa, S; Pereira, D; Rodrigues, H; Lopes, C; Medeiros, R. "HER2 polymorphism and the risk of breast and ovarian cancer". 2004.
    10.1016/s1359-6349(04)90770-7
Tese / Dissertação
  1. Abreu, Bárbara Sofia de Oliveira. "Anorexia associada ao cancro". Mestrado, 2017. http://hdl.handle.net/10284/6632.
  2. Cunha, João Miguel Figueiredo da. "Pesquisa de poliomavírus em amostras cervicovaginais". Mestrado, 2017. http://hdl.handle.net/10284/6577.
  3. Breda, Eduardo Luís Fernandes Ribeiro. "Carcinoma da nasofaringe: aspectos epidemiológicos clínicos e moleculares". Doutoramento, 2011. http://hdl.handle.net/10773/3948.
  4. Campos, Carla Manuela Moutinho Silva. "Detecção molecular de Pneumocystis jirovecii no doente imunodeprimido". Mestrado, 2009. http://hdl.handle.net/10773/856.
  5. Fernandes, Isabel Oliveira. "Importância do gene CARD15 no desenvolvimento de doenças prostáticas". Mestrado, 2008. http://hdl.handle.net/10773/815.
  6. Rodrigues, Carla Andrade. "Detecção e caracterização molecular do poliomavírus em transplantados". Mestrado, 2006. http://hdl.handle.net/10773/717.
  7. Catarino, Raquel Jorge Ferreira. "Polimorfismo no gene da Ciclina D1 em neoplasias associadas a vírus". Mestrado, 2005. http://hdl.handle.net/1822/3468.

Outros

Outra produção
  1. The history of cancer pain and bone-targeted agents: 10 most commonly asked questions. 2019. Pereira Vieira, CMP; Fragoso, M; Ferreira, M; Pereira, FF; Pereira, D; Medeiros, R.
    10.2147/cmar.s174731
  2. Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice. 2017. Faculdade de Engenharia. http://hdl.handle.net/10216/104673.
  3. The Role of Inflammation in Lung Cancer. 2014. Mónica Gomes; Ana Luísa Teixeira; Ana Coelho; António Araújo; Rui Medeiros. http://dx.doi.org/10.1007/978-3-0348-0837-8_1.
    10.1007/978-3-0348-0837-8_1
  4. Genetic Profile and Cancer-Related Pain: A Tale from Two Outlier Cases with Bone Metastatic Disease. 2014. Ana Oliveira; Ricardo Jorge Dinis Oliveira; Augusto Nogueira; Azevedo, AS; Ferraz Goncalves; Paula Silva; Felix Carvalho; Rui Medeiros. https://hdl.handle.net/10216/102894.
    10.1111/pme.12314
  5. The impact of GGH -401C>T polymorphism on cisplatin-based chemoradiotherapy response and survival in cervical cancer. Aims: Cervical cancer is the third most frequent cancer in women worldwide, mostly treated with cisplatin-based chemoradiotherapy. Since it is known that folate metabolism might interfere with cisplatin effectiveness, we intended to study the influence of the Gamma Glutamyl Hydrolase -401C > T polymorphism in treatment response in cervical cancer. Methods: We retrospectively reviewed the clinical. 2013. Silva, Inês Hilário; Silva, Cristina Nogueira; Figueiredo, Tiago; Lombo, Liliana; Faustino, Ilda; Catarino, Raquel; Nogueira, Augusto; Pereira, Deolinda; Medeiros, Rui. http://hdl.handle.net/1822/28252.
    10.1016/j.gene.2012.10.038
  6. The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Non-Hodgkin lymphoma (NHL) has been associated with immunological defects, chronic inflammatory and autoimmune conditions. Given the link between immune dysfunction and NHL, genetic variants in toll-like receptors (TLRs) have been regarded as potential predictive factors of susceptibility to NHL. Adequate anti-tumoral responses are known to depend on TLR9 function, such that the use of its synthet. 2012. Carvalho, Agostinho; Cunha, Cristina; Almeida, A. J.; Osório, Nuno S.; Saraiva, Margarida; Coelho, Maria Teixeira; Pedreiro, Susana; et al. http://hdl.handle.net/1822/23858.
    10.1038/gene.2011.59
  7. Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro. Background - Obesity is associated with prostate cancer aggressiveness and mortality. The contribution of periprostatic adipose tissue, which is often infiltrated by malignant cells, to cancer progression is largely unknown. Thus, this study aimed to determine if periprostatic adipose tissue is linked with aggressive tumor biology in prostate cancer. Methods - Supernatants of whole adipose tissue. 2012. Ribeiro, Ricardo; Monteiro, Cátia; Cunha, Virgínia; Oliveira, Maria José; Freitas, Mariana; Fraga, Avelino; Príncipe, Paulo; et al. http://hdl.handle.net/10316/20208.
Atividades

Orientação

Título / Tema
Papel desempenhado
Curso (Tipo)
Instituição / Organização
2023/11/16 - Atual MicroRNAs immune response profile to COVID-19 vaccine boost in cancer patients under active treatment
Orientador de Tânia Rolo Dias
Phd in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/10/11 - Atual From genomics to proteomics: introducing a panel of venous thromboembolism-related biomarkers for prognosis assessment of ovarian cancer patients
Orientador de Valéria Delgado Tavares
PhD in Pathology and Molecular Genetics (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020/11/20 - Atual Genomic Profile of Athletes and Former Athletes of High Sports Performance
Orientador de Hugo Henrique Santos Silva
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019/11/10 - Atual Silver nanoparticles meet prostate cancer cells: nanomedicine applied to treatment optimization and its effects on microRNA's dynamic
Orientador de Mariana Gomes Morais
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/01/01 - 2023/03/04 The Role of the Renin-Angiotensin-aldosterone System and hypoxia in lung cancer Progression
Orientador de Maria Joana Pereira Catarata
PhD in Pharmacology and Clinic and Experimental Toxicology, FMUP-UPorto (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2018/01/01 - 2023/01/18 Decoding the role and potential applications of microRNAs and inflammation in HPV-induced carcinogenesis and cancer cachexia
Orientador de Joana Oliveira Santos
PhD in Biomedicine (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2018/01/01 - 2022/09/26 Non-coding RNAs as prognostic biomarkers in Non-Hodgkin Lymphoma: Predictive biomarkers towards precision medicine
Orientador de Mara Fernandes
PhD in Biomedicine (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2017/01/01 - 2020/12/09 Pharmacogemonic Determinants as predictors of therapeutic response in patients with cervical cancer Identificação de determinantes farmacogenómicas preditivas de resposta ao tratamento em doentes com cancro do cólo do útero
Orientador de Augusto José André Nogueira
PhD in Biomedicine (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2017/01/01 - 2020/07/16 Synergic effect of microRNAs and metalloproteinases derived from extracellular vesicles in the establishment of the metastatic niche in renal cancer
Orientador de Francisca Guilherme Carvalho Dias
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015/01/01 - 2019/10/14 Pharmacogenomic profile of ovarian cancer patients submitted to taxane-based chemotherapy
Orientador de Joana Isabel Gomes Assis
PhD in Biomedicine (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2015/01/01 - 2019/07/19 Genetic polymorphisms - An approach to canine mammary tumors
Coorientador de Ana Maria Canadas Pereira de Sousa
PhD in Pathology and Molecular Genetics (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014/01/01 - 2019/07/09 Characterization of Pain and Genetic Variants Associated with Pain in Patients with Metastatic Bone Disease
Orientador de Cláudia Margarida Pereira Vieira
PhD in Medicine and Molecular Oncology (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2015/01/01 - 2019/02/05 Anal squamous intraepithelial lesions
Orientador de Andreia Fernanda de Albuquerque Dias
PhD in Medicine and Molecular Oncology (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2015/01/01 - 2019/01/09 Epstein-Barr virus and development of PTLD in hematopoietic stem cell transplant recipients: viral activity and host susceptibility
Coorientador de Joana Sousa Gonçalves de Marinho Dias
PhD in Pathology and Molecular Genetics (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013/01/01 - 2017/12/18 Molecular study of inflamatory profile linked to the development and behaviour of lung cancer: Molecular epidemiology and Phatmacogenomics Estudo molecular de um perfil de medidores inflamatórios associados ao desenvolvimento e comportamento de cancro do pulmão: epidemiologia molecular e farmacogenómica
Orientador de Mónica Patrícia Silva Gomes
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014/01/01 - 2017/12/11 Sexually transmited infections in women of reproductive age: epidemiology, risk factors and genetic susceptibility profile
Orientador de Jani Viviana Alves Vital da Silva
PhD in Biomedicine (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2013/01/01 - 2017/07/10 Ovarian cancer: GST polimorphisms and impact on yjerapy-from clinical to molecular biology. Carcinoma do ovário: polimorfismos das glutationas S-transferase e implicações nas opções terapêuticas - da clínica à biologia molecular
Orientador de Maria Deolinda Paulino Pereira de Sousa Pereira
PhD in Medical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2012/01/01 - 2016/10/20 Pharmacogenomics of antidepressants response in major depressive disorder
Orientador de Marlene Elisabete Moreira dos Santos Lima
PhD in Biomedicine (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2011/01/01 - 2016/10/17 Hypoxia biomarkers in prostate cancer: from genetic polymorphisms to intratumoral protein expression
Orientador de Avelino Manuel Fraga Ferreira
PhD in Medical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2012/01/01 - 2016/09/26 Angiopoietin-2 and VEGF in non-small cell lung cancer prognosis: can vessel co-option have a role here?
Orientador de Ana Luísa Pequeno Coelho
PhD in Biomedicine (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2012/01/01 - 2016/05/31 Phenotipic Relevance of MDR genetic polymorphisms in hematologic diseases
Orientador de Ana Isabel Vieira do Espírito Santo
PhD in Medicine and Molecular Oncology (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2012/01/01 - 2015/12/14 Aplication of Autosomal SNPs Study to Forensic Cases. Aplicação da Análise de SNPs Autossómicos à Resolução de Casos Forenses
Orientador de Maria de Lurdes Pontes Rebelo
PhD in Forensic Sciences (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2010/01/01 - 2014/11/03 Proteomic Characterization of Lung Cancer and Chronic Obstructive Pulmonary Disease.
Orientador de Ana Barbosa de Sousa Nogal
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2009/01/01 - 2014/10/06 Role of Polymorphisms in Prostaglandin E2 (PGE2) pathway genes in Colorectal Carcinogen-esis.
Coorientador de Ana Carina Martins Pereira
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2011/01/01 - 2014/09/10 Methotrexate Pharmacogenomics and Predictors of Therapeutic Outcome in Rheumatoid Ar-thritis
Orientador de Aurea Rosa Nunes Pereira Lima
PhD in Medical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2010/01/01 - 2014/07/26 Signalling Pathways EGF/EGFR-HER2 e TGFß1/TGFßRII and the development of urologic cancer: Molecular Epidemiology and Pharmacogenomics
Orientador de Ana Luisa Pereira Teixeira
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2009/01 - 2014/03/21 Predictive Factors and the response to BCG intravesical therapeutics
Coorientador de Luís Carlos Oliveira Lima
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2010/01/01 - 2014/03/03 Study of Genetic Factors Involved in Pain Perception and Morphine Analgesia in Cancer-Related Pain
Orientador de Ana Elisabete Pereira Correia de Oliveira
PhD in Pharmaceutical Sciences (Doutoramento)
Universidade do Porto Faculdade de Farmácia, Portugal
2008/01/01 - 2012/07/01 Obesity and Prostate Cancer: epidemiology, genetics and molecular and cellular mechanisms
Orientador de Ricardo Jorge Teixeira Ribeiro
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2008/01/01 - 2011/11/15 Pharmacogenomic Profile and Solid Tumors
Orientador de Raquel Jorge Ferreira Catarino
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2008/01/01 - 2011/09/30 Oncovirogenomics: Genetics susceptibility to viral associated neoplasias
Orientador de Hugo Manuel Lopes de Sousa
PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2008/01/01 - 2011/07/01 Biomarkers and Cofactors on Cervical Cancer
Orientador de Maria Clara Gomes da Fonseca Pedro Bicho
PhD in Medical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2007/01/01 - 2011/01/31 Nasopharyngeal Carcinoma: Epidemiology, Clinical Perspective and Molecular Biology
Orientador de Eduardo Luís Fernandes Ribeiro Breda
PhD in Biomedical Sciences (Doutoramento)
Universidade de Aveiro Escola Superior de Saúde de Aveiro, Portugal
2007/01/01 - 2010/12/03 From selection of patients with non-small-cell lung cancer to the cost of treatment in Portugal: eval-uation of second and third lines treatment
Orientador de António Manuel Ferreira Araujo
PhD in Medical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2007/01/01 - 2010/04/01 Genetic Study of Breast cancer in Dogs
Coorientador
PhD in Veterinary Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Distinções

Prémio

2011 Sanofi-Aventis SPO-National Oncology Award
Sociedade Portuguesa Oncologia, Portugal
2010 Astrazeneca Foundation Prize Research Found 2010
Astrazeneca Foundation, Bélgica
2009 European Cervical Cancer Prevention Award- (European parliament/ECCA)
European parliament PPCA/ECCA, Bélgica
2008 Prémio Sociedade Portuguesa de Oncologia-Melhor Trabalho de Investigação em Oncologia Sanofi A
Sociedade Portuguesa Oncologia, Portugal
2006 Prémio Jornadas de Oncologia Médica (melhor trabalho científico-Poster)
Jornadas Nacionais de Oncologia Médica, Portugal
2006 Prémio Jornadas de Oncologia Médica (melhor trabalho científico-comunicação)
Jornadas Nacionais de Oncologia Médica, Portugal
2005 Prémio Nacional de Oncologia
Sociedade Portuguesa Oncologia, Portugal
2005 Prémio Universidade de Coimbra/BluePharma-Ciências da Saúde
Universidade de Coimbra, Portugal
2005 Yamanouchi European Foundation Award
Astellas Yamanouchi European Foundation, Reino Unido
2004 Prémio Nacional Labmed 2003-Menção Honrosa
LABMED Saude, Portugal
2004 Prémio “Silva Araujo” das XVI Jornadas de Terapêutica
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2003 Melhor trabalho em Poster
Sociedade Portuguesa de Senologia, Portugal
2002 Melhor comunicação oral
Sociedade Portuguesa de Ginecologia, Portugal
2001 Melhor trabalho em poster
Jornadas Nacionais de Oncologia Médica, Portugal
2001 Primeiro Prémio
Secção de Colposcopia e Patologia Cervico-Vulvo-Vaginal-SPG, Portugal
2001 Prémio Nacional de Ginecologia-2001-Menção Honrosa
Sociedade Portuguesa de Ginecologia, Portugal
2001 Primeiro prémio SPPV 2001
SPPV - HPV Portugal, Sociedade Portuguesa de Papilomavirus, Portugal
1999 Prémio Nacional da Sociedade Portuguesa de Genética Humana 1999
Sociedade Portuguesa de Genetica Humana, Portugal
1999 Prémio de Melhor Póster- VIII Congresso Português de Ginecologia
Sociedade Portuguesa de Ginecologia, Portugal
1999 Melhor trabalho apresentado
Simpósio Internacional de Papilomavirus Humano, Portugal
1999 Prémio Nacional de Ginecologia-1999-Menção Honrosa
Sociedade Portuguesa de Ginecologia, Portugal
1998 Prémio de Investigação em Oncologia
Fundação Rotária Portuguesa, Portugal